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SUMMARY IN FRENCH 
 
La dégénérescence valvulaire mitrale (MVD) représente 75 à 80% des cardiopathies dans l'espèce 
canine. Les chiens de petit format, très populaires en France et en particulier en région urbaine, y 
sont malheureusement prédisposés. La MVD se caractérise par une dégénérescence et une 
malposition des feuillets mitraux, ayant pour conséquence une régurgitation mitrale (RM) plus ou 
moins importante. Une RM grave entraine au long court une dilatation des cavités cardiaques 
(atriale puis ventriculaire) ainsi qu’une augmentation de la pression dans les capillaires 
pulmonaires conduisant vers l’insuffisance cardiaque congestive (ICC). Les animaux atteints de 
MVD peuvent rester asymptomatiques pendant une très longue période, mais l’apparition de 
symptômes d’ICC tels que toux, dyspnée et intolérance à l’effort ou de complications extra-
cardiaques telle que l’insuffisance rénale, peut conduire au décès de l’animal. Les techniques 
d’imagerie ultrasonore comme l’échocardiographie conventionnelle et le Doppler sont les 
examens de choix pour diagnostiquer la MVD, évaluer la gravité de la RM et ses conséquences 
sur la morphologie et la fonction cardiaques. De plus, certaines variables échocardiographiques 
(diamètre atrial gauche, onde proto-diastolique mitrale par exemple) sont significativement 
corrélées au stade clinique de la maladie. En effet, ces variables permettent d’obtenir des 
informations précises sur le pronostic de la maladie à court et long terme, seules ou en 
combinaison avec des biomarqueurs circulants, comme les peptides natriurétiques ou encore 
certaines variables biochimiques évaluées en routine, comme la créatinine par exemple. En 
médecine, toute valeur obtenue à la suite d’un examen complémentaire réalisé chez un sujet 
malade doit être comparée à des valeurs de référence établies chez des sujets sains. En effet, le 
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but est de déterminer si la valeur observée par le clinicien chez un patient peut être considérée 
normale ou non. Ce concept d’intervalle de référence (IR) a été introduit en médecine humaine 
dans les années 60 et suivi par l’élaboration de recommandations spécifiques concernant 
l’établissement de ces IR par des experts de l’International Federation of Clinical Chemistry-
Clinical Laboratory and Standard Institute (IFCC-CLSI). En biologie clinique vétérinaire, 
quelques études ont établi des IR pour des variables biochimiques et hématologiques en suivant 
ces recommandations dans différentes races ou catégories de races canines. Il ressort de ces 
études que des spécificités raciales existent ainsi que des effets de certains facteurs, comme le 
poids, le sexe et l’âge. Concernant le domaine de la cardiologie canine, l’effet de la race et du 
poids sur les variables échocardiographiques a été largement démontré. Cependant, les effets du 
sexe et de l’âge demeurent méconnus et aucun IR établi selon les recommandations IFCC-CLSI 
n’a été publié à ce jour. 
L’hypothèse principale de ce travail a donc été la suivante : la détermination d’IR spécifiques 
chez les races de chiens de petit format les plus populaires en France et prédisposées à la 
cardiopathie la plus fréquente en cardiologie vétérinaire (MVD), pourrait être pertinente pour le 
clinicien. Trois études ont été réalisées : 
1) Etude 1 : Evaluation des effets de la race, du poids, de l’âge et du sexe sur l’hématocrite ainsi 
que 15 variables biochimiques de routine et détermination d’IR pour ces mêmes variables dans 
une population de chiens adultes sains de petit format, selon les recommandations IFCC-CLSI ;  
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2) Etude 2 : Evaluation des effets de la race, du poids, de l’âge et du sexe sur le biomarqueur 
plasmatique N-terminal pro-brain-type natriuretic peptide (NT-proBNP) et détermination d’un 
IR pour ce même biomarqueur dans une population de chiens adultes sains de petit format, selon 
les recommandations IFCC-CLSI ;  
 3) Etude 3 : Evaluation des effets du poids, de l’âge et du sexe sur 14 variables écho-Doppler et 
détermination des IR pour ces mêmes variables dans une population de Cavalier King Charles 
(CKC) adultes sains, selon les recommandations IFCC-CLSI. 
Dans les études 1 et 2, une population incluant 154 chiens de 7 races différentes appartenant à des 
éleveurs de la région Ile de France (CKC, King Charles, Yorkshire Terrier, Caniche, Bichon, 
Teckel, Shih-Tzu) a été recrutée de manière prospective. Dans l’étude 3, une population de 134 
CKC, présentée à l’Unité de Cardiologie d’Alfort pour un dépistage cardiaque a été sélectionnée. 
Les prélèvements sanguins ainsi que les examens cardiovasculaires ont été réalisés dans des 
conditions standardisées et en utilisant des méthodes validées, afin de minimiser les sources de 
variabilité (pré-analytique et analytique pour la biologie clinique ou liée au manipulateur pour 
l’échocardiographie) qui auraient pu interférer avec l’interprétation des IR.  
La détermination des IR a été faite en suivant les recommandations IFCC-CLSI et l’effet des 
facteurs comme la race, le poids, l’âge ou le sexe sur les variables a été testé en utilisant un 
modèle de régression linéaire. 
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Dans l’étude 1, un effet de la race, du poids, du sexe et de l’âge a été identifié, respectivement 
pour 7/16, 8/16, 4/16 et 3/16 variables. En revanche, la nécessité d’établir des IR spécifiques en 
fonction de ces facteurs n’a pas montré d’intérêt clinique pertinent. De plus, il est ressorti de cette 
étude que les IR fournis par les laboratoires d’analyses vétérinaires ne sont pas spécifiquement 
adaptés aux chiens de petit format. En effet, 4 à 76% des valeurs observées dans la présente étude 
étaient respectivement au dessus et en dessous des valeurs de l’IR (supérieures ou inférieures) 
fournies par le laboratoire.  
Dans l’étude 2, un effet du sexe a été identifié sur le NT-proBNP plasmatique. En raison de 
problèmes analytiques et de la grande variabilité inter-individuelle de ce biomarqueur, non 
décrite jusqu’ici dans la littérature chez les chiens de petit format, il n’a pas été possible de 
déterminer un IR pour ce biomarqueur (notamment concernant la limite supérieure de cet IR). Il a 
donc été conclu que l’interprétation d’un dosage plasmatique du NT-proBNP chez un chien sain 
de petit format doit être réalisée avec prudence et en complément de l’échocardiographie, qui 
demeure l’examen de choix dans l’évaluation cardio-vasculaire du chien. 
Dans l’étude 3, un effet significatif du poids a été identifié sur les variables 
échocardiographiques, en particulier l’épaisseur des parois et le diamètre des cavités du 
ventricule gauche. De plus, en comparaison aux IR déterminés dans des études antérieures 
concernant les mêmes variables échographiques, mais à partir d’une population incluant des 
chiens de races très différentes, il a été montré que des IR spécifiques élaborés pour le CKC dans 
la présente étude sont plus précis. Il a donc été conclu que la race et le poids doivent être pris en 
compte dans l’établissement d’un IR pour les variables écho-Doppler chez le CKC. 
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En conclusion, ce travail a permis d’identifier l’intérêt de déterminer des IR spécifiques dans une 
sous-population canine (dans le présent travail, les races de chiens de petit format) pour certaines 
variables plasmatiques et échocardiographiques. De plus, l’effet de certains facteurs comme le 
poids, l’âge et le sexe doivent être pris en compte, mais seulement si un intérêt clinique est 
identifié. 
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present along the distal leaflet segments. LVPW, left ventricular posterior wall; P, papillary muscle; W, 
LA posterior wall. Scale in mm. Photograph and legend: Fox PR. Pathology of myxomatous mitral valve 
disease in the dog. J Vet Cardiol 2012;14:103-126. 
Figure 3. Bidimensional right parasternal long axis 4-chamber view showing echocardiographic 
images of a normal (A) and a degenerative mitral valve (B). Note the thickening of the mitral leaflet 
(B), especially the distal part of the anterior mitral leaflet (AML). LA, left atrium; LV, left ventricle; PML, 
posterior mitral leaflet; RA, right atrium; RV, right ventricle. Photograph: Cardiology Unit of Alfort. 
Figure 4. (A) Left parasternal long axis 4-chamber view using the color Doppler mode showing a 
severe mitral regurgitation. (B) Bidimensional right parasternal long axis 4-chamber view showing 
a chordae tendineae rupture and a prolapse of the mitral anterior leaflet (arrow). LA, left atrium; LV, 
left ventricle. Photograph: Cardiology Unit of Alfort. 
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Figure 5. Kaplan-Meier survival curves according to both International Small Animal Cardiac 
Health Council (ISACHC) class and plasma concentration of N-terminal pro-brain-type natriuretic 
peptide (NT-proBNP) obtained from 46 dogs with symptomatic degenerative mitral valve disease: 
ISACHC class 2 with NT-proBNP <1265 pmol/L (n= 13, solid line) and >1265 pmol/L (n=10, dashed 
line); ISACHC class 3 with NT-proBNP <2700 pmol/L (n= 13, dotted line) and >2700 pmol/L (n= 10, 
alternate dotted and dashed line). n, number of dog. From Serres et al., Plasma N-terminal pro-B-type 
natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral 
valve disease regardless of and in combination with the initial clinical status at admission. J Vet Cardiol 
2009;11:103-121. 
Figure 6. Relationship between the terms defined in the International Federation of Clinical 
Chemistry and the Clinical and Laboratory Standards Institute recommendations. From Geffré et al. 
Reference values: a review. Vet Clin Pathol 2009;38:290.  
Figure 7. Curves showing different types of distribution: bell shape Gaussian distribution (dotted 
curve) as well as skewness and kurtosis (continuous curves) with the two upper figures showing 
asymmetric distributions (A and B, positive and negative skewnesses, respectively) and the two 
lower figures showing distributions with non-Gaussian peakedness (C and D, positive and negative 
kurtosis, respectively). From Solberg. Establishment and use of reference values. In: Burtis CA, 
Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia, PA: Saunders;1999:336-
356. 
Figure 8. Graphic determination of the central 95% reference interval (2.5th and 97.5th percentiles) 
for a variable expressed in the “International System of Units” (SI) by plotting the cumulative 
distribution. 
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Figure 9. Serum creatinine concentration in Greyhound versus non-Greyhound dogs. The horizontal 
white bar represents the median value. The upper and lower limits of the box represent the 25th and 75th 
percentiles. The whiskers represent the 10th and 90th percentiles. The rounds represent extreme values. 
From Feeman et al. Serum creatinine concentrations in retired racing greyhounds. Vet Clin Pathol 
2003;32:40-42. 
Figure 10. Box-and-whisker plot depicting the serum troponin I concentrations in healthy 
Greyhound, non-Greyhound and Boxer dogs. The horizontal bar represents the median value and the 
whiskers represent the 2.5% and 97.5 percentiles. From LaVecchio et al. Serum cardiac troponin I 
concentration in retired racing Greyhounds. J Vet Intern Med 2009;23:87-90. 
Figure 11. Boxplots showing distribution of the natriuretic peptides pro-atrial-type (proANP 31-67, 
Figure 11A) and N-terminal pro-brain-type (NT-proBNP, Figure 11B) by breed. The top, bottom, and 
line through the middle of each box correspond to the 75th percentile (top quartile), the 25th percentile (bottom 
quartile) and the 50th percentile (median), respectively. The whiskers extend from the bottom 2.5th percentile to the 
top 97.5th percentile. Outliers are represented by black dots. Box, Boxer; BS, Belgian Shepherd; CKCS, Cavalier 
King Charles Spaniel; Dach, Dachshund; Dob, Doberman Pinscher; Fin L, Finnish Lapphund. From Sjöstrand et al. 
Breed differences in natriuretic peptides in healthy dogs. J Vet Intern Med 2014;28:451-457. 
Figure 12. Linear regression plot for plasma N-terminal atrial-type natriuretic peptide (NT-ANP) 
concentrations in 17 healthy Cavalier King Charles Spaniels. The regression formula is Y = 184.9 + 
25.4x with Y, the NT-ANP concentration and x, the age of the dogs. From Eriksson et al. Effect of age and 
body weight on neurohumoral variables in healthy Cavalier King Charles spaniels. Am J Vet Res 
2001;62:1818-1824. 
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Figure 13. Body condition system in dogs based on a 9-point scale. From Nestlé Purina. 
Figure 14. Right parasternal transaortic short-axis view in bidimensional mode showing positioning 
of calipers (double arrows) allowing calculation of the left atrium (LA) on aorta (AO) ratio. HR, 
heart rate (in beat per minute); PA, pulmonary artery. 
Figure 15. M-mode right parasternal left ventricular short-axis view. HR, heart rate (in beats per 
minute); IVS: interventricular septum; LV, left ventricle; LVFW, left ventricular free wall; RV, right 
ventricle. Photograph: Cardiology Unit of Alfort. 
Figure 16. Pulsed wave Doppler mode showing the maximal systolic aortic velocity, on the left apical 
long axis 4-chamber view (A) and the maximal systolic pulmonary velocity (B), on the right 
parasternal transaortic short-axis view. Photograph: Cardiology Unit of Alfort. 
Figure 17. Material used for systemic arterial blood pressure measurement using the Doppler 
method. Source: www.dispomed.com 
Figure 18. Distribution of plasma N-terminal-pro-brain-type natriuretic peptide (NT-proBNP) 
concentrations among the 154 healthy small size dog population. The thick horizontal bar represents 
the median (i.e., 783 pmol/L) and the thin horizontal bars represent the first and third quartiles (i.e., 476 
and 1232 pmol/L, respectively). 
Figure 19. Comparison between plasma N-terminal pro-brain-type natriuretic peptide (NT-
proBNP) concentrations assessed in the 11 outlier dogs at first sampling and 3 months later. 
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GENERAL INTRODUCTION 
 
 
The dog was the first domesticated animal (Ovodov et al., 2011) and had been the most 
widely kept working, hunting, and pet animal in the whole human history. In France, there are 
more than 7.8 millions of dogs including 50% of purebred dogs. Additionally, no less than 
25% of French households own at least one dog (Santé Vet, 2009). In the canine population, 
there are more than 300 different canine breeds from small to giant size, among which small 
size dogs (i.e., dogs with a body weight (BW) lower than 12 kg) are very popular, especially 
in urban areas (Société Centrale Canine, LOF Registration Statistics, 2012; American Kennel 
Club 2011 Dog Registration Statistics). Among this small size dog population, 7 breeds 
(Figure 1, Table 1), i.e., Cavalier King Charles Spaniel (CKCS), King Charles Spaniel 
(KCS), Bichon (B), Dachshund (D), Miniature Poodle (MP), Shih-Tzu (ST) and Yorkshire 
Terrier (YT) represent almost 13% of all registrations to “Le livre des Origines Françaises” 
(Société Centrale Canine, LOF Registration Statistics, 2012).  
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Figure 1. Photographs showing the 7 most common small size breeds in France. A, Miniature 
Poodle; B, Yorkshire Terrier; C, Cavalier King Charles Spaniel; D, King Charles Spaniel; E, 
Dachshund; F, Bichon Frisé; G, Shih-Tzu.  
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Table 1. Origin and standard of the 7 most common small size breeds in France. Source: Société Centrale Canine. 
 
 
Breed 
 
Country of origin 
 
Coat 
 
Colour 
 
Weight (kg) 
 
Height (cm) 
Miniature Poodle Germany 
Corded or curly, generally groomed 
(continental, puppy, English saddle or 
sporting clips) 
Black, white, grey, brown, apricot - 28-35 
Yorkshire Terrier England Long-haired (usually groomed) Black and tan < 3.2 - 
Cavalier King Charles 
Spaniel 
United Kingdom Long-haired Blenheim, tricolour, black and tan and ruby 5.4-8.2 30-33 
King Charles Spaniel United Kingdom Long-haired Blenheim, tricolour, black and tan and ruby 3.6-6.3 23-28 
Dachshund Germany Short, long and wire-haired 
Single-colored, single-colored with spots 
(merle), single colored with tan points, two-
colored 
4.0-9.0 - 
Bichon Frisé France and Belgium Long-haired and curly White 3.0-7.0 23-30 
Shih-Tzu China Long-haired 
Various shades of gold, white, brown, and 
black 
4.0-7.25 20-28 
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Although these dogs are highly appreciated by people, they are unfortunately prone to 
develop degenerative mitral valve disease (DMVD), which is the most common heart disease 
in dogs. This acquired valvular disease consists of incomplete apposition of the two mitral 
valve leaflets resulting in chronic- mild to severe- mitral regurgitation (MR). During the 
course of DMVD, several neuro-hormonal mechanisms may be activated, in order to maintain 
adequate cardiac output, blood pressure, and tissue perfusion. As the disease worsens, those 
mechanisms may be deleterious, leading to fluid retention and therefore to the development of 
congestive heart failure (CHF) and CHF-related symptoms such as cough, dyspnea and 
exercise intolerance. Even if most of the small size dogs suffering from DMVD remain 
asymptomatic for years or even in their lifetime, severe complications may occur, such as 
CHF and alteration of other functions, such as renal function, leading to death or euthanasia 
because they no longer respond to medical treatments. The standard transthoracic 
echocardiography (TTE) is considered as the gold standard to assess mitral valve lesions and 
severity of MR, as well as its consequences on heart morphology and function. Moreover, 
TTE can be used in combination with evaluation of several blood markers, also called 
biomarkers, in order to assess severity and complications of DMVD. Additionally, biomarkers 
may help clinicians to make a prognosis and evaluate medical therapy efficiency. One of the 
most common biomarker used in veterinary cardiology is the plasma cardiac biomarker N-
terminal pro-brain-type natriuretic peptide (NT-proBNP), a peptide synthesized by atrial and 
ventricular cardiomyocytes in response to increased filling pressures and myocardial wall 
stress. 
The dog represents a unique animal model because there are more than 300 breeds with large 
phenotypic variations. The morphological differences between canine breeds can be 
significant, for example a BW may vary from less than 1 kg (Chihuahua dogs) to more than 
100 kg (Mastiff dogs). Therefore, the effect of covariates such as breed and BW on blood and 
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echocardiographic variables in dogs has been extensively studied in the literature. 
Additionally, numerous other physiological effects have been pointed out, the most common 
being age and gender. Other effects include neutering status, exercise and body condition, 
since overweight and obesity increased dramatically in dogs as it does in humans. Owing to 
these observations, the major hypothesis of this work was that determination of specific 
reference interval (RI) in healthy small size dogs regarding the most common blood and 
echocardiographic variables used in the longitudinal evaluation of DMVD could be relevant.  
The concept of RI is critical because it helps clinicians to make medical decisions about a 
patient’s test result. A RI is defined as an interval into which 95% of values of a reference 
group fall (Solberg et al., 1987a). In other words, 2.5% of the values are under the lower limit 
of this interval and the remaining 2.5% are above the upper limit of this interval, whatever the 
distribution of the reference values. In human medicine, experts from the International 
Federation of Clinical Chemistry (IFCC) and from the Clinical and Laboratory Standards 
Institute (CLSI) wrote guidelines providing definitions and specific recommendations about 
the determination of RI in clinical laboratory (Solberg, 1987a, 1987b, 1988; Solberg and 
Stamm, 1991; Petit Clerc and Solberg, 1987; Dybkaér 1987; CLSI 2008). In veterinary 
medicine, the American Society for Veterinary Clinical Pathology (ASVCP) advised 
adherence to the IFCC-CLSI guidelines while including recommendations for the 
determination of population-based RI in animals (ASVCP, 2012; Friedrichs et al., 2012). 
However, in veterinary medicine, there is a lack of studies focusing on RI determination with 
respect to these guidelines, especially in dogs, for which the quality of healthcare improves 
daily while remaining similar to human healthcare.  
For this purpose, this work includes three studies, whose main objective was to determine RI 
according to the IFCC-CLSI guidelines in healthy small size dogs regarding plasma 
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biochemistry, packed cell volume (PCV), plasma NT-proBNP and standard 
echocardiographic and conventional Doppler variables. 
 
The present manuscript is divided into chapters as follows:  
 Chapter I presents the epidemiological, clinical, pathophysiological and 
echocardiographic features of canine DMVD, as well as echocardiographic and blood 
variables commonly used in the assessment of disease severity and prognosis.  
 Chapter II describes the recommendations for RI determination in clinical pathology 
according to the IFCC-CLSI and the ASVCP guidelines. 
 Chapter III summarizes the RI previously determined in studies regarding veterinary 
clinical pathology and cardiology. Additionally, the effect of covariates such as breed, 
BW, age and gender on clinical pathology and cardiology variables in dogs will also be 
addressed. 
 Chapter IV presents the scientific aim of this work.  
 Chapter V describes the material and methods used in the present work to carry the 
studies. 
 Chapter VI summarizes the studies and provides the corresponding original articles. 
 Chapter VII is dedicated to the discussion, perspectives and conclusion of this work. 
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CHAPTER I. THE DEGENERATIVE MITRAL VALVE 
DISEASE 
 
I. INTRODUCTION  
        
The DMVD, also previously called myxomatous mitral valve disease or mitral 
endocardiosis, is the most common acquired heart disease in dogs (Buchanan, 1977; 
Thrusfield et al., 1985; Pedersen et al., 2000; Häggström et al., 2004; Kvart et al., 2005). 
Degenerative lesions of the mitral valve leaflets and associated chordae tendineae lead to 
insufficient coaptation, and therefore a chronic regurgitation through the mitral valve. At 
physical examination, DMVD is characterized by a left apical systolic heart murmur of 
varying intensity, i.e., from grade 1/6 to 6/6 according to the Freeman and Levine’s scale 
(1933). Progression of the disease is generally slow, especially in small size dogs, and the 
pre-clinical phase (i.e., the asymptomatic period) may last for years and even for life. 
Nevertheless, progression is sometimes unpredictable and severe complications may occur, 
leading to the occurrence of clinical signs related to CHF, and ultimately death or 
euthanasia because of worsening or unresponsive clinical signs (Ettinger et al., 1998; 
Pouchelon et al., 1999; Kvart et al., 2002; Atkins et al., 2007; Borgarelli et al., 2008; 
Häggström et al., 2008). Medical treatment of naturally occurring DMVD includes 
numerous drugs or therapeutic classes, the most common being angiogensin-converting 
enzyme inhibitors (Pouchelon et al., 1999; Kvart et al., 2002; Amberger et al., 2004; Atkins 
et al., 2007; Besche et al., 2007, Pouchelon et al., 2008), spironolactone (Bernay et al., 
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2010; Guyonnet et al., 2010), pimobendan (Smith et al., 2005; Lombard et al., 2006; 
Häggström et al., 2008) and loop diuretics such as furosemide (Sisson and Kittleson, 1999; 
De Madron et al., 2011). More recently, surgical mitral valve repair including suture 
annuloplasty and chordae tendineae replacement has been advocated (Mizuno et al., 2013). 
 
In 2009, the American College of Veterinary Internal Medicine (ACVIM) consensus panel 
formulated guidelines for the diagnosis, classification (Table 2) and treatment of the 
DMVD (Atkins et al., 2009).  
 
Table 2. American College of Veterinary Internal Medicine Consensus Statement for 
classification of dogs with degenerative mitral valve disease. Atkins et al. Guidelines for the 
diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009;23:1142-
1150. 
STAGE A 
 
 
Patients at high risk for developing DMVD but that currently have no 
identifiable structural disorder of the heart (e.g., every Cavalier King 
Charles Spaniel without a heart murmur). 
STAGE B B1 
 
Asymptomatic patients with DMVD having no radiographic or 
echocardiographic evidence of cardiac remodeling in response to DMVD. 
B2 
 
Asymptomatic patients with DMVD having radiographic or 
echocardiographic evidence of left-sided heart enlargement. 
STAGE C 
 
Symptomatic patients with DMVD having past or current clinical signs of 
heart failure associated with structural heart disease. 
STAGE D Symptomatic patients with end-stage DMVD with clinical signs of heart 
failure that are refractory to standard therapy.  
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II. PREVALENCE AND EPIDEMIOLOGY 
 
            Prevalence of DMVD is quite high in small size dogs and may attain 14% to 40% 
depending on the breed and even reach higher values in geriatric canine populations 
(International Small Animal Cardiac Health Council 1999; Chetboul et al., 2004a; Serfass et 
al., 2006). Both prevalence and progression are believed to be higher and faster in males than 
females (Beardow and Buchanan, 1993).  The most common small size breeds known to be 
predisposed to DMVD include: CKCS, KCS, D, B, YT, ST, MP and Lhassa Apso (Thrusfield 
et al., 1985; Pedersen et al., 1999a; Ettinger et al., 1998; Pouchelon et al., 1999; Pedersen et 
al., 2000; Kvart et al., 2002; Chetboul et al., 2004a; Serfass et al., 2006; Atkins et al., 2007; 
Häggström et al., 2008; Borgarelli et al., 2008). Within this small size dog population, the 
CKCS show specific features, as they develop DMVD at a relatively young age with a high 
prevalence as compared to other small breed dogs. Nevertheless, the time course of their 
disease progression to CHF does not appear to be markedly different from that of other small 
size dogs except for the early age of onset (Häggström et al., 1992; Beardow and Buchanan, 
1993; Chetboul et al., 2004a). Less commonly, large breed dogs such as German Shepherds 
may also be affected by the disease and DMVD progression seems to be more rapid in this 
breed than that observed in small size dogs (Borgarelli et al., 2004 & 2007).
  
 
III. ETIOLOGY 
 
            Little is known about the signaling mechanisms that initiate the pathological process 
of DMVD in dogs. Such initiating mechanisms may include genetic, chemical and mechanical 
stimuli (Buchanan, 1977; Häggström et al., 2004; Madsen et al., 2011), among which the 
circulating serotonin concept has recently been studied with interest in dogs with naturally 
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occurring DMVD (Gustafsson et al., 2008; Arndt et al., 2009; Oyama et al., 2010; Ljungvall 
et al., 2013; Cremer et al., 2014). Other examples of potential mechanisms include heritable 
connective tissue disorders (Boudoulas, 2003), transforming growth factor beta (Disatian et 
al., 2009; Aupperle et al., 2008; Obayashi et al., 2011), nitric oxyde (Moesgaard et al., 
2007a) and angiotensin II (Mow et al., 1999). 
 
IV. PATHOPHYSIOLOGY 
 
           The normal mitral valve apparatus (Figure 2) is composed of two leaflets (anterior or 
septal and posterior or mural), which are thin and transparent (Buchanan, 1977; Fox, 2012). 
Macroscopically, DMVD consist on degeneration of valve leaflets, mainly the anterior 
(Tamura et al., 1995), and associated chordae tendineae (Trautwein et al., 1973; Liu et al., 
1975; Kogure et al., 1980; Terzo et al., 2009). The degeneration is characterized by nodular 
thickening, incomplete apposition of the valve leaflets during systole and secondary MR 
(Kittleson et al., 2003; Muzzi et al., 2003; Gouni et al., 2007). Microscopically, canine 
DMVD is characterized by increased cellularity in the different leaflet layers, valve structure 
disorganization, as well as differentiation of valve endothelial and interstitial cells, and 
glycosaminoglycan infiltration (Schneider et al., 1973; Buchanan, 1977; Rabkin et al., 2001; 
Corcoran, et al., 2004; Black et al., 2005; Disatian et al., 2008; Aupperle et al., 2009).  
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Figure 2. (A) Sagittal section through the left atrium (LA) and the left ventricle of a dog with a 
normal mitral valve apparatus. The two mitral leaflets are attached at the junction of atrial and 
ventricular myocardium. The leaflets are thin, clear and translucent and the chordae tendineae are 
smooth and symmetric (arrows). (B) Close up view of a degenerative mitral valve. The leaflet edges 
are rounded and thickened at their contact point (thin arrows) and nodular thickening (broad arrow) 
is present along the distal leaflet segments. LVPW, left ventricular posterior wall; P, papillary muscle; 
W, LA posterior wall. Scale in mm. Photograph and legend: Fox PR. Pathology of myxomatous mitral 
valve disease in the dog. J Vet Cardiol 2012;14:103-126. 
 
Depending on MR severity, several potential hemodynamic consequences such as reduced 
forward cardiac output and increased intracardiac pressures may occur (Buchanan, 1977; 
International Small Animal Cardiac Health Council, 1999; Borgarelli et al., 2008). In human 
beings, such hemodynamic alterations may result in complex neurohormonal activation, 
especially adrenergic nervous and renin-angiotensin-aldosterone system (RAAS) activation, 
in order to maintain adequate cardiac output, blood pressure, and tissue perfusion (Francis
 
et 
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al., 1990; Ferrari et al., 1998). The prolonged and excessive RAAS and sympathetic 
activations have deleterious effects with adverse consequences at both cardiac and vascular 
levels (water and sodium retention, increased heart rate and blood pressure, myocardial and 
endothelial fibrosis, etc.), which contribute, inter alias, to CHF aggravation (Francis, 1998) 
and to occurrence of the cardiorenal syndrome.  The cardiorenal syndrome (particularly type 
II) defines the decline of renal function in the setting of advanced CHF (Bongartz et al., 2005; 
Ronco, 2012).  
In dogs with DMVD, few studies have reported the activation of adrenergic system and 
RAAS, but results remain conflicting (Ware et al., 1990; Pedersen et al., 1995a; Fujii et al., 
Häggström et al., 1996 & 1997).  Regarding the occurrence of type-II cardiorenal syndrome in 
dogs with naturally occurring DMVD, a study showed that the prevalence of azotemia was 
high (i.e., up to 50%), and increased with CHF severity (Nicolle et al., 2007). Moreover, the 
glomerular filtration rate decreased by 45% in advanced classes of CHF as compared with the 
early stages based on the New York Heart Association classification (Nicolle et al., 2007). 
More recently, another study reported a prevalence of azotemia of 29% and indicated that 
interlobar renal resistive index increased with CHF severity in 55 dogs suffering from DMVD 
(Chetboul et al., 2012a). 
In fine, chronic and severe MR causes enlargement of the cardiac chambers and leads to the 
development of CHF-related symptoms including exercise intolerance, cough, and dyspnea 
caused by left-sided CHF (Häggström et al., 2004; Borgarelli et al., 2008; Atkins et al., 
2009), and ascitis or pleural effusion as signs of right-sided CHF secondary to pulmonary 
arterial hypertension (Serres et al., 2006; Stepien, 2009; Chiavegato et al., 2009).  
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V. DIAGNOSIS 
 
           Although DMVD is characterized at cardiac auscultation by a left apical systolic heart 
murmur, whose grade is known to be well correlated with MR severity (Häggström et al., 
1995; Pedersen et al., 1999b), the standard TTE (including bidimensional, M-mode, as well 
as color, pulsed and continuous wave Doppler) is currently considered as the non-invasive 
diagnostic method of choice for early detection of mitral valve lesions (Figure 3), evaluation 
of MR severity (Figure 4A) and complications (Figure 4B), and also for assessing its impact 
on cardiac remodeling, myocardial function, left ventricular filling pressures as well as 
pulmonary arterial pressure (Boon, 1983; Chetboul and Tissier, 2012). The ACVIM 
consensus statement recommends accordingly that standard TTE should be performed in 
every dog diagnosed with a left apical systolic heart murmur (Atkins et al., 2009). More 
recently, advanced echocardiographic techniques such as tissue Doppler imaging, speckle 
tracking imaging and three-dimensional echocardiography have been developed in veterinary 
cardiology and applied to dogs with DMVD in order to quantify global and regional 
myocardial function as well as cardiac chamber volumes (Ljungvall et al., 2011a; Tidholm et 
al., 2010; Chetboul and Tissier, 2012).  
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Figure 3. Bidimensional right parasternal long axis 4-chamber view showing echocardiographic 
images of a normal (A) and a degenerative mitral valve (B). Note the thickening of the mitral 
leaflet (B), especially the distal part of the anterior mitral leaflet (AML). LA, left atrium; LV, left 
ventricle; PML, posterior mitral leaflet; RA, right atrium; RV, right ventricle. Photograph: 
Cardiology Unit of Alfort. 
 
Figure 4. (A) Left parasternal long axis 4-chamber view using the color Doppler mode showing a 
severe mitral regurgitation. (B) Bidimensional right parasternal long axis 4-chamber view 
showing a chordae tendineae rupture and a prolapse of the mitral anterior leaflet (arrow). LA, 
left atrium; LV, left ventricle. Photograph: Cardiology Unit of Alfort. 
 
VI. PROGNOSTIC FACTORS 
 
VI.1. CLINICAL AND EPIDEMIOLOGICAL FACTORS 
 
Reported clinical and epidemiological risk factors in dogs with DMVD for negative 
progression of disease and/or death are numerous. A study found that age more than 8 years 
was associated with a reduced survival time, both when all and only cardiac causes of death 
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were included (Borgarelli et al., 2008). Moreover, another study showed that survival of class 
2 dogs from the International Small Animal Cardiac Health Council (ISACHC, 1999) 
classification (corresponding to stage C of the ACVIM classification) was significantly higher 
than that of ISACHC class 3 (corresponding to stage D of the ACVIM classification), i.e., 6 
months versus 157 days (Serres et al., 2009a). A heart murmur grade of 3/6 or greater 
(Borgarelli et al., 2008), as well as being a male (Beardow and Buchanan, 1993) is associated 
with a higher risk of death. Other factors associated with a negative progression of the disease 
include presence of tachycardia (heart rate >140 bpm), arrhythmias and clinical findings such 
as syncope, dyspnea, or ascites (Buchanan, 1977; Egenvall et al., 2006; Serfass et al., 2006; 
Serres et al., 2007; Borgarelli et al., 2008).  
 
VI.2. RADIOGRAPHIC AND ECHOCARDIOGRAPHIC FACTORS 
 
Several radiographic and echocardiographic variables are known to be associated with 
prognosis and outcomes in dogs with DMVD. The first proposed paraclinical marker of 
potential prognosis interest was heart size, assessed from thoracic radiographs (Hamlin et al., 
1968; Buchanan and Bücheler, 1995). Although rapidly replaced by echocardiography, the 
usefulness of vertebral heart scale (VHS) to predict development of CHF has been reported 
(Lord et al., 2011). There are lots of echocardiographic variables known to affect outcome in 
canine DMVD. Dogs with a high degree of valve prolapse and severe valve lesions (thickness 
of the leaflets and chordae tendineae rupture) are at higher risk of decompensation and death 
(Serres et al., 2007, Terzo et al., 2009). Moreover, degree of MR, assessed by using the color 
mapping or the PISA (Proximal Isovelocity Surface Area) methods are useful prognostic 
factors in asymptomatic and symptomatic dogs with DMVD (Pedersen et al., 1999a; Olsen et 
al., 2003; Chetboul et al., 2009). Variables reflecting the hemodynamic consequences of MR 
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such as cardiac chamber enlargement, myocardial dysfunction and pulmonary arterial 
pressure are also commonly used for prediction of CHF and death. Among these variables, 
heart size (especially left atrium (LA) size, LA on aorta (Ao) ratio and left ventricular internal 
diameter at end-systole (LVES) and end-diastole (LVED)), fractional shortening (FS%), 
systolic pulmonary arterial pressure and mitral early (E) wave velocity are the most accurate 
(Häggström et al., 1992; Serres et al., 2008; Borgarelli et al., 2008; Moonarmart et al., 2010; 
Reynolds et al., 2012; Hezzell et al., 2012a). 
 
VI.3. CIRCULATING BIOMARKERS 
 
During the last decade, the use of circulating biomarkers in combination with routine cardio-
vascular examination has been advocated. A biomarker is "a characteristic (…) objectively 
measured and evaluated as an indicator of normal biologic processes, pathogenic processes, 
or pharmacologic responses to a therapeutic intervention" (Atkinson et al., 2001). There are 
many biomarkers in veterinary medicine (Boswood, 2009) but this paragraph will only focus 
on biomarkers with a demonstrated clinical usefulness in cardiology. 
 
VI.3.1 NATRIURETIC PEPTIDES 
 
To date, B-type natriuretic peptides, including brain natriuretic peptide (BNP) and its inactive 
aminoterminal portion of brain natriuretic peptide (NT-proBNP), are considered as being the 
most reliable neurohormonal markers of heart diseases in dog (Schober, 2005; Boswood et al., 
2008; Oyama, 2009; Sisson, 2009). Brain natriuretic peptide is secreted as an inactive 
precursor molecule (proBNP) mainly by atrial and to a greater extent ventricular 
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cardiomyocytes in response to increased filling pressures and wall stress (Schober, 2005). 
Inactive proBNP is then cleaved into the circulating biologically active BNP and the inactive 
NT-proBNP fragment (Schober, 2005). The NT-proBNP has a longer half-life and a better 
stability in a sample than BNP (Schober, 2005). Therefore, NT-proBNP is the most 
commonly used natriuretic peptide in veterinary cardiology. 
Plasma NT-proBNP concentration is correlated with canine DMVD severity, and may be used 
in combination with clinical status to predict outcomes in both asymptomatic dogs and dogs 
with CHF (Chetboul et al., 2009; Serres et al., 2009a; Tarnow et al., 2009; Takemura et al., 
2009; Reynolds et al., 2012; Hezzell et al., 2012b). A study (Serres et al., 2009a) showed that 
the median survival time of dogs from ISACHC class 3 with a plasma NT-proBNP 
concentration >2700 pmol/L was extremely short (5 days), whereas that of dogs from the 
same class but with NT-proBNP <2700 pmol/L was significantly higher (>6 months, 
P<0.0001, Figure 5). Additionally, several other studies showed that plasma NT-proBNP 
concentration decreased after initiation of medical treatment of CHF, although benefit on 
survival remains unclear (Atkinson et al., 2009; Schober et al., 2011; Wolf et al., 2012).  
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Figure 5. Kaplan-Meier survival curves according to both International Small Animal Cardiac 
Health Council (ISACHC) class and plasma concentration of N-terminal pro-brain-type 
natriuretic peptide (NT-proBNP) obtained from 46 dogs with symptomatic degenerative mitral 
valve disease. ISACHC class 2 with NT-proBNP <1265 pmol/L (n= 13, solid line) and >1265 pmol/L 
(n=10, dashed line); ISACHC class 3 with NT-proBNP <2700 pmol/L (n= 13, dotted line) and >2700 
pmol/L (n= 10, alternate dotted and dashed line). n, number of dog. From Serres et al., Plasma N-
terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with 
symptomatic degenerative mitral valve disease regardless of and in combination with the initial 
clinical status at admission. J Vet Cardiol 2009;11:103-121. 
 
Another natriuretic peptide of interest is atrial natriuretic peptide (ANP). Even though this 
biomarker has been the first identified natriuretic peptide, it has been less extensively studied 
than NT-proBNP. Several studies demonstrated that plasma ANP concentration is 
significantly correlated with LA size, severity of disease, and may also help to predict 
outcomes in dogs with naturally occurring DMVD (Häggström et al., 1994 & 1997; Greco et 
al., 2003; Ebisawa et al., 2013). In a recent report, the median time to CHF in CKCS with N-
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terminal-pro-atrial-type natriuretic peptide (NT-proANP) levels >1000 pmol/L was 11 months 
compared to 54 months in those with concentrations ≤1000 pmol/L (Eriksson et al., 2014). 
 
VI.3.2 CARDIAC TROPONIN I 
 
Cardiac troponin I is a protein exclusively present in cardiac muscle (Archer, 2003) and 
specifically used to detect acute myocardial infarction in humans, as well as marked 
myocardial damage (Khan et al., 1999). The presence of cardiac disease may lead to 
myocardial injury and release of troponin I in blood. Serum troponin I concentration is 
therefore proportional to the severity of myocardial damage (Boswood et al., 2009). In dogs 
with moderate to severe DMVD, significantly higher concentrations of plasma troponin I 
were found as compared to healthy controls, and severely affected DMVD dogs had 
significantly higher concentrations than do mildly and moderately affected dogs (Ljungvall et 
al., 2010b; Noszczyk-Nowak, 2011). Moreover, a study showed that troponin I was 
independently associated with survival (all-cause mortality) in dogs with DMVD (Hezzell et 
al., 2012b).  
 
VI.3.3 CIRCULATING NON-CARDIAC BIOMARKERS 
 
Variables measured as part of standard laboratory investigations, such as hemoglobin (HGB), 
creatinine, albumin and sodium may help to predict outcomes in human patients with heart 
disease (Packer et al., 1987; Cowie et al., 2000; Horwich et al., 2002 & 2008). In one study 
including patients with CHF, the one-year survival was 66% in those with and 83% in those 
without hypoalbuminemia (Horwich at al., 2008). Similarly, low HGB concentration proved 
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to be an independent predictor of mortality in human patients presenting advanced stage of 
heart failure with a low relative risk of 1.113 for each HGB decrease of 1 g/dL (Horowich et 
al., 2002). Concentrations of some of these substances are known to change in response to 
CHF development and its treatment in canine patients. Hence, dogs with CHF have significant 
lower, although normal, value of PCV (i.e., 42%) compared with healthy controls (i.e., 45%, 
Farabaugh et al., 2004). Moreover, worsening of CHF is characterized by a significant fall in 
serum sodium, potassium and chloride (Boswood and Murphy, 2006) and a significant 
increase in the serum urea and creatinine concentrations (Boswood and Murphy, 2006, Nicolle 
et al., 2007; Boswood et al., 2009) in dogs with DMVD. In one previous study (Boswood and 
Musphy, 2006), asymptomatic dogs with DMVD had lower value of creatinine compared to 
dogs with CHF (respectively, 92 and 127 μmol/L). To the contrary, a fall in serum sodium 
was found in dogs with advanced CHF compared to healthy dogs (i.e., 140 versus 147 
mmol/L, respectively). Although these biomarkers are easy to evaluate and known to be 
correlate with CHF severity, further studies are warranted regarding their prognostic 
significance. 
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VII. CONCLUSION 
 
         The DMVD is the most common heart disease in small size dogs and has extensively 
been documented in the veterinary literature since decades. This acquired valvular disease 
may affect quality and duration of life of dogs to a more or less extend, depending of age of 
onset, breed, gender, cardiac and extra-cardiac complications and response to medical 
therapy. Reliable variables measured in routine are known to be correlated with disease 
severity, help to make a prognosis and monitor efficacy of medical treatment. These variables 
include echocardiographic variables (e.g., LA size) and blood variables such as creatinine and 
NT-proBNP.  
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CHAPTER II. THE CONCEPT OF REFERENCE INTERVAL 
 
 
 
I. INTRODUCTION 
 
            The concept of RI consists in determining a set of values into which a specific percentage, 
most often 95%, of the values of a particular analyte in a population would fall (Solberg et al., 
1987a).
 
It should be emphasized that RI are often established from general healthy populations. 
However, sets of values may also be determined from individuals with specific diseases or 
conditions (children, pregnant women, or smokers for example). These two types of RI are 
defined as health-related and disease-associated, respectively (Solberg et al., 1995a et 1995b). 
This RI is then used to help clinicians make the proper medical decisions about their patients’ test 
results. In human beings, the concept of ‘normal value’ was introduced by Grasbeck and Saris in 
1969. Since then, because the term ‘normal’ leads to different meanings, i.e., ‘normal’ might 
describe a value common in a population, a value arising from a healthy population or a value 
which follows a Gaussian distribution in the population (Grasbeck and Fellman, 1968; Murphy, 
1972; Vacha, 1978; Petit Clerc and Solberg, 1987), the term ‘normal value’ was replaced by the 
term ‘reference value’ to avoid such confusions.  
Soon after, the IFCC issued recommendations for the determination of RI that were 
internationally accepted in the “Approved Recommendation on the Theory of Reference Values” 
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(Solberg, 1987a & 1987b; Petit Clerc and Solberg, 1987; Dybkaér 1987; Solberg, 1988; Solberg 
and Stamm, 1991). Later, the former recommendations were adopted and updated in 2008 by the 
CLSI (CLSI, 2008). In veterinary medicine, as early as in 1979, several authors applied the 
concept of RI in animals, such as dogs, horses, cattles and swines (Lumsden et al., 1979, 1980a & 
1980b; Friendship et al., 1984). The first reported RI established according to the IFCC 
recommendations was intended for plasma creatine kinase in a population of dogs (Aktas et al., 
1994). Additionally, the ASVCP recently advised adherence to the IFCC-CLSI guidelines and 
provided recommendations for the determination of population-based reference RI in veterinary 
medicine (ASVCP, 2012; Friedrichs et al., 2012). 
In the “Approved Recommendation on the Theory of Reference Values”, the IFCC provided the 
following general definitions (Solberg, 1987a & 1987b; Petit Clerc and Solberg, 1987; Dybkaér 
1987; Solberg, 1988; Solberg and Stamm, 1991): 
 Reference individual: an individual selected for comparison by using defined criteria. 
 Reference value: the value obtained by measuring an analyte on a reference individual. 
 Observed value: the measured value for an analyte produced with the aim of making a 
medical decision by comparison with the reference value. 
 Reference population: all possible reference individuals. 
 Reference sample group: adequate number of reference individuals representing the 
reference population. 
 Reference distribution: statistical distribution of reference values. 
 Reference limit: derived from the reference distribution and used for descriptive purposes. 
Usually, a reference limit is defined so that a stated fraction of the reference values is 
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inferior than or equal to the limit with a given probability, that is to say the 2.5th or 97.5th 
percentiles. 
 Reference interval: interval between and including two reference limits (should not be 
named ‘reference range’ as it represents only one figure). 
 Decision limit: predetermined threshold that distinguishes 2 populations. Decision limits 
are defined by consensus and based on investigations on individuals with and without a 
specific disease or condition. 
 
The relationships between the terms defined above are illustrated in Figure 6 (Geffré et al., 
2009a). 
After this introduction, the first part of this chapter will focus on the procedures recommended by 
the IFCC-CLSI (Solberg, 1987a & 1987b; Petit Clerc and Solberg, 1987; Dybkaér 1987; 
Solberg, 1988; Solberg and Stamm, 1991; CLSI, 2008) for determination of population-based 
univariate reference values (i.e., the production, treatment and use of separate reference values 
for one ore more analyte (s), leading to one or more set (s) of univariate reference values).  
Multivariate reference values, defined as results of two or more analytes obtained from the same 
reference population that are treated in combination (Solberg, 1995c; Concordet et al., 2008), 
will not be discussed in the present work since this method is not routinely used in veterinary 
medicine.  
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Figure 6. Relationship between the terms defined in the International Federation of Clinical 
Chemistry and the Clinical and Laboratory Standards Institute recommendations. From Geffré et al. 
Reference values: a review. Vet Clin Pathol 2009;38:290.  
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II. GENERAL PROCEDURES FOR THE DETERMINATION OF 
REFERENCE INTERVALS  
 
            The IFCC-CLSI (Solberg, 1987a & 1987b; Petit Clerc and Solberg, 1987; Dybkaér 1987; 
Solberg, 1988; Solberg and Stamm, 1991; CLSI 2008) recommendations imply following a step-
by-step sequence of operations for RI determination (Table 3). 
 
Table 3. Procedures recommended by the International Federation of Clinical Chemistry and the 
Clinical and Laboratory Standards Institute for reference interval determination. 
1. Establish a list of analytical interferences and source of biological variability 
2. Establish selection and partition criteria  
3. Execute a written consent  
4. Categorize the potential reference individuals (questionnaires)  
5. Exclude individuals (exclusion criteria)  
6. Decide on appropriate number of reference individuals  
7. Prepare the selected subject for specimen collection  
8. Collect and handle the biological specimens  
9. Collect the reference values by analyzing the specimens 
10. Inspect the reference values data distribution and prepare a histogram  
11. Identify possible data errors and/or outliers  
12. Analyze the reference values  
13. Document all the previously mentioned steps and procedures 
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III. ANALYTICAL INTERFERENCE AND SOURCE OF 
BIOLOGICAL VARIABILITY 
 
An important preliminary investigation is to define the analyte (s) for which the RI is being 
determined, as well as the main reason of its measurement (Solberg, 1999; CLSI, 2008; Jones 
and Barker, 2008). Secondly, biological variability should be investigated. Variation may occur 
at the level of the individual (i.e., intra-individual variability), between individuals (inter-
individual variability) and as a result of pre-analytical and analytical imprecision. In dogs, this 
variability has been studied for biochemical (Ruaux et al., 2012), hematological (Jensen et al., 
1998) and hemostatic (Wiinberg et al., 2007) variables by calculating intra-individual, inter-
individual, and analytical coefficients of variation (CV). Results of these studies indicate that 
high individuality (reflected by the index of individuality, which is the ratio of within-subject to 
between-subject biologic variability) is present for many routinely measured analytes in dogs. 
Hence, index of individuality values were between 0.9 and 3.4, 1.03 and 1.40, 0.5 and 0.8 for 
respectively 14 biochemical, 4 hematological and 6 hemostatic variables, confirming that 
population-based RI are of significant value in the clinical setting.  
 
By investigating on these potential sources of interference, clinicians can determine 
specifications regarding: 
 The population selection (i.e., inclusion and exclusion criteria); 
 The need to separate RI according to criteria (i.e., partitioning); 
 The procedure of collection and handling of samples. 
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IV. SELECTION AND PARTITIONING OF REFERENCE 
INDIVIDUALS 
 
Firstly, the reference sample group used to determine the RI should be as much as possible 
representative of the reference population.  Selection criteria define the desired characteristics of 
a reference individual whereas partitioning criteria are used to further subdivide a reference 
population into a more refined demographic group (Petit Clerc and Solberg, 1987). Setting 
selection criteria allows determination of which individual should or should not be included in a 
group of reference individuals. Then, depending on the purpose, the use of partition criteria (e.g., 
gender, age) may be useful to divide the reference individual group into more homogenous sub-
groups (Petit Clerc and Solberg, 1987).  
In the case of RI determination within a healthy population, the concept of ‘health’ should be 
defined. In human beings, there is no consensus on the definition of health, but The World Health 
Organization (Anonymous, 1946)
 
defines health as “complete physical, mental and social well-
being”. Nevertheless, this definition hardly applies to human beings and definitely does not apply 
to animals. Therefore, criteria used to determine the health status must be clearly defined and 
documented (Petit Clerc and Solberg, 1987).   
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Strategies for the selection of individuals are as follows
 
(Solberg, 1999; CLSI, 2008):  
 
 Direct or indirect 
Direct: individuals are selected from a parent population using specific criteria.  Although this de 
novo method is the only one in keeping with the IFCC-CLSI recommendations (Solberg, 1987a 
& 1987b; Petit Clerc and Solberg, 1987; Dybkaér 1987; Solberg, 1988; Solberg and Stamm, 
1991; CLSI, 2008), it is considered as time-consuming and expensive. 
 
Indirect: instead of selecting reference individuals, investigators apply certain statistical methods 
to analytical values arising from a laboratory database in order to obtain assessments with 
specific characteristics. For example, determination of RI from large hospital-based data has been 
developed and represents an interesting way to constitute a reference sample group when direct 
sample is not possible. Several statistical methods are described (Bhattacharya, 1967; Solberg, 
1994; Ferre-Masferrer et al., 1999; Grossi et al., 2005), among which the modified Bhattacharya 
method seems to be the most reliable (Baadenhuijsen and Smit, 1985; Oosterhuis et al., 1990; 
Concordet et al., 2009). 
 
 A priori or a posteriori (direct methods) 
A priori: individuals are selected for specimen collection and analysis if they fulfill defined 
inclusion criteria. 
 
A posteriori: method using a database containing both analysis results and information about a 
large number of individuals. Values are selected if individuals fulfill defined inclusion criteria. 
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 Random and non-random 
Random: a process of selection giving each item (individual or test results) an equal chance of 
being chosen. 
 
Non-random: a process of selection giving each item an unequal chance of being chosen. 
 
 Partitioning of the reference sample group 
Determination of partition criteria in order to divide the reference sample group into more 
homogenous sub-groups may be requested, but their number should be as low as possible to 
maintain a sufficient sample size (Alström et al., 1993). Procedures used to determine if 
partitioning is necessary and justified will be discussed later in the manuscript. Examples of the 
most frequent partition criteria to be used for potential sub-grouping of the reference sample 
group include age, gender, genetic factors, physiological factors (e.g., reproductive status, 
pregnancy, lactation) and other factors such as environmental and chronobiological factors 
(Alström et al., 1993; Solberg, 1999). 
 
V. PRE-ANALYTICAL PROCEDURES 
 
Numerous pre-analytical factors may influence generations of reliable RI: preparation of 
individuals before specimen collection (e.g., acclimatization to the room, room temperature), 
procedure of specimen collection (e.g., material, position of the patient, training of the 
investigator) and handling of the specimen before analysis (e.g., centrifugation, temperature, 
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storage of blood specimens, shipment conditions). Standardization of all pre-analytical 
procedures is therefore a critical step (Solberg, 1988). As an example, a study in dogs (Collins et 
al., 2010) showed that serum NT-proBNP concentration was altered to a greater or lesser extend 
depending on storage temperature. In this report, serum NT-proBNP concentration was 
sufficiently increased after 3-months freezing at -20°C (median: 413 versus 709 pmol/L, before 
and after freezing, respectively) and decreased after 24 hours at room temperature (median: 629 
after 24 hours at 22.4°C versus 1052 pmol/L) to affect clinical interpretation of results (Collins et 
al., 2010). Although general procedures for control of pre-analytical factors are available in 
veterinary medicine (Gunn-Christie et al., 2012), no specific recommendations are provided 
according to a given specific analyte. Therefore, the preparation of the subject prior to, and 
during specimen collection, as well as the procedure itself should be described in sufficient 
details to allow reproduction by adequately trained staff. This is also strongly recommended in 
human medicine as soon as a laboratory investigation requires a particular protocol (Alström et 
al., 1993; Solberg, 1999).  
 
VI. ANALYTICAL PROCEDURES AND QUALITY CONTROL 
 
Analytical method should be described in details, including equipment, reagents, calibrators, 
types of raw data and calculation methods.
 
Estimates of analytical error, i.e., CV and bias, should 
also be recorded (Solberg and Stamm, 1991; Alström et al., 1993; Flatland et al., 2010; Gunn-
Christie et al., 2012). Analytical error includes random error (i.e., CV) and systematic error 
(bias). Random error, also called imprecision, refers to the variation between repeated 
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measurements on the same sample. Systematic error (also called inaccuracy) refers to the 
difference between the measurement of a quantity and its true value. The true value may be 
defined by a gold-standard method. All these stages are greatly important for the validation and 
the transference of a RI (i.e., adoption by a laboratory of previously determined RI).  
 
VII. STATISTICAL TREATMENT OF REFERENCE VALUES 
 
VII.1. INSPECTION OF DISTRIBUTION 
 
Inspection of distribution is an important step in the statistical treatment of reference values 
because it avoids the misapplication or the misinterpretation of statistical methods. One of the 
more valid methods for inspection of distribution consists in displaying the reference distribution 
graphically (histogram prepared manually or using by a computer program). Histogram 
inspection allows identification of highly deviating values (outliers), shape of the distribution 
(i.e., Gaussian, skewness and kurtosis, Figure 7) and also if bi- or polymodal distributions are 
present and therefore provides initial information regarding the approximate location of reference 
limits. Using Boxplots is an interesting method for inspection of distribution but less 
recommended than histogram (Solberg, 1987b & 1999).  
CHAPTER II- THE CONCEPT OF REFERENCE INTERVAL 
 
 
60 
fhealth  
Figure 7. Curves showing different types of distribution: bell shape Gaussian distribution (dotted 
curve) as well as skewness and kurtosis (continuous curves) with the two upper figures showing 
asymmetric distributions (A and B, positive and negative skewnesses, respectively) and the two 
lower figures showing distributions with non-Gaussian peakedness (C and D, positive and negative 
kurtosis, respectively). From Solberg. Establishment and use of reference values. In: Burtis CA, 
Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia, PA: Saunders;1999:336-
356. 
VII.2. IDENTIFICATION OF OUTLIERS 
 
Outliers are values that do not belong to the underlying distribution of the data. Outliers may 
result from erroneous inclusion of results from an individual who did not meet the selection 
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criteria, such as the inclusion of results from a diseased individual. Outliers may also result from 
pre-analytical, analytical and post-analytical errors. True outliers can affect the location of the 
reference limits and should be identified and eliminated prior to calculating RI.   
The first step in the identification of outliers consists in histogram inspection (see above), 
followed by the application of statistical methods. Many statistical techniques are available for 
outlying observations (Barnett and Lewis, 1978). Among these tests, the Dixon’s outlier range 
statistic (Dixon, 1983) and the Horn’s algorithm using Tukey’s interquartile fences (Horn and 
Pesce, 2003 & 2005) are the most commonly used.  
 
 The test proposed by Dixon (Dixon, 1983) estimates the ratio R/D, where D is the 
absolute difference between an extreme observation (large or small) and the next (largest 
or smallest) observation, and R is the range of all observations, including extreme values. 
If the difference D is equal or greater than one-third of the range R, the extreme 
observation is deleted (Reed and Henry, 1971).   
 
 The Horn’s algorithm using Tukey’s interquartile fences identifies multiple outliers 
located at the upper and lower extremities (Horn and Pesce 2003 & 2005). The criterion 
for rejection is values exceeding interquartile (IQ) fences set at IQ1 - 1.5*IQR and IQ3 + 
1.5*IQR (IQR = interquartile range; IQR = IQ3 – IQ1 where IQ1 and IQ3 are the 25th 
and 75th percentiles, respectively). This test is more stringent than Dixon’s range 
statistic, which favors retention. Once outliers have been eliminated using one or the 
other statistical test, the remaining data should be retest for additional outliers.  
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However, an important prerequisite is that data should approximate a Gaussian distribution or be 
transformed to fit Gaussian distribution (Horn et al., 2001) because these procedures may 
erroneously identify values located in the tail of skewed distributions as outliers. One of the most 
common methods used for transformation is the method described by Box and Cox (Box and 
Cox, 1964; Gillard, 2012). If data cannot be transformed, the nonparametric approach can be 
directly applied (see below) for RI determination, as outliers have fewer effects on the RI 
calculated with this method (CLSI, 2008).  
Identification of all outliers using the statistical methods described above may not be possible, 
particularly if several outliers are present in one or both extremities (Horn et al., 2001; Solberg 
and Lathi, 2005).  Therefore, a strict selection of the reference sample group as well as a watchful 
control of pre-analytical and analytical procedures are compulsory in order to minimize the 
number of “false” outliers. Finally, the decision to include or exclude “true outliers” should be 
made on a rational basis. 
 
VII.3. SAMPLE SIZE DETERMINATION 
 
Usually, the sample size required for the estimation of the 100α and 100(1- α) percentiles equals 
to 1/α. Thus, the sample size required for estimation of the 2.5th percentile would be 1/0.025= 40 
observations. Nevertheless, as the number of observations increases, precision of percentiles 
becomes more accurate. A sample size of at least 120 subjects has been advocated (Solberg, 
1987b; Harris and Boyd, 1995; Solberg, 1999; CLSI, 2008) when using the nonparametric 
method for determination of RI. For the robust and parametric methods, sample size should be 
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between 40 and 120 observations. The particular case of very small sample sizes in veterinary 
medicine will be discussed later. 
 
VII.4. METHODS FOR DETERMINATION OF REFERENCE INTERVAL  
 
VII.4.A. CONDIDENCE INTERVAL FOR REFERENCE LIMITS 
 
The reference limits of a RI are determined in a selected population but are only estimates of the 
corresponding reference limits in a more general population. Therefore, another sample from the 
same population would probably yields to different reference limits. A useful way to assess the 
variability in samples estimates is to associate a confidence interval (CI) to the percentile that is 
being estimated (CLSI, 2008). In other words, the CI is a range of values including the true 
percentile (2.5th or 97.5th) with a known probability (usually 90%). The CI are useful because 
they provide a quantitative measurement of the estimates variability and may narrow as the size 
of the sampling increases. In the following parts, for each statistical method allowing RI 
determination, method for calculation of the corresponding CI will be provided. 
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VII.4.B. NONPARAMETRIC METHOD 
 
Estimation of the 2.5th and 97.5th percentiles using the nonparametric method consists in cutting 
off a percentage of the values from each tail of the reference distribution. It should be emphasized 
that Gaussian distribution is not required.  
 
Three techniques have been described: 
1. Graphic method: percentiles are determined by plotting the cumulative distribution on a 
graph paper (Figure 8).  
 
 
Figure 8. Graphic determination of the central 95% reference interval (2.5th and 97.5th percentiles) 
for a variable expressed in the “International System of Units” (SI) by plotting the cumulative 
distribution. 
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2. Mathematic method: a function may be fitted to the reference distribution and percentiles 
determined by use of the fitted function. In the present work, the nonparametric method 
was applied for RI determination by using a specific software (Geffré et al., 2011). 
3. Rank numbers method: ranking numbers turns out to be the simplest and is considered 
reliable by the IFCC-CLSI (Solberg, 1987a & 1987b; Petit Clerc and Solberg, 1987; 
Dybkaér 1987; Solberg, 1988; Solberg and Stamm, 1991; CLSI, 2008). To illustrate the 
nonparametric approach, the procedure using the rank number method will be described 
according to Solberg’s description (Solberg, 1999), by determining the RI for plasma 
sodium (expressed in mmol/L) in a 154 healthy small size dog population (see Chapter 
VI entitled “Results” for details). 
 
The procedure is made up of 5 steps: 
a) Sort the n reference values of plasma sodium in ascending order of magnitude (n 
being the sample size). 
b) Rank the values (the minimum value has rank number 1 and the maximum value 
has rank number n).  
 
In our example, the 2 latter points are summarized in the following charts (Tables 4 and 5). 
However, to be clearer for the reader, only the 20 first and 20 last out of the 154 observed values 
of the distribution are presented. 
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Table 4. Observed values, ranked from 1 to 20, for plasma sodium of the 20 healthy small size dogs 
present in the left tail of the distribution. 
Value 
(mmol/L) 
132 135 136 137 138 138 138 139 140 140 
Rank 
number 
1 2 3 4 5 6 7 8 9 10 
Value 
(mmol/L) 
140 140 140 140 141 141 141 141 141 141 
Rank 
number 
11 12 13 14 15 16 17 18 19 20 
 
Table 5. Observed values, ranked from 1 to 20, for plasma sodium of the 20 healthy small size dogs 
present in the right tail of the distribution.  
Value 
(mmol/L) 
151 151 151 151 151 151 151 151 151 151 
Rank 
number 
135 136 137 138 139 140 141 142 143 144 
Value 
(mmol/L) 
152 152 152 152 152 152 152 153 154 154 
Rank 
number 
145 146 147 148 149 150 151 152 153 154 
 
c) Display the rank number of the 100α and 100(1- α) percentiles as α.(n+1) and (1-
α).(n+1), respectively. The limits of the conventional 95% RI have rank numbers 
equal to 0.025.(n+1) and 0.975.(n+1), with n being the total number of subject in the 
studied population (i.e., the sample size). 
 
The calculation of rank numbers of the percentiles in our example (i.e., n= 154 healthy small size 
dogs) is: 
           Lower: 0.025.(154+1)= 3.87  
           Upper: 0.975.(154+1)= 151.1 
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d) Determine the percentiles by finding the original reference values that correspond 
to the displayed rank, provided the rank numbers are integers. Otherwise, 
interpolate between the two limiting values. 
 
           Here is the original value corresponding to these rank numbers in our example: 
           Lower reference limit (2.5th percentile): 137 mmol/L 
           Upper reference limit (97.5th percentile): 152 mmol/L 
 
e) Determine the 90% CI for the 2.5th and 97.5th percentiles using a chart provided 
by the IFCC-CLSI (Table 6).  
 
In our example, the sample size is 154, therefore: 
Regarding the lower reference limit (i.e., the 2.5th percentile), the rank numbers are 1 and 8 
(Table 6) and the corresponding 90% CI are 132 and 139 mmol/L (Table 4). 
Regarding the upper reference limit (i.e., the 97.5th percentile), the rank numbers are:  
 (n+1)-upper rank number, i.e., 154+1-8= 147 (Table 6); 
 (n+1)-lower rank number, i.e., 154+1-1= 154 (Table 6). 
 
 According to Table 5, the corresponding 90% CI are 152 and 154 mmol/L. 
 
 
 
 
CHAPTER II- THE CONCEPT OF REFERENCE INTERVAL 
 
 
68 
Table 6. Rank numbers of the 90% confidence interval of the 2.5th percentile for sample size 
between 119 to 1000 values. To obtain the corresponding rank number of the 97.5th percentile, subtract 
the rank numbers in the table from (n+1). n, sample size. From the International Federation of Clinical 
Chemistry, Expert Panel on Theory of Reference Values: Approved recommendation on the theory of 
reference values: part 5. Statistical treatment of reference values. J Clin Chem Biochem 1987;25:650. 
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Summary:  
The RI for plasma sodium within a population of 154 small size dogs illustrated by the 2.5th and 
the 97.5th percentiles and the 90% CI determined using the nonparametric approach are: 
 
Lower reference limit (CI): 137 (132-139) mmol/L 
Upper reference limit (CI): 152 (152-154) mmol/L 
 
As illustrated here, this method can be easily performed manually, even if a spreadsheet program 
may be used. 
 
VII.4.C. BOOTSTRAP METHOD 
 
This method is an extension of the nonparametric method described above (Shultz et al., 1985; 
Harris and Boyd, 1995; Linnet, 2000). Although it is considered as one of the most reliable 
methods of reference limit and CI determination, a computer is needed because of the heavy re-
sampling requested (Solberg, 1995b).  
 
The method is as follows (Solberg, 1999; Henderson, 2005): 
1. Draw, with replacement, random samples of size “n” from the set of “n” reference values. 
The terms “draw with replacement” mean that each value randomly selected from the set 
is kept in the set so that it may participate in the random selection of the next value. The 
number of re-sampling should be high (500 is a reasonable default number). 
CHAPTER II- THE CONCEPT OF REFERENCE INTERVAL 
 
 
70 
2. For each re-sample, estimate the upper and lower reference limits (percentiles) by the 
nonparametric method described above. 
3. Compute the mean of the resample estimates of the two reference limits and use the two 
mean values as the final estimates. 
4. The 90% CI of each percentile may be calculated as follows:  
x ± 1.645 .  Sx 
 
withx  and Sx corresponding to the mean and standard deviation (SD), respectively.  
 
In case sample size is inferior to 120 observations, percentiles can be estimated by using the 
nonparametric approach and the 90% CI by resorting to the Bootstrap method (CLSI, 2008). 
VII.4.D. PARAMETRIC METHOD 
 
The parametric method is recommended when sample size is comprised between 40 and 120 
observations and assumes that the distribution in Gaussian. Moreover, this method usually 
requires a computer (Solberg, 1995b). The Gaussian distribution of data may be evaluated by 
using one of the following goodness-of-fit tests (CLSI, 2008): 
- Anderson-Darling (recommended by the IFCC-CLSI guidelines) 
- Kolomogorov-Smirnov 
- Shapiro-Wilk 
- D’Agostino and Pearson omnibus. 
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After the normality of data has been tested, there may be three different possibilities: 
 
1. The distribution is Gaussian 
If distribution has an approximately Gaussian shape, the 2.5th and 97.5th
 
percentiles can be 
calculated directly and correspond to: 
x ± 1.960 .  Sx 
 
withx  and Sx corresponding to the mean and SD, respectively.  
 
The 90% CI is estimated as follows:         
percentile ± 2.81 . Sx/n 
 
with Sx and n corresponding to the SD and number of observations in the reference sample group, 
respectively.  
 
2. The distribution is not Gaussian and can be transformed to Gaussian distribution 
If the distribution is not Gaussian, the IFCC-CLSI guidelines recommend transformation by using 
simple methods (square roots and logarithmic functions) or two-stage methods transformations 
(Linnet, 1987), such as exponential function (Manly, 1977) or modulus function (John and 
Draper, 1980). More recently, the Box-Cox transformation has been advocated and recent 
publications suggested that the generalized Box-Cox family (Box and Cox, 1964) could be more 
advantageous. There are two reasons: first, it achieves a lower bias than the two-stage 
CHAPTER II- THE CONCEPT OF REFERENCE INTERVAL 
 
 
72 
transformation; afterwards, the two-stage transformation resulting in percentile estimates may not 
always be back-transformed to obtain the required RI (Gillard, 2012).  
 
After transformation to Gaussian distribution, the estimate of the 2.5th and 97.5th percentiles 
corresponds to: 
y  ± 1.960 . Sy  
 
withy and Sy corresponding to the mean and SD of transformed data, respectively. 
The final step is reconversion of the percentiles to the original data scale with inverse function 
transformations and calculation of 90% CI as follows: 
percentile ± 2.81 . Sy/n 
 
with Sy and n corresponding to the SD and number of observations in the reference sample group, 
respectively. 
 
3. The distribution is not Gaussian and cannot be transformed to Gaussian 
distribution 
If the Gaussian distribution cannot be achieved, two alternatives may be used: 
a) Estimate percentiles and 90% CI using the nonparametric and bootstrap methods, respectively. 
b) Estimate percentiles and 90% CI using the robust approach (see next paragraph), although this 
method is more powerful when reference data have a symmetrical distribution (CLSI, 2008; Horn 
and Pesce 2005). 
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VII.4.E. ROBUST METHOD 
 
The robust approach is a compromise between the parametric and the nonparametric methods. It 
does not require as many observations as the non-parametric procedure (i.e., recommended when 
sample size is 40 ≤ x ≤ 120) and yet does not require that data follow a Gaussian distribution 
(Horn, 1999; CLSI 2008). This method has the same form as the parametric except that it is based 
on iterative processes estimating the location and spread of the distribution (Horn and Pesce 
1998; Horn et al. 1999). The initial location (center) is estimated by the median and the initial 
scale (spread) by the median absolute deviation about the median (Horn and Pesce, 2005; CLSI 
2008). During the process, observations are down-weighted according to their distance from the 
central tendency of the sample. In each iteration, the quantity representing the updated estimate 
of central tendency is calculated until the change in consecutive iterative value is negligible. The 
advantages of this approach is that firstly, it is more tolerant of outliers in the reference 
population data and secondly, it does not require a large sample size compared to the 
nonparametric calculation method. A study showed that the robust statistical analysis was the 
most reliable method for determination of RI from limited or possibly unreliable data compared 
to the nonparametric method (Horn and Pesce, 1998).  
 
VII.4.F. THE CASE OF SMALL POPULATIONS IN VETERINARY MEDICINE 
 
 In veterinary clinical pathology, RI are often determined in small populations such as neonates, 
special species, zoological species and wildlife animals. A study showed that the results of CI 
calculations depend on the hypothesis made about the distribution of values, which cannot be 
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correctly evaluated in small reference sample groups as normality tests lack power. Moreover, 
when the distribution is skewed, the CI of the upper limit is strongly enlarged as skewness 
increases, which means that the true limit is located somewhere in a relatively large interval, 
making users erroneously confident in the upper reference limit (Braun et al., 2013). 
Therefore, the ASVCP Quality Assurance and Laboratory Standards Committee Guidelines for 
the Determination of Reference Intervals in Veterinary Species provided specific 
recommendations regarding determination of RI within small populations (Friedrichs et al., 
2012). 
1. Sample size 20 ≤ x ≤ 40 
The parametric or robust methods should be used when distribution is Gaussian and non-
Gaussian, respectively. Moreover, the following data should be provided to allow clinical 
decisions to be made (Geffré et al., 2009b; Friedrichs et al., 2012): 
- A histogram of the data; 
- Mean (in the case of a Gaussian distribution) or median (in the case of a non-Gaussian 
distribution); 
- The minimum and maximum values or a table of all reference values listed in 
ascending order. 
 
2.   Sample size <20 
Reference interval should not be determined when sample size comprises fewer than 20 
observations. However, several data could be disclosed to allow clinical decisions to be made 
(Friedrichs et al., 2012): 
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- A histogram of the data; 
- Mean (in the case of Gaussian distribution) or median (in the case of non-Gaussian 
distribution); 
- The minimum and maximum values or a table of all reference values listed in 
ascending order. 
 
 
VII.5. PARTITIONING 
 
Partitioning reference values into homogenous population sub-groups is an essential part of RI 
determination as it helps to decrease variability between individuals and narrows the RI (Lahti et 
al., 2002a). Nevertheless, partitioning should not be carried out if there are fewer than 40 
individuals in each sub-group and if the decision to partition is not clinically relevant. 
Several methods have been described in the literature: 
1. Partitioning is recommended if the absolute difference between sub-group means 
exceeds 25% of the reference range (range = upper limit – lower limit) of the combined 
central 95% RI (Sinton et al., 1986). This method requires a Gaussian distribution. 
 
2. Partitioning is recommended if the ratio of sub-group SD (larger SD/smaller SD) 
exceeds 1.5, regardless of the sub-group means (Harris and Boyd, 1990). If this 
criterion is exceeded, Harris and Boyd recommend that sub-group means should be 
compared by the standard normal deviate z-test.  
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Two scenarios are possible:  
a) If each sub-group includes at least 120 samples, then partitioning is recommended if z > 3 
(critical z-statistic). The z value is calculated as follows:  
z = mean1 – mean2 / [(SD1
2
/n1) + (SD2
2
/n2)]
1/2
 
            
with SD1 and SD2, standard deviation of sub-groups 1 and 2, respectively; n1 and n2, number of 
individuals in sub-groups 1 and 2, respectively. 
 
b) If each sub-group includes less than 120 samples, z should be compared to an alternative 
critical z-statistic based on the average size (n) of the sub-groups (alternative critical z-statistic). 
The z value is calculated as follows: 
z = 3 x (n/120)
1/2
 
  
This procedure works optimally when the data has a Gaussian distribution and the subclasses are 
of similar size and SD (Lathi et al., 2004).  
 
3. Partitioning is recommended if the ratio of sub-group SD (larger SD/smaller SD) 
exceeds 1.5. However, if the SD ratio is ≤1.5, the differences between upper (ΔLU) and 
lower (ΔLL) limits of the 2 sub-groups should take the smaller SD of the subgroups into 
account (Lahti et al., 2002b). Hence, partitioning is recommended if ΔLU, ΔLL or both 
are ≥ 0.75 of the smaller SD and not recommended if they are < 0.25 of the smaller SD. 
Again, this method requires Gaussian distribution. 
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4. Partitioning is recommended if more than 4.1% or less than 0.9% of a sub-group falls 
outside the upper or lower limits of a combined RI. On the contrary, if the proportion of 
the sub-group falling outside the combined RI is comprised between 1.8% and 3.2%, 
partitioning is not advised (Lahti et al., 2004). This method has been proposed to 
partition non-Gaussian reference data into sub-groups. 
 
5. Partitioning may be recommended on the basis of non-statistical criteria. Hence, 
partitioning should be considered if the literature indicates important clinical 
differences between sub-groups or if a clinical relevance may be identified (Harris and 
Boyd 1990; CLSI, 2008). To the contrary, partitioning into sub-groups should not be 
undertaken if the physiological differences would not result in important clinical 
differences in RI. Therefore, the process of partitioning should be viewed as a serial 
process including statistical and clinical evidence (Kjelgaard-Hansen, 2010). 
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VIII. CONCLUSION 
 
In conclusion, a “good” RI allows correct inclusion of most of the subjects with characteristics 
similar to the reference group and excludes the others (Ceriotti, 2007). Factors of variation 
known to be responsible for this misclassification are intra-individual, inter-individual and 
analytical (Schneider, 1960; Harris, 1974). The statistical method used to determine the RI 
mainly depends on sample size and distribution of reference values. Therefore, strict procedures 
should be applied to determine a reliable RI and precise reference limits. Furthermore, 
presentation of results in a clear and concise laboratory report is strongly advised in order to 
facilitate transference and validation of RI from other laboratories and also to help clinicians in 
making the most appropriate medical decisions. Finally, although determination of RI is based on 
statistical methods, the associated decision limits (i.e., diagnosis thresholds that are used to 
discriminate between patients with or without disease) should be defined by consensus 
established from clinical investigations (Jorgensen et al., 2004; Plebani, 2004).  
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CHAPTER III. REFERENCE INTERVALS IN VETERINARY 
MEDICINE 
 
 
I. INTRODUCTION 
 
As in human patients, every variable assessed in an animal should be compared with a RI 
previously established within a reference population, in order to find out if the observed value 
can be considered normal or not. Behind this simplicity lies the complexity to interpret such a 
result because biological variables are subjected to high variability, owing to the patient 
himself (breed, age, BW, height, gender, physical status etc.), but also to pre-analytical and 
analytical factors. Moreover, in veterinary medicine, there are plenty of diverse species such 
as mammals, avians, reptiles and there are also lots of phenotypical variations within a 
specific species. This observation has been already emphasized in dogs with BW varying 
from less than 1 kg to more than 100 kg, depending on the breed. Therefore, determination of 
population-based RI is crucial to interpret in the best possible way a veterinary patient test’s 
result. Most of the RI established in veterinary medicine concerns the clinical pathology 
(mainly hematology and biochemistry) but other specialties are also involved, including 
diagnostic techniques such as radiology and echography. However, studies on RI 
determination according to the IFCC-CLSI recommendations in veterinary medicine are 
lacking, except in veterinary clinical pathology, for which this methodology has been 
increasingly used since the last two decades. 
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II. REFERENCE INTERVALS IN VETERINARY 
CLINICAL PATHOLOGY 
 
II.1. INTRODUCTION 
 
In veterinary clinical pathology, a lot of reports illustrated RI determination in wild and 
domestic animals using different statistical methods. However, the first reported RI 
established according to the IFCC recommendations was for plasma creatine kinase in a 
population of 232 healthy dogs (Aktas et al., 1994). Since then, several studies have followed 
the IFCC-CLSI guidelines for RI determination in healthy populations of dogs, cats (Table 7) 
and other animal species (Table 8). Moreover, determination of RI in a diseased population of 
dogs according to the latter guidelines has been undertaken, as shown in one previous study 
including 192 dogs with CHF. In the latter report, RI were established for several serum 
variables (i.e., urea, creatinine, sodium and potassium) in dogs with DMVD (Lefebvre et al., 
2013).  
Within the canine species, since large phenotypic variations have been observed, the effect of 
breed on clinical pathology variables has been well-documented and is known to affect 
interpretation of laboratory test results in a more or less degree. Therefore, it is now 
consensual that breed-specific RI should be established for some biochemical and 
hematological variables in dogs. Since the BW is strongly dependent of the breed, this effect 
may often be confounded by the breed and difficult to identify. Even so, two studies reported 
the effect of BW on serum/plasma creatinine in dogs (Médaille et al., 2004; Craig et al., 
2006). Finally, effect of other covariates (e.g., age and gender) has been reported, but the need 
for partitioning a reference sample group according to the latter covariates remains unclear.  
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Table 7. Studies about the determination of reference intervals in healthy dogs and cats according to the International Federation of Clinical 
Chemistry and the Clinical and Laboratory Standards Institute recommendations in clinical pathology. 
Authors Analyte Breed Number of animals Method 
Reynolds et al., 2008 Plasma biochemistry Adult Domestic shorthair cats 95 Parametric and nonparametric 
Sharkey et al., 2009 Serum biochemistry Four adult large-breed dogs 304 Nonparametric 
Geffré et al., 2010 Coagulation markers Adult pure-breed dogs 139 Nonparametric 
Nielsen et al., 2010  Plasma biochemistry and hematology Adult Bernese Mountain dog 32 Robust  
Reynolds et al., 2010 Plasma biochemistry Five adult pure-breed cats 536 Nonparametric 
Bourgès-Abella et al., 2011 Hematology Adult pure-breed dogs 132 Nonparametric 
Campora et al., 2011a  Hematology Adult Greyhound 304 Nonparametric 
Campora et al., 2011b  Hematology Adult Greyhound and Lurcher 217 Nonparametric and robust  
Dunlop et al., 2011  Plasma biochemistry Adult Greyhound 499 Nonparametric 
Nikolic Nielsen et al., 2011  Coagulation markers Adult Bernese Mountain dog 32 Robust method 
Sako et al., 2011  Plasma biochemistry Dogs <1 year old 896 Parametric and nonparametric 
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Authors Analyte Breed Number of animals Method 
Rosset et al., 2012  Plasma biochemistry and hematology Borzoi and Beagle puppies 31 Parametric and nonparametric 
Serra et al., 2012 Hematology Adult medium and large-breed 259 Nonparametric 
Heilmann et al., 2013 Serum alpha-1-proteinase inhibitor Dogs 87 Nonparametric 
Lavoué et al., 2013 Plasma biochemistry Adult Dogue de Bordeaux 62 Nonparametric 
Lavoué et al., 2014 Hematology Adult Dogue de Bordeaux 58 Nonparametric 
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Table 8. Studies about the determination of reference intervals in different healthy animal species according to the International Federation of 
Clinical Chemistry and the Clinical and Laboratory Standards Institute recommendations in clinical pathology. 
Authors Analyte Species Number of animals Method 
Knowles et al., 2006 Hematology and biochemistry Cultured shortnose sturgeon 77 Nonparametric 
Thoresen et al., 2009 Hematology and biochemistry Scandinavian Grey wolve 79 Parametric 
Klem et al., 2010  Hematology and biochemistry Pig 104 Nonparametric and parametric 
Cooper-Bailey et al., 2011 Hematology and biochemistry Gila monster 14 wild and 2 captive  Descriptive statistics 
Dawson et al., 2011a Biochemistry Alpaca 74 Nonparametric 
Dawson et al., 2011b Hematology and coagulation markers Alpaca 68 Nonparametric 
House et al., 2011  Coagulation markers Alpaca 29 Descriptive statistics 
Hein et al., 2012 Hematology, biochemistry, serum total thyroxine Ferret 111 Robust 
Young et al., 2012 Hematology and biochemistry Wild Australian tree frog 146 Nonparametric bootstrap 
Niedźwiedź et al., 2013 Biochemistry Polish horse 74 Robust 
Matsche et al., 2014 Hematology and biochemistry Captive Atlantic Sturgeon 119 Robust 
Rossi et al., 2014 Hematology and biochemistry Hedgehog 50 Nonparametric bootstrap 
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II.2. EFFECT OF COVARIATE ON LABORATORY VARIABLES IN DOGS 
 
II.2.A. BREED EFFECT 
 
As stated in the introduction, the breed effect is the most commonly reported effect on blood 
variables within the canine species.  
1. Hematology 
A recent study involving more than 6000 dogs from 75 different breeds demonstrated that all 
hematological variables, except the mean corpuscular hemoglobin concentration (MCHC), 
showed significant differences between specific individual breeds and mixed breeds (Lawrence et 
al., 2014). However, this breed effect has been importantly investigated in sighthound dogs and 
especially in Greyhounds (Zaldívar-López et al., 2011; Lefebvre, 2011). Hence, as compared to 
the general canine population, mean and RI in this special breed category were higher for red 
blood cell (RBC) count, HGB, PCV and mean corpuscular volume (MCV), whereas they were 
lower for white blood cell (WBC) and platelet (PLT) counts (Porter and Canaday 1971; 
Campora et al., 2011a & 2011b; Uhríková et al., 2013). Indeed, in a study (Campora et al., 
2011a), mean HGB concentration was higher in Greyhounds (19.8 g/dL) compared to non-
Greyhound dogs (17.1 g/dL) from another report (Moritz et al., 2004). In another study, mean 
WBC and PLT counts were lower in Greyhounds compared to a non-Greyhound group (5.58 
versus 10.55 x 10
9
/ L and 214 versus 338 x 10
9
/L, for WBC and PLT counts, respectively). 
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Similar hematologic differences were observed in Galgos Españoles (Spanish Greyhound), 
although these differences were not as striking as in Greyhounds (Mesa-Sanchez et al., 2012). 
Interestingly, another study showed that more than 78% of Greyhounds had RI regarding PLT 
count below those established in a general population of dogs (Uhríková et al., 2013). 
Additionally, differences within sighthound breeds have also been documented (Uhríková et al., 
2013; Campora et al., 2011b), as shown in Table 9. The most significant difference was 
observed for mean PLT count, which was 2 times higher in Azawakh dogs than in Greyhounds 
(Uhríková et al., 2013). Furthermore, within the sighthound dog category, Lurchers showed 
higher RI for RBC count (6.74-9.90 x 10
12
/L) compared to Greyhounds and non-Greyhounds 
(6.67-9.30 and 5.85-8.40 x 10
12
/L, respectively, Campora et al., 2011b). 
Table 9. Hematological values of eight sighthound breeds. LRI, laboratory reference interval; % ALRI, 
% of dogs above LRI; % ULRI, % of dogs below LRI; Hb, hemoglobin; Hct, hematocrit; MCH, mean 
corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular 
volume; PLT, platelet count; RBC, red blood cell count; WBC, white blood cell count. From Uhríková et 
al. Hematological and biochemical variations among eight sighthound breeds. Aust Vet J 2013;91:452-
459. 
 
CHAPTER III- REFERENCE INTERVAL IN VETERINARY MEDICINE 
 
86 
 
Several other studies pointed out breed particularities in other canine breeds. Firstly, in CKCS, 
low PLT count (less than 150 x 10
9
/L) and greater platelet diameter were observed as compared 
to other breeds, without evidence of excessive bleeding problems, suggesting physiological 
macrothrombocytopenia (Brown et al., 1994). Similarly, this macrothrombocytopenia was 
described in a group of healthy Norfolk Terriers from Northern Italy and also in isolated cases in 
Cairn Terriers (Gelain et al., 2014). However, as far as 1999, a leucopenia was documented in 6 
healthy Belgian Tervurens (Greenfield et al., 1999). Soon after, the same authors (Greenfield et 
al., 2000) performed a study including 180 healthy Belgian Tervurens and showed that, 
compared to other breeds, Tervurens had lower mean WBC (7.04 versus 9.03 x 10
9
/L), neutrophil 
(4.05 versus 5.50 x 10
9
/L) and monocyte (0.65 versus 0.70 x 10
9
/L) counts as well as higher 
mean RBC count (6.62 versus 6.45 x 10
12
/L) and PCV (46.5 versus 44.7%).  
In another report, 10 routine hematological variables were assessed in 32 Bernese Mountain dogs 
(Nielsen et al., 2010). In 8 out of the 10 tested variables, standard laboratory RI were considered 
suitable. However, de novo establishment of new RI was undertaken for 2 variables because RI in 
Bernese dogs were higher than those provided by the standard laboratory (MCHC: 21.2-22.2 
versus 19.2-21.0 nmol/L; eosinophil count: 0-1.5 versus 0-1.2 x 10
9
/L, in Bernese and other 
breeds, respectively). Same observations were found in a population of 96 North American 
Scottish Deerhounds (Sheerer et al., 2013) with a majority of hematological results similar to the 
generic intervals except for PLT count, for which more than 50% of observed values were below 
the nonbreed-specific RI. One more study pointed out an isolated hematological difference in 3 
large breeds compared to the general population (Bourgès-Abella et al., 2011). Hence, median 
eosinophil counts were higher in Brittany Spaniels (1.87 x 10
9
/L), Rottweilers (1.41 x 10
9
/L), and 
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German Shepherd dogs (1.38 x 10
9
/L) compared to the overall population (0.91 x 10
9
/L). 
Recently, dogs from a small size breed (i.e., D) had higher mean PCV (52% versus 50%), mean 
RBC count (7.7 versus 7.1 x 10
12
/L) and HBG concentrations (18.2 versus 16.8 g/dL) compared 
to a mixed-breed population (Torres et al., 2014). Finally, a report (Lavoué et al., 2014) 
emphasized that Dogue de Bordeaux exhibited higher RI compared to the standard laboratory’s 
RI regarding a lot of hematological variables including HGB (12.8-20.6 versus 12.4-19.2 g/dL), 
PCV (35-56% versus 35-52%), MCV (22.6-26.1 versus 21.9-26.3 pg) and MCHC (347-382 
versus 344-381 g/L). To the contrary, this molossoid type breed exhibited lower RI for 
reticulocyte (13.7-128.0 versus 19.4-150.1 x 10
9
/L) and PLT (87-328 versus 108-562 x 10
9
/L) 
counts compared to the generic RI. 
 
2. Biochemistry 
As early as in 1969, a breed effect on serum biochemistry was reported in Beagle dogs (Cramer 
et al., 1969; Pickrell et al., 1974; Craig et al., 2006). As for hematological variables, this effect 
has been more commonly described in Greyhounds (Zaldívar-López et al., 2011; Lefebvre, 
2011). In one previous study including 30 adult healthy Greyhounds, the mean serum creatinine 
concentration (1.6 mg/dL, range 1.2-1.9 mg/dL) in this breed was significantly higher than that in 
30 adult healthy non-Greyhound dogs (1.03 mg/dL, range 0.8-1.7 mg/dL), (Figure 9, Feeman et 
al., 2003). Besides, in 14 out of the 30 Greyhounds (46.6%), the serum creatinine concentration 
was above the RI established in the general canine population. 
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Figure 9. Serum creatinine concentration in Greyhound versus non-Greyhound dogs. The horizontal 
white bar represents the median value. The upper and lower limits of the box represent the 25th and 75th 
percentiles. The whiskers represent the 10th and 90th percentiles. The rounds represent extreme values. 
From Feeman et al. Serum creatinine concentrations in retired racing Greyhounds. Vet Clin Pathol 
2003;32:40-42. 
Another study established RI for 12 biochemical variables in a population of 499 healthy 
Greyhound blood donors. The results showed that RI for total protein, albumin, globulin and 
creatinine differed from the generic RI (Dunlop et al., 2011). The difference was important 
mainly for creatinine (RI in Greyhounds: 99-174 μmol/L versus 20-150 μmol/L in non-
Greyhounds), according to previous studies (Feeman et al., 2003; Steiss et al., 2000).  The low 
serum total protein value in Greyhounds was explained here by low concentrations of alpha- and 
beta-globulins demonstrated in another study (Fayos et al., 2005). Other authors reported that 
basal serum total and free-thyroxine concentrations were significantly lower in Greyhounds than 
in non-Greyhounds, even after thyroxine stimulating and releasing hormones administration 
(Gaughan and Bruyette, 2000). Same results were found regarding serum total thyroxine 
concentration in Basenjis (Seavers et al., 2008). 
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Regarding other breeds, one study (Sharkey et al., 2009) evaluated a total of 16 serum 
biochemical analytes among dogs from 4 different healthy adult large breeds (59 Alaskan 
Malamutes, 78 Siberian Huskies, 90 Golden Retrievers and 77 English Setters). The authors 
found statistically significant differences within the breeds for most of the tested variables (Table 
10). However, the authors stated that there was a large degree of overlap in analyte ranges within 
the different breeds. More interestingly, the between-breed differences for many analytes were 
within the analytical imprecision of the assays. 
Table 10. Pairwise comparison between breeds indicating significant differences (X). AM, Alaskan 
malamute; SH, Siberian Huskies; ES, English Setters and GR, Golden retrievers. From Sharkey et al., 
Breed-associated variability in serum biochemical analytes in four large-breed dogs. Vet Clin Pathol 
2009;38:375-380. 
 
Among 11 evaluated plasma biochemistry variables in 62 healthy Shetland sheepdogs (Sato et 
al., 2000), the plasma cholesterol concentration was significantly higher (mean±SD: 333±311 
mg/dL) in Shetlands than in healthy control dogs from other breeds (191±79 mg/dL).  
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Additionally, in Bernese Mountain dogs (Nielsen et al., 2010), RI derived from the general 
canine population regarding the majority of 18 tested biochemical variables were readily 
applicable. However, for 5 analytes (alkaline phosphatase (ALP), gamma-glutamyl-transferase, 
albumin, cholesterol and total bilirubin), significant deviations were observed, requiring de novo 
establishment of new RI within the breed.  
Moderate to marked differences were observed between RI in Dogue de Bordeaux and generic RI 
for 6 biochemical variables (Lavoué et al., 2013). Hence, as compared to the manufacturer’s RI, a 
marked downward shift for total thyroxine and upward shifts for lipase, activities of aspartate 
(AST) and alanine (ALT) aminotransferases, as well as for total proteins and cholesterol 
concentrations were observed. The most significant difference was identified for lipase activity, 
for which the RI of 75% of Dogues de Bordeaux was largely above the usual RI.  
Among 96 North American Scottish Deerhounds (Sheerer et al., 2013), most of RI were similar 
to the generic RI, although narrower. An exception was the total calcium concentration, for which 
more than 50% of the studied population was below the nonbreed-specific RI. 
Finally, a breed effect has been identified for more specific analytes in dogs such as lipoproteins 
(Downs et al., 1993), C-reactive protein (Wong et al., 2011), immunological and coagulation 
markers (Gerber et al., 2010; Nikolic Nielsen et al., 2011), neuro-hormones such as plasma 
renine, aldosterone (Pedersen et al., 1995b) and endothelin (Moesgaard et al., 2007b), as well as 
hormones involved in calcium homeostasis (Tryfonidou et al., 2003). 
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II.2.B. EFFECT OF AGE  
 
A report including young, healthy, pre-training Greyhounds demonstrated that from the age of 9 
to 10 months, Greyhounds had higher PCV, HGB concentration and RBC counts compared to 
adults (Shiel et al., 2007). These differences were less marked in Greyhounds from 5 to 6 months 
old. Moreover, in the same study, the platelet count correlated negatively with age (Shiel et al., 
2007). In a study including 68 puppies subjected to blood samples at different ages (i.e., 4, 10, 
12, 16, 28, 70, 77 and 84 days), HCT, HGB, and glucose were significantly different at all ages 
(except at day 4) compared to adults for several variables such as sodium, potassium, chloride, 
ionized calcium and magnesium (O’Brien et al., 2014). Same observations were found in a 
population of 896 dogs <1 year old, where age significantly affected plasma albumin, ALT, ALP, 
blood urea nitrogen (BUN), glucose, lipase, and total protein (Sako et al., 2011). The most 
relevant effect of age in the later study was for ALP activity, with a mean of 471 UI/L in dogs 
aged between 4 and 5 months and 231 UI/L in dogs aged between 10 and 11 months. In 
Labradors and Beagles (Harper et al., 2003), RBC counts, HGB concentration, and PCV 
increased during the first year of life whereas WBC count decreased with increasing age. In 
young Beagles < 8 weeks and <1 year, median WBC count was, respectively, 19.0 x 10
9
/L and 
9.9 x 10
9
/L (Harper et al., 2003). In the same report (Harper et al., 2003), plasma ALP activity, 
total protein and total calcium were higher in the first years of life, according to a previous study 
in Beagles (Ikeuchi et al., 1999), whereas plasma phosphorus decreased progressively. Another 
report in the same breed showed that young beagles had a different renal function compared to 
older dogs and characterized by a higher daily urinary volume, glomerular filtration rate, free 
water reabsorption, a lower daily protein excretion, and fractional excretion of phosphorus 
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(Laroute et al., 2005). One report found that WBC, lymphocyte, and neutrophil counts decreased 
significantly with age, the most marked decrease being for the lymphocyte count, which 
decreased by about 50% between the ages of 1 year and 9-10 years (Bourgès-Abella et al., 2011). 
However, in Borzoï and Beagle puppies, there was no significant difference between puppies and 
adults regarding ALT activity, glucose concentration, MCHC, WBC and platelet counts (Rosset 
et al., 2012). Conflicting results were also found regarding the effect of age on hematological and 
biochemical variables in adult Dogue de Bordeaux (Lavoué et al., 2013 & 2014). More 
specifically, mean creatine kinase activity was 2 to 5 times higher in young animals up to one 
year old, after which there was no more significant effect of age (Aktas et al., 1994). 
Additionally, mean serum α-1-acid glycoprotein concentration (i.e., an acute-phase protein and a 
serum marker of inflammation and neoplasia in humans) was lower in newborns (122 mg/L) and 
gradually increased to adult levels (364 mg/L) by 3 months of age (Yuki et al., 2010). Finally, in 
one study, effect of age on thyroid and adrenocortical hormones was also pointed out (Reimers et 
al., 1990).  
 
II.2.C EFFECT OF GENDER  
 
Limited data are available in the literature regarding the effect of gender on blood variables. 
Moreover, as for age, the results remain conflicting. In a population of dogs from different 
breeds, several authors found no effect of gender on biochemical variables such as creatine kinase 
(Aktas et al., 1994), serum α-1-acid glycoprotein concentration (Yuki et al., 2010) and thyroid 
hormones (Reimers et al., 1990). Same observations were found in reports including a specific 
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breed or breed category. Hence, in Greyhounds (Shiel et al., 20017; Dunlop et al., 2011) and 
Dogue de Bordeaux (Lavoué et al., 2013 & 2014), methods to investigate the differences between 
male and female regarding hematological and biochemical RI did not provide any evidence 
supporting data partitioning by gender. To the contrary, a study including Greyhounds found that 
partitioning according to gender was statistically recommended for 8 out of 10 hematological 
variables except PCV and WBC, which fell into the grey zone, leaving the decision to non-
statistical considerations (Campora et al., 2011a). In a population of 132 healthy purebred dogs 
(Bourgès-Abella et al., 2011), gender was a partitioning factor only for PCV and PLT counts, and 
separate RI for males and females were established. Finally, in young dogs (<1 year old), gender 
significantly influenced ALP activity as well as amylase, lipase, and total cholesterol 
concentrations (Sako et al., 2011). 
 
II.2.D. OTHER EFFECTS  
 
Numerous other physiological effects may influence the generation of a RI although some of 
them remain unknown in dogs. Exercise has been the most documented effect in dogs, especially 
in Greyhounds and sled dogs. Training or exercise in sled dogs may induce significant increase in 
sodium, chloride, albumin, calcium, and cortisol concentrations (Angle et al., 2009) as well as a 
decrease in PCV and an increase in WBC count (Davis et al., 2008). In Greyhounds, an increase 
in PCV immediately after racing that return to baseline in few hours has been demonstrated 
(Horvath et al., 2014). Additionally, a study including 15 dogs subjected to an agility test showed 
that this competition induced mild to moderate changes in hematologic and biochemical results 
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consistent with splenic contraction, increased lipolysis, and utilization of anaerobic pathways 
involved in energy re-synthesis in muscles (Rovira et al., 2007). However, in untrained Beagle 
dogs, strenuous exercise did not induce major variations in any of plasma routine plasma 
variables (Chanoit et al., 2002). Diet is also known to affect few biochemical and hematological 
variables in dogs, particularly the cholesterol concentration (Swanson et al., 2004). In one 
previous study, obesity influenced plasma leptin concentration (Ishioka et al., 2007).  Finally, 
other effects such as pregnancy, lactation and neutered status may modify blood variables in 
dogs, but warrant investigations. 
 
II.3. CONCLUSION 
 
In conclusion, most of the studies within the literature agree that the influence of breed on 
hematological and biochemical variables exists in the canine species. However, results are more 
conflicting regarding the effect of age and gender and also the influence of BW, which is often 
confounded by the breed. Some of these effects may be significant, as shown for the creatinine 
values in Greyhounds compared to non-Greyhounds or the ALP activity in young compared to 
adult dogs. However, some differences may have little impact on the clinical interpretation of the 
results, as remarkably pointed out in the study by Sharkey et al (2009), where the differences 
between breeds for most of the biochemical analytes were within the analytical imprecision of the 
assays. Finally, numerous other effects may or may not influence blood variables in dogs but 
remain unknown. 
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III. REFERENCE INTERVAL IN VETERINARY 
CARDIOLOGY 
 
III.1. INTRODUCTION 
 
To date, no RI according to the IFCC-CLSI guidelines have been published in veterinary 
cardiology. However, a lot of studies focused on the evaluation of heart morphology and function 
in healthy dogs by using radiography (Table 11), electrocardiography (ECG, Table 12), cardiac 
biomarkers (Table 13) and echocardiography (Table 14). Moreover, heart evaluation, especially 
by using TTE, has been performed in healthy individuals within other animal species including 
cats (Kayar et al., 2014; Chetboul et al., 2006 & 2012b; Mottet et al., 2012), horses (Blissit and 
Bonagura, 1995; Grenacher and Schwarzwald, 2010), cattle (Hallowell et al., 2007; Buczinski, 
2009), goats (Leroux et al., 2012), pigs (Konrad et al., 2000), ferrets (Malakoff et al., 2012), 
rabbits (Casamian-Sorrosal et al., 2014), hares (Noszczyk-Nowak et al., 2009), dolphins 
(Sklansky et al., 2006; Chetboul et al., 2012c), chimpanzees (Sleeper et al., 2014), gorillas 
(Murphy et al., 2011), manatees (Gerlach et al., 2013), camels (Tharwat et al., 2013), terrapins 
(Poser et al., 2011), hedgdogs (Black et al., 2011), wolves (Estrada et al., 2009), zebras (Adin et 
al., 2007), psittacine birds (Pees et al., 2004) and birds of prey (Straub et al., 2003) and grizzly 
bears (Nelson et al., 2003).  
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Table 11. Studies about radiographic evaluation of heart in healthy dogs. CKCS, Cavalier King Charles Spaniel; SD, Standard deviation. 
 
Authors Breed Number of dogs Age Body weight  Variable Data provided 
Lamb et al., 2001 Boxer, Labrador, 
Doberman, CKCS, 
Yorkshire Terrier, 
German Shepherd 
107 Range: 1.0-15.0 years Data not shown Vertebral heart scale Mean±SD and 95% 
confidence interval 
Sleeper et al., 2001 Golden and Labrador 
Retrievers, Beagle and 
German Shepherd 
puppies 
11 Range: 3.0-36.0 
months 
Range: 5.3-10.0 kg Vertebral heart scale Mean±SD 
Bavegems et al., 2005 Whippet 44 Range: 11.0-142.0 
months 
Range: 9.3-17.2 kg Vertebral heart scale Mean±SD 
Marin et al., 2007 Greyhound 42 Data not shown Data not shown Vertebral heart scale Mean±SD 
Kraetschmer et al., 
2008 
Beagle 19 Range: 3.0-5.0 years Range: 14.5-22.2 kg Vertebral heart scale Mean±SD, range 
Jepsen-Grant et al., 
2012 
Pug, Pomeranian, 
Yorkshire Terrier, 
Dachshund, Bulldog, 
Shih-Tzu, Lhassa 
Apsos, Boston Terrier 
204 Range: 1.5-15.5 years Data not shown Vertebral heart scale Mean±SD 
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Table 12. Studies about electrocardiography in healthy dogs. CKCS, Cavalier King Charles Spaniel; SD, Standard deviation. 
 
Authors Breed Number of dogs Age Body weight  Variable Data provided 
Eckenfels and Trieb, 
1979 
Beagle 432 Range: 187-646 days Range: 5.8-18.5 kg Electrocardiography 
and heart rate 
Range 
Tilley, 1992 Data not shown Data not shown Data not shown Data not shown Electrocardiography Range 
Calvert et al., 1998 Doberman 55 Range: 1-13 years Data not shown Electrocardiography 
(signal average) 
Mean±SD, 
Mean±2SD, range  
Hanton and 
Rabemampianina, 
2006 
Beagle 1880 Range: 13.0-20.0 
months 
Data not shown Electrocardiography Mean±SD, range 
Bavegems et al., 2009 Whippet 105 Range: 10.0-169.0 
months 
Range: 9.3-17.2 kg Electrocardiography Median and 
interquartile range 
Rasmussen et al., 2011 CKCS, Dachshund, 
Cairn Terrier 
50 Range: 2.0-9.0 years Data not shown Holter and heart rate Mean and range 
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Table 13. Studies about cardiac biomarkers in healthy dogs. CKCS, Cavalier King Charles Spaniel; SD, Standard deviation. 
Authors Breed Number 
of dogs 
Age Body weight  Variable Data provided 
Eriksson et al., 2001 
 
CKCS 17 Range: 5.0-9.5 
years 
Range: 6.6-12.0 kg N-terminal pro-atrial-type, brain 
natriuretic peptides, endothelium 
derived relaxing factor, nitrate, nitrite, 
endothelin-1, cyclic guanosine 
monophosphate 
Mean±SD, range 
Sleeper et al., 2001b Mixed breed, Labrador 
retriever, American Pitt Bull 
Terrier, German Shepherd 
and other 
41 Range: 5.0-10.0 
years 
Data not shown Troponin I Range, 90th percentiles with 
95% confidence interval 
Adin et al., 2005 Mixed breed, Boxer, Golden 
and Labrador Retrievers, 
Doberman and other  
54 Mean±SD: 
4.8±3.1 years 
Mean±SD: 24.4±11.2 
kg 
Troponin I 5th and 95th percentiles 
LaVecchio et al., 2009 Greyhound 20 Range: 5.0-9.0 
years 
Data not shown Troponin I Median, range, 25th and 75th 
percentiles 
Kellihan et al., 2009 Mixed breed, Labrador 
Retriever, Keeshonds, 
American Staffordshire 
Terrier and other  
53 Range: 0.8-10.0 
years 
Range: 6.8-50.0 kg N-terminal pro-brain-type 
natriuretic peptide 
Median, range, 25th and 75th 
percentiles 
Sjöstrand et al., 2014 Labrador retriever, Belgian 
and German Shepherds, 
Finnish Lapphund and other  
535 Median: 3.3 
years 
Median: 30.2 kg N-terminal-pro-brain-type and 
pro-atrial-type natriuretic peptides 
Median and interquartile 
range 
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Table 14. Studies about echocardiography in healthy dogs. CKCS, Cavalier King Charles Spaniel; SD, Standard deviation; ST, speckle 
tracking imaging; TDI, tissue Doppler imaging; 2D, bidimensional. 
Authors Breed Number 
of dogs 
Age Body weight Variable Data provided 
Boon et al., 1983 Beagle, Golden Retriever, 
Dingo, Doberman and other  
20 Range: 0.5-6.0 years Range: 9.8-28.6 kg M-mode echocardiography Mean±SD, range, 95% confidence 
interval 
Lombard, 1984 Data not shown 40 Range: 1.0-9.0 years Range: 5.0-44.0 kg M-mode echocardiography Mean±SD 
Gooding et al., 1986 English Cocker Spaniel 17 Range: 2.0-7.0 years Range: 8.5-16.3 kg M-mode echocardiography Mean±SD 
O’Grady et al., 1986 Data not shown 18 Range: 0.8-5.5 years Range: 5.5-30.0 kg M-mode echocardiography Mean±SD, range, regression 
equation 
Yuill and O’Grady, 
1991 
Data not shown 20 Range: 1.5-8.0 years Range: 3.0-41.0 kg Standard Doppler Mean±SD 
Crippa et al., 1992 Beagle 50 Around 28 weeks Mean: 8.9 kg M-mode echocardiography Mean±SD, range 
Morrison et al., 1992 Miniature Poodle, Pembroke 
Welsh Corgi, Afghan Hound, 
Golden Retriever 
80 Range: 2.0-7.0 years Range: 1.4-41.0 kg M-mode echocardiography Median and range 
Bayon et al., 1994 Spanish Mastiff 66 Range: 1.0-12.0 months Range: 3.3-52.4 kg M-mode echocardiography Mean±SD 
Snyder et al., 1995 Greyhound 11 Mean±SD: 5.5±2.5 years Mean±SD: 25.0±36.3 kg M-mode echocardiography Mean±SD, range, regression 
equation 
Page et al., 1996 Greyhound 16 Adult Range: 20.7-32.5 kg M-mode echocardiography Mean±SD, range 
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Authors Breed Number 
of dogs 
Age Body weight  Variable Data provided 
Lonsdale et al., 1998 Greyhound 55 Range: 1.5-11.0 years Range: 21.9-39.0 kg M-mode echocardiography Mean±SD 
Vollmar et al., 1999 Irish Wolfhound 262 Range: 1.0-8.5 years Range: 48.0-93.0 kg 2D and M-mode 
echocardiography 
Mean±2SD 
Della Torre et al., 
2000 
Greyhound, Whippet and Italian 
Greyhound 
60 Range: 2.0-9.0 years Range: 3.2-31.5 kg 2D, M-mode and standard 
Doppler echocardiography 
Mean±SD 
Gonçalves et al., 
2002 
Data not shown 69 Mean±SD: 4.1±2.6 years Range: 3.9-97.7 kg M-mode echocardiography Equation for 95% predictive 
interval 
Hansson et al., 2002 CKCS 56 Mean±SD: 5.2±2.6 years Mean±SD: 8.7±1.4 kg 2D and M-mode 
echocardiography  
Mean±SD, range 
Brown et al., 2003 Golden and Labrador Retrievers, 
Great Dane, mixed-breed 
53 Median: 5.3; Range: 0.12-
12.7 years 
Median: 24.6 
Range: 2.3-76.4 kg 
M-mode echocardiography Ratio indices based on aortic root or 
weight-based aortic root 
O’Leary et al., 2003 Bull Terrier 14 Range: 9.0-30.0 months Range: 18.0-32.0 kg 2D, M-mode and standard 
Doppler echocardiography 
Equation for 95% predictive 
interval 
Cornell et al., 2004 CKCS, Dachshund, Boxer, Irish 
Wolfhound and other  
494 Data not shown Range: 2.2-95 kg M-mode echocardiography Linear regression analysis and 
prediction intervals 
Baumwart et al., 
2005 
Data not shown 45  Range: 0.6-8.0 years Range: 3.0-55.0 kg Tei index of right myocardial 
performance 
Mean±SD and 95% confidence 
interval 
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Authors Breed Number 
of dogs 
Age Body weight  Variable Data provided 
Chetboul et al., 2005 Beagle, German Shepherd, 
Belgian Malinois, Golden 
Retriever and other  
100 Range: 0.4-8.8 years Range: 6.0-49.0 kg 2D, M-mode, standard Doppler 
and Tissue Doppler imaging 
echocardiography 
Mean±SD, range 
Hetyey et al., 2005 Irish Wolfhound, Bull Mastiff, 
Caucasian and German 
Shepherds and other  
20 Range: 0.5-13.0 years Range: 1.0-60.0 kg 2D echocardiography  Raw data 
Kayar et al., 2006 German Shepherd 50 Data not shown Range: 28.0-40.0 kg 2D and M-mode 
echocardiography  
Mean±SD 
Muzzi et al., 2006 German Shepherd 60 Range: 1.0-5.0 years Range: 22.0-37.0 kg 2D, M-mode and standard 
Doppler echocardiography 
Mean±SD 
Bavegems et al., 
2007 
Whippet 125 Mean±SD: 4.9±3.2 years Mean±SD: 13.2±2.1 2D, M-mode and standard 
Doppler echocardiography 
Mean±SD, range, mean±2SD 
Cunningham et al., 
2008 
Boxer 81 Median: 6.1; Range: 2.1-
11.0 years 
Median: 28.9; Range: 
18.9-40.5 kg 
2D, M-mode and standard 
Doppler echocardiography 
Median, range and weight-based 
ratio indices 
Lobo et al., 2008 Estrela Mountain dog 74 Range: 18-123 months Range: 30.0-75.0 kg 2D, M-mode and standard 
Doppler echocardiography 
Mean±SD, mean±2SD 
Serres et al., 2009b CKCS, mixed breed, Labrador 
and Golden Retrievers and other  
50 Range: 0.8-13.0 years Range: 1.8-52.0 kg 2D and Doppler 
echocardiography (pulmonary 
to systemic flow ratio) 
Mean±SD, range 
Vöros et al., 2009 Hungarian Vizla, Mudi and 
Hungarian Greyhounds 
95 Range: 6.0-10.0 years Range: 12.5-32.5 kg 2D and M-mode 
echocardiography  
Mean±SD, range 
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Authors Breed Number 
of dogs 
Age Body weight  Variable Data provided 
Diez-Prieto et al., 
2010 
Beagle 6 4 to 21 months 7.2-10.9 kg 2D, M-mode and standard 
Doppler echocardiography 
Mean±SD at 4, 7, 10, 13, 17 and 21 
months 
Griffiths et al., 2011 Shih-Tzu, Boxer, Tornjak, 
Greyhound, Beagle 
10 Range: 1.5-7.0 years Range: 5.5-41.7 kg ST echocardiography 
(ventricular synchrony) 
Mean±SD, range 
Locatelli et al., 2011 Dogue de Bordeaux 31 Mean±SD: 30.1±7.8 
months 
Mean±SD: 51.2±6.5 kg 2D, M-mode and standard 
Doppler echocardiography 
Range and regression equation 
Simak et al., 2011 Doberman 100 Mean±SD: 6.3±1.9 years Mean±SD: 36.2±4.6 ST echocardiography and TDI Mean±SD, range 
Pariaut et al., 2012 Data not shown 50 Data not shown Mean±SD: 16.0±10.5 kg M-mode echocardiography 
(triscuspid annular plane 
systolic excursion) 
Range, 2.5th and 97.5th percentiles  
Stephenson et al., 
2012 
Great Dane 40 Data not shown Data not shown M-mode and 2D 
echocardiography 
Median, 2.5th and 97.5th 
percentiles  
Höllmer et al., 2013 Chihuahua, Border Terrier, 
Dachshund, CKCS and other  
237 Range: 1.0-15.4 years Range: 1.9-92.0 kg 2D echocardiography Mean±SD 
Jacobson et al., 2013 Border Collie 20 Range: 2.0-12.0 years Range: 15.0-29.0 kg 2D, M-mode and standard 
Doppler echocardiography 
Mean±SD, range, 95% confidence 
interval  
Westrup and 
McEvoy, 2013 
Irish Wolfhound 46 Range: 1.0-8.2 years Range: 53.0-85.0 kg ST echocardiography Mean±SD 
Smets et al., 2014 Boxer 85 Range: 1.0-14.5 years Mean±SD: 29.8±4.6 kg Conventional echocardiography 
(ejection fraction of left 
ventricle) 
Mean±SD 
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III.2. EFFECT OF COVARIATES ON CARDIOLOGIC VARIABLES IN DOGS 
 
III.2.A. EFFECT OF BODY WEIGHT 
 
1. Radiographic and echocardiographic variables 
The effect of BW on heart size assessed by thoracic radiographs and TTE has been demonstrated 
in many studies in dogs because size of the heart is strongly correlated to BW (Lombard et al., 
1984; Sisson and Schauffer, 1991). In the radiographic assessment of the heart, determination of 
VHS has been proposed to encompass the BW effect (Buchanan and Bücheler, 1995). Hence, 
VHS allows assessment of lengths of long and short axis of the heart scaled against the length of 
vertebrae dorsal to the heart (i.e., a BW-dependent variable). Concerning TTE, all studies (Table 
14) agree that a BW effect exists on echocardiographic variables, especially for M-mode 
measurements of left ventricle diameter and wall thickness, Ao and LA. Therefore, authors have 
developed different mathematical equations from general canine populations to predict M-mode 
RI according to BW (Lombard et al., 1984; O’Grady et al., 1986; Jacobs and Mahjoob, 1988; 
Morrison et al., 1992; Gonçalves et al., 2002; Cornell et al., 2004), body surface area (Boon, 
1983) and aortic root dimension (Brown et al., 2003). As an example, according to Cornell et al., 
2004, the 95% prediction interval of LVED is 19.0-28.0 mm and 38.0-55.0 in dogs weighing 
respectively 4 and 40 kg. Similarly, these methods have been applied to specific breeds, as 
described in Spanish Mastiffs (Bayon et al., 1994), Greyhounds (Snyder et al., 1995), Bull 
Terriers (O’Leary et al., 2003), Boxers (Cunningham et al., 2008) and Dogues de Bordeaux 
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(Locatelli et al., 20011). While considering Doppler echocardiography, a BW effect was reported 
but considered modest by the authors for pulmonary and aortic velocities assessed by continuous 
wave Doppler (Brown et al., 1991; Yuill and O’Grady, 1991). Additionally, no significant BW 
effect was observed for isovolumic relaxation time (Schober and Fuentes, 2001), trans-mitral 
(Yuill and O’Grady, 1991; Schober and Fuentes, 2001) or trans-tricuspid flows (Yuill and 
O’Grady, 1991).  
 
2. Electrocardiographic variables 
Studies on ECG and Holter examination did not find any BW effect in Beagles (Eckenfels and 
Trieb, 1979; Hanton and Rabemampianina, 2006), Dobermans (Calvert et al., 1998) and 
Whippets (Bavegems et a., 2009), as well as in CKCS, D and Cairn Terriers (Rasmussen et al., 
2011).  
 
3. Cardiac biomarkers 
The effect of BW on cardiac biomarkers has been poorly investigated. Most of the studies did not 
identify any age or BW effect on the biomarker NT-proBNP (Boswood et al., 2008; Tarnow et 
al., 2009; Kellihan et al., 2009; Oyama et al., 2008; Ettinger et al., 2012). However, one study 
performed in 539 healthy dogs from 9 different breeds including CKCS found that NT-proBNP, 
but not pro-ANP concentration, was significantly increased with increasing BW (Sjöstrand et al., 
2014). To the contrary, NT-proBNP was inversely related to BW in a group of 39 asymptomatic 
CKCS with DMVD (Tarnow et al., 2009). Another study identified a positive correlation 
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between NT-proBNP and BW in a group of 40 healthy control dogs (Oyama et al., 2008). In 
CKCS, NT-proANP concentration decreased with increasing BW, whereas no effect was found 
regarding the BNP (Eriksson et al., 2001). Nevertheless, although a correlation was identified, 
the magnitude of BW effect on cardiac biomarker concentration in dog was not investigated. 
 
III.2.B. EFFECT OF BREED 
 
1. Radiography and echocardiography 
In 1992, Morrison et al. performed a study on M-mode echocardiographic measurements 
including 80 healthy dogs from 4 different breeds and somatotypes (Pembroke Welsh Corgi, MP, 
Afghan Hound and Golden Retriever). Interestingly, the results showed that for 10 out of 11 M-
mode variables, means were significantly different between all breeds after the differences in BW 
were taken into account. The authors concluded therefore that not only the BW, but also the 
breed, must be taken into account while establishing echocardiographic RI. Soon after, numerous 
studies started to illustrate breed effect in veterinary cardiology. Concerning heart radiography, 
one study (Lamb et al., 2001) reported that normal Boxer dogs had significantly higher VHS 
mean value (i.e., 11.6) compared to 3 other large breeds (e.g., mean VHS: 9.7 in German 
Shepherd, 10.0 in Dobermans and 10.8 in Labradors). The same observation was made between 
YT and CKCS (mean VHS: 9.7 versus 10.6, in YT and CKCS respectively) and between 
Greyhounds and other breeds (Bavegems et al., 2005; Marin et al., 2007). Another study (Jepsen-
Grant et al., 2013) showed that brachycephalic dogs (Pugs, Bulldogs, Boston Terriers) and 
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Pomeranians had significantly higher VHS compared to the previously published RI (Buchanan 
and Bücheler, 1995). 
Considering echocardiography, sighthound dogs have again been the most commonly studied 
breed category. Greyhounds have been reported with an increased heart weight to BW ratio and 
gross evidence of myocardial thickening as well as chamber dilation compared to other breeds 
(Schneider et al., 1964; Steel et al., 1976). These observations were further demonstrated in this 
breed by using TTE (Page et al., 1993; Snyder et al., 1995) and were more striking in trained 
versus non-trained dogs (Lonsdale et al., 1998). The same findings were emphasized in 105 
healthy adult Whippets (Bavegems et al., 2007). Regarding LVED and LVES measurements, 
29.6% and 35.2% of Whippets were above the predictive value established by Cornell et al., 
2004. 
One study reported that several healthy English Cocker Spaniels had low fractional shortening 
but the reason of such a finding remained unclear (Gooding et al., 1986). Moreover, compared to 
other breeds, German Shepherds (Muzzi et al., 2006) and Border Collies (Jacobson et al., 2013) 
had larger left ventricle diameter, whereas Bull Terriers (O’Leary et al., 2003) and Boxers 
(Cunningham et al., 2008) exhibited larger left ventricular wall thicknesses, LA diameter, greater 
aortic velocity and smaller aortic root size. 
 
2. Electrocardiography 
A study showed that ECG characteristics in Whippets were similar to those reported in human 
athletes (Bavegems et al., 2007). Regarding some parameters (P-wave amplitude, ST-segment 
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deflection and T-wave amplitude, R-wave amplitude), a marked percentage (i.e., 21 to 81%) of 
the Whippet values were above the published maximum reference limits established in other 
dogs. The most important difference was for the median R-wave amplitude, which was higher in 
Whippets and could have been considered as pathological in such a dog when compared to a non-
Whippet RI. Additionally, a study in small size dogs (including CKCS and D) showed that 15 out 
of 27 Holter-derived variables were significantly influenced by the breed (Rasmussen et al., 
2011). 
 
3. Cardiac biomarkers 
The breed effect on troponin I concentration has only been evaluated within Greyhounds. In one 
previous study (LaVecchio et al., 2009), retired racing Greyhounds had significantly higher 
median troponin I concentration (0.08 ng/mL) compared to a non-Greyhound group (0.02 
ng/mL), requiring specific RI establishment. However, no difference was found between 
Greyhounds and a group of healthy Boxer dogs (Figure 10). 
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Figure 10. Box-and-whisker plot depicting the serum troponin I concentrations in healthy 
Greyhound, non-Greyhound and Boxer dogs. The horizontal bar represents the median value and the 
whiskers represent the 2.5% and 97.5 percentiles. From LaVecchio et al. Serum cardiac troponin I 
concentration in retired racing greyhounds. J Vet Intern Med 2009;23:87-90. 
 
Considering natriuretic peptides, a recent study involving 535 healthy dogs from 9 different 
breeds showed that significant differences exist between breeds (Sjöstrand et al., 2014). Plasma 
proANP concentration was lowest in Doberman Pinschers, with a median concentration almost 
half of the median values in German Shepherds and CKCS, which had the highest concentrations 
(Figure 11A). Moreover, concentrations of plasma NT-proBNP were lowest in D, whereas 
Labrador Retrievers and Newfoundlands had the highest concentrations with median values 3 
times the median value in D (Figure 11B). 
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Figure 11. Boxplots showing distribution of the natriuretic peptides pro-atrial-type (ANP 31-67, 
Figure 11A) and N-terminal pro-brain-type (NT-proBNP, Figure 11B) by breed. The top, bottom, and 
line through the middle of each box correspond to the 75th percentile (top quartile), the 25th percentile (bottom 
quartile) and the 50th percentile (median), respectively. The whiskers extend from the bottom 2.5th percentile to the 
top 97.5th percentile. Outliers are represented by black dots. Box, Boxer; BS, Belgian Shepherd; CKCS, Cavalier 
King Charles Spaniel; Dach, Dachshund; Dob, Doberman Pinscher; Fin L, Finnish Lapphund. From Sjöstrand et al. 
Breed differences in natriuretic peptides in healthy dogs. J Vet Intern Med 2014;28:451-457. 
 
III.2.C. EFFECT OF AGE 
 
1. Radiography and echocardiography 
In adult dogs, no significant effect of age on VHS has been demonstrated. Similarly, in growing 
puppies, although absolute measurements (e.g., lateral and dorso-ventral long and short axis of 
the heart) increase with age as expected, differences among VHS measurements at 3, 6 and 12 
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months were not significant (Sleeper et al., 2001). Regarding TTE variables, the effect of age has 
been documented in several breeds or breed categories, but results remain conflicting, especially 
in adults. In growing Beagle aged between 4 and 21 months, a significant effect of age was 
demonstrated for variables reflecting heart size such as ventricular diameter and wall thicknesses. 
However, variables evaluating systolic and diastolic function were not affected by age (Diez-
Prieto et al., 2010). In adult German Shepherds, no correlation was found between age and M-
mode (Kayar et al., 2006; Muzzi et al., 2006) or Doppler (Muzzi et al., 2006) echocardiographic 
variables. However, in Dogues de Bordeaux >12 months old, age was positively associated with 
left ventricular wall thicknesses, left ventricular mass and right ventricular diameter (Locatelli et 
al., 2011). Additionally, increasing age resulted in a decrease in pulmonary velocity. 
Nevertheless, the differences were negligible as illustrated by the low slope coefficients found in 
the regression equation model. Hence, a difference in 5 years between 2 Dogues de Bordeaux 
will result in a 0.33 mm increase in right ventricular diameter, a 3.4 g increase in left ventricular 
mass and a 0.05 m/s decrease in maximal pulmonary velocity (Locatelli et al., 2011). Same 
results were found in Irish Wolfhounds (Vollmar et al., 1999) and Estrela Mountain dogs (Lobo 
et al., 2008) regarding several M-mode, bidimensional and Doppler variables. In 3 Hungarian 
breeds, a positive correlation was found between LA/Ao ratio and age, but the clinical relevance 
of such a finding was not investigated (Vörös et al., 2009). Finally, an age effect was found 
concerning several Doppler variables reflecting left ventricle diastolic function. One study 
(Schober et al., 2001) reported that the isovolumic relaxation time was significantly higher in 
dogs > 13 years compared to young dogs <2 years and that mitral E wave decreased whereas A 
wave increased with increasing age, resulting in a decreased E/A ratio (Schober et al., 2001). 
These findings were consistent with increasing ventricular stiffness, delayed relaxation and 
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altered diastolic function in old dogs, as previously described in human’s elderly (Gardin et al., 
1998). 
 
2. Electrocardiography 
In CKCS, D and Cairn Terriers, no effect of age was found on Holter variables (Rasmussen et al., 
2011). Other report studying ECG did not evaluate the age effect. 
 
3. Cardiac biomarkers 
Only few studies reported the effect of age on cardiac biomarkers and the clinical relevance of 
this effect remains unclear. In a study including 453 healthy Doberman Pinschers (Wess et al., 
2010), mean serum cardiac troponin I was significantly higher in dogs > 8 years (0.22 ng/mL) 
compared to younger dogs (0.12 ng/mL in dogs between 6-8 years and 0.03 ng/mL in dogs 
between 2-4 years). Additionally, plasma NT-proBNP concentration was significantly increased 
in healthy Doberman Pinschers > 8 years as compared with younger dogs (median: 295 versus 
395 pmol/L) from the same breed (Wess et al., 2011). In CKCS, only plasma NT-proANP was 
positively associated with age, as shown in Figure 12 (Eriksson et al., 2001).  
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Figure 12. Linear regression plot for plasma N-terminal atrial-type natriuretic peptide (NT-ANP) 
concentrations in 17 healthy Cavalier King Charles Spaniels. The regression formula is Y = 184.9 + 
25.4x with Y, the NT-ANP concentration and x, the age of the dogs. From Eriksson et al. Effect of age and 
body weight on neurohumoral variables in healthy Cavalier King Charles spaniels. Am J Vet Res 
2001;62:1818-1824. 
 
III.2.D. EFFECT OF GENDER 
 
1. Radiography and echocardiography 
The VHS in Beagle dogs was not different according to gender (Kraetschmer et al., 2008). 
However, in a study including 6 different small and large breed dogs (Lamb et al., 1991), as well 
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as in Greyhounds (Marin et al., 2007), females had smaller VHS than males, but the magnitude 
of such a result was not investigated.  
Concerning echocardiography, a gender effect has been reported in several studies whereas no 
effect was observed in Irish Wolfhounds (Vollmar et al., 1999), Hungarian dogs (Vörös et al., 
2009) and Border Collies (Jacobson et al., 2014). In German Shepherds, one study did not find 
any gender effect on echocardiographic variables (Kayar et al., 2006), whereas another report 
found a significant difference between males and females only for thicknesses of left and right 
ventricular walls (Muzzi et al., 2006). In Beagles (Crippa et al., 1992), among 10 M-mode 
variables, only the left ventricular free wall (in both systole and diastole) was higher in males 
than in females (14.3% and 21.0% higher, respectively). In Whippets, although no significant 
difference in BW was observed between males and females, the later had larger left ventricular 
dimension, higher E-point to septal separation and also higher pulmonary velocity flow than 
males (Bavegems et al., 2007). In Dogues de Bordeaux, only the end-diastolic left ventricular free 
wall thickness was influenced by gender but the difference was not relevant according to the low 
slope coefficient in the regression equation (i.e., 0.024). Finally, in Estrela Mountain dogs (Lobo 
et al., 2008), a significant effect of gender was demonstrated for interventricular septum 
thickness at end-systole and left ventricular diameter at end-diastole, leading to the determination 
of separate RI for these variables. However, there was a large overlap between RI in males and 
females. 
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2. Electrocardiography 
In Beagle (Hanton et al., 2006), CKCS, D and Cairn Terrier dogs (Rassmusen et al., 2011), no 
major differences in ECG variables between males and females. In Whippets (Bavegems et al., 
2009), males had significantly larger R wave amplitude than females (4.58 versus 4.13 mV, 
respectively). This difference, however, was no longer significant when the model was adjusted 
for weight and age (P = 0.28). 
 
3. Cardiac biomarkers 
No study identified a gender effect on the cardiac troponin I concentration. Regarding other 
natriuretic peptides, a recent report including 116 healthy control dogs found an effect of gender 
and neutered status (Wolf et al., 2013), with intact females having higher mean plasma NT-
proBNP and NT-proANP values than intact males (i.e., 593 versus 315 pmol/L and 1036 versus 
836 fmol/L, respectively). However, when considering only spayed dogs, no significant effect of 
gender was observed (Wolf et al., 2013).  
 
III.2.E. OTHER EFFECTS 
 
In sled dogs, the effect of endurance training has been reported to modify ECG variables such as 
decrease heart rate, increase of QRS duration and QT-interval prolongation, reflecting exercise-
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induced cardiac hypertrophy also called athletic heart syndrome (Constable et al., 1994 and 
2000). This syndrome has been described by using TTE in sled dogs and Greyhounds, with an 
eccentric hypertrophy of the left ventricle (Lonsdale et al., 1998; Stepien et al., 1998).  
Pregnancy is also known to induce mild echocardiographic (Abbott, 2010) changes in healthy 
bitches such as increased FS (%), pulmonary and aortic ejection velocities and mitral E-wave. 
Regarding body condition, left ventricular hypertrophy and diastolic dysfunction have been 
documented in several obese dogs (Mehlman et al., 2013). Finally, a recent study showed that 
emotional stress affected peak aortic velocity in healthy Boxers and Boxers with sub-aortic 
stenosis (Pradelli et al., 2014). 
 
III.3. CONCLUSION 
 
A consensus between studies exists regarding the effect of BW on echo-Doppler variables. 
Moreover, the breed should be taken into account when establishing such RI because canine 
breeds may have particularities, as demonstrated in athletic breeds such as the Greyhound. 
However, the effect of age and gender is more controversial and considered clinically irrelevant 
in most of the cases. Regarding ECG, radiography and cardiac biomarkers, only few studies 
investigated the effect of physiological covariates such as breed, BW, age and gender. Therefore, 
further studies are needed to clearly identify their impact on clinical cardiology. 
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Small size dogs are very common in France, especially the following 7 breeds: CKCS, KCS, B, 
YT, D, MP, ST. These breeds are among the most common breeds seen in veterinary medical 
consultations, especially in urban areas. Unfortunately, these dogs are predisposed to develop 
DMVD, which is the most common heart disease in the canine species. Echocardiography 
represents the gold standard for the diagnosis of DMVD. Moreover, TTE variables, alone or in 
combination with cardiac and non-cardiac biomarkers assessment (plasma NT-proBNP and 
creatinine) can be used to assess severity of the disease and its complications, as well as to 
provide reliable data regarding prognosis and efficacy of medical therapy. However, other 
variables of interest, such as albumin, sodium, potassium chloride and PCV have been shown to 
be altered in the course of CHF in humans and dogs, but their prognostic significance remains 
unclear in dogs and warrants further investigations. To adequately interpret echocardiographic or 
blood variables in a dog with heart disease, they should be compared with a RI established in a 
healthy population. For this purpose, experts from the IFCC-CLSI (in humans medicine) and the 
ASVCP (in veterinary medicine) wrote specific recommendations including definition and 
establishment of RI. In dogs, numerous RI have been determined in veterinary medicine 
regarding biochemical and hematological variables for a specific breed or breed category. 
However, no study specifically focused on small size dogs. Regarding echocardiographic 
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variables as well as plasma NT-proBNP, no RI according to the IFCC-CLSI guidelines have been 
reported in the literature. Therefore, the purposes of the present work were to assess the effects of 
breed, BW, age, and gender and to determine RI according to the IFFC-CLSI guidelines for PCV, 
routine plasma biochemistry and plasma NT-proBNP, as well as for conventional 
echocardiographic and standard Doppler variables in healthy adult small size dogs. 
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CHAPTER V- MATERIAL AND METHODS- OVERALL 
PRESENTATION 
 
 
 
The purpose of this section is to describe the material and methods used in the present work: 
 
- In study 1: “Basal plasma concentrations of routine variables and packed cell volume in 
clinically healthy adult small size dogs: effect of breed, body weight, age, and gender, and 
reference intervals.” 
 
- In study 2: “Basal plasma concentrations of N-terminal pro-B-type natriuretic peptide in 
clinically healthy adult small size dogs: effect of body weight, age, gender and breed, and 
reference intervals.” 
 
- In study 3: “Conventional echocardiographic and Doppler examinations in clinically 
healthy adult Cavalier King Charles Spaniels: effect of body weight, age and gender, and 
reference intervals.” 
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I. ANIMALS 
 
I.1. CANINE BREED 
 
In all studies, the following small size pure-breed dogs were selected regarding to their 
predisposition to develop DMVD (Chetboul et al., 2004a, Serfass et al., 2006),
 
as well as the 
breed distribution in France (Société Centrale Canine, LOF Registration Statistics, 2012): 
MP, YT, ST, D, CKCS, KCS and B. 
In studies 1 and 2, all animals were breeder-owned dogs living in the area of Paris, France. 
The breeders were contacted by phone by the investigator before inclusion. An animal 
information form and an owner consent request were sent to the breeders. A maximum of ten 
dogs was recruited for a given breeder in order to avoid any bias on the final results due to 
breeder-dependent environmental effects (housing, diet, exercise, etc.). Recruitment of the 
different breeds was performed in a parallel design and not sequentially. In other words, the 
study was initiated for all the breeds simultaneously to avoid bias due to potential period 
effects.  
In study 3, animals were breeder or client-owned dogs presented at the Cardiology Unit of 
Alfort, National Veterinary School of Alfort, Maisons-Alfort, France for echocardiographic 
screening. 
In studies 1 and 2, all the 7 breeds cited above were selected (MP, YT, CKCS, KCS, D, B and 
ST). In study 3, only CKCS were included. 
 
 
 
CHAPTER V- MATERIAL AND METHODS- OVERALL PRESENTATION 
 
121 
 
I.2. AGE 
 
In studies 1 and 2, selected dogs were adult animals ( 10 months and < 9 years). For each 
breeder, as much as possible, dogs over a wide range of ages were included, to avoid 
confounding factors between age and breeder.  
In study 3, the animals were breeder or client-owned adult CKCS dogs ( 12 months), 
presented for echocardiographic screening. As much as possible, dogs over a wide range of 
ages were included. For each study, the accurate date of birth was known and checked from 
the pedigree. 
 
I.3. GENDER 
 
A sex ratio (male:female) of 1:1 was obtained as much as possible. A sex ratio of 2:3 or 3:2 
was considered as acceptable. Only intact dogs were included.  
 
I.4. BODY WEIGHT AND BODY CONDITION SCORE 
 
The BW had to match the standard of the breed. Additionally, in studies 1 and 2, a body 
condition score (BCS) was assigned for each dog using a 9-point BCS scale (Laflamme et al., 
1997). Briefly, body condition scoring is a technique used to assess the fat (or lack thereof) 
found in a dog. The BCS is measured on a scale from 1 to 9 (Figure 13), where 1-3 is very 
thin to thin, 4-5 is ideal, and 6-9 is heavy to obese. 
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Figure 13. Body condition system in dogs based on a 9-point scale. From Nestlé Purina. 
 
I.5. PHYSIOLOGICAL CONDITION 
 
All the recruited dogs had to be healthy. Female dogs had to be non-lactating, non-pregnant 
and in anoestrus. 
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I.6. POST-PRANDIAL STATUS 
 
Because dogs in studies 1 and 2 underwent plasma biochemistry and NT-proBNP dosages, an 
overnight 10-hour fasting was scheduled. Dogs could have free access to water. 
 
II. INCLUSION CRITERIA 
 
The inclusion criteria were as follows: 
- Dogs had to be individually identified; 
- Dogs had to be regularly vaccinated and dewormed (studies 1 and 2); 
- Dogs had to be pure-breed dogs (i.e., a copy of the pedigree had to be provided). In 
studies 1 and 2, a specific attention was paid to avoid inclusion of dogs from the same 
family (for example, siblings, parents and littermates). Alternatively, half-brothers and 
half-sisters could be included; 
- Dogs had to be healthy; the “healthy” status was defined according to history and 
physical examination; 
- Absence of previous history was ideal; 
- Dogs had to receive a commercial pet food diet whose composition was known and 
documented (studies 1 and 2). 
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III. EXCLUSION CRITERIA 
 
The exclusion criteria were as follows: 
- Puppies and dogs under 10 months; 
- Dogs aged ≥9 years (studies 1 and 2); 
- Presence of a left apical systolic heart murmur consistent with DMVD; 
- Body condition score superior to 7/9 or inferior to 3/9 (studies 1 and 2); 
- Unfasted dogs (studies 1 and 2); 
- Dogs on medication at the time of examination; 
- Dogs receiving home-made diet (studies 1 and 2); 
- Dogs receiving more than two treats per day (studies 1 and 2); 
- The diet had been changed over the last two months before blood collection 
(studies 1 and 2); 
- Lactating or pregnant female dogs; 
- Administration of antiparasitic drugs or vaccines over the 15 days prior to blood 
sampling (studies 1 and 2); 
- Presence of clinical signs and past history of medical events (such as infectious 
diseases, lameness, etc.), were not an exclusion criteria if the animal had totally 
recovered and if the treatment had been stopped at least three months prior to 
blood collection time or echocardiographic examination; 
- Occurrence of clinical signs between the time of collection and two months later, 
assessed by phone interview of the owner. The clinical signs were considered as 
clinically relevant and as a factor of exclusion if they had persisted for over 72 
hours and had required a therapeutic intervention (studies 1 and 2). 
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IV. STUDY PROCEDURES 
 
Breeder or owner’s consents were obtained for each animal before its enrolment in the study. 
Moreover, the latter was conducted in accordance with conditions approved by the French 
Ministry of Agriculture and all procedures were approved by a local ethic committee and in 
compliance with the Procedures and Principles of Good Clinical Practice (Food and Drug 
Administration, Good Clinical Practice, 2001). 
 
IV.1. GENERAL STUDY PROCEDURES 
 
 
IV.1.A. BLINDING 
 
No blinding was requested except for the assays in studies 1 and 2 (the analyst was unaware 
of the dogs corresponding to the sample tubes). 
 
IV.1.B. OWNER INTERVIEW 
 
An information form was filled-in by the owner after she/he had given his consent. In study 1 
and 2, two months after blood collection, a phone interview of the breeder was performed to 
assess the medical condition of the animal over the two-month period following the blood 
collection. 
CHAPTER V- MATERIAL AND METHODS- OVERALL PRESENTATION 
 
126 
 
IV.1.C. IDENTIFICATION OF DOGS 
 
Identification, breed, gender and age were checked from the pedigree and electronic 
microchip or tattoo. A study number was assigned for each dog. 
 
IV.1.D. ANAMNESIS 
 
History as well as vaccine status and deworming were documented. The common food was 
recorded regarding brand, manufacturer and daily amount. For bitches, the date of last oestrus 
was noted. Finally, absence of current medication and clinical signs over the last 4 weeks 
were checked. 
 
IV.1.E. PHYSICAL EXAMINATION 
 
In studies 1 and 2, the dog was weighed on the day of blood collection or echocardiographic 
examination and a BCS was attributed for each dog according to a 9-point scale (Figure 13, 
Laflamme et al., 1997).  
A complete clinical examination was performed and included rectal temperature evaluation, 
inspection of demeanour, hydration status, mucous color, capillary refilling time and also 
examination of uro-genital apparatus. Palpation included arterial femoral pulse, peripherial 
lymph node (mandibular, pre-scapular and popliteal) and abdomen. The respiratory rate was 
determined by observation of thoraco-abdominal movements and reported in respiratory 
cycles/min. The investigator recorded the intensity of normal sounds and the presence or the 
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absence of pulmonary crackles heard during the auscultation. Finally, during cardiac 
auscultation, the investigator explored the following areas: right and left apex and basal areas. 
Heart rate was determined by cardiac auscultation and reported in beat per minute. 
 
IV.2. PROCEDURES FOR BLOOD SPECIMEN  
 
This part concerns studies 1 and 2. 
 
IV.2.A. BLOOD COLLECTION  
 
To minimize the impact of circadian periodicity (especially on plasma NT-proBNP 
concentration), blood was collected at the same period of the day (between 10 AM and 2 PM). 
The dog was acclimated for a period of time (15 minutes) to the investigator and the room just 
before blood sampling. Blood was drawn from the left jugular vein of awake animal in the 
same sitting position using a 20 G needle (Neolus NN-2038S, Terumo Europe, Leuven, 
Belgium), a 5-mL syringe (BD Discardit II H-905S, Becton Dickinson, Fraga, Espana), a 
lithium heparin tube for plasma biochemistry (Venosafe VF-054SHL, Terumo France, 
Guyancourt, France) and a K3-EDTA tube (Venosafe VF-052STK, Terumo France, 
Guyancourt, France) for plasma NT-proBNP. A blood sampling form was filled in for each 
animal indicating information about the dog, the day and the time of blood collection, 
estimated duration of blood sampling, as well as potential adverse events during blood 
sampling. A maximum of 5 mL of blood was collected (at least 3 mL for plasma 
biochemistry, and 1 mL for NT-proBNP).  
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IV.2.B. PACKED CELL VOLUME MEASUREMENT 
 
In study 1, well-mixed anticoagulated blood was collected into two microhematocrit tubes by 
capillary action.  One end of each tube was sealed with a small amount of clay.  The filled and 
sealed capillary tubes were placed into the centrifuge. Tubes were centrifuged (Haemofuge 
3522, Heraeus, MN, USA) for five minutes at a set speed (about 12 000 g). The PCV value 
was read on the hematocrit reader and expressed in percent. 
 
IV.2.C. HANDLING OF BLOOD SPECIMEN   
 
Plasma was prepared by centrifugation for 15 minutes at 1500g (EBA 20, Hettich, Tuttlingen, 
Germany), within 30 minutes of blood sampling. For plasma biochemistry, at least 1.5 mL of 
the supernatant was then placed into two different Eppendorf tubes. Regarding NT-proBNP, 
the supernatant was placed into specific transport tubes containing protease inhibitors 
provided by the laboratory (Cardiopet, IDEXX, Alfort, France). 
 
IV.2.D. STORAGE OF PLASMA SAMPLES  
 
Plasma (at least 0.3 mL for NT-proBNP and 1.5 mL for plasma biochemistry) was transferred 
at 4°C within 45 minutes of blood sampling and then stored at -80°C within 6 hours. 
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IV.2.E. SHIPMENT OF PLASMA SAMPLES  
 
Plasma samples (1.5 mL for biochemistry and 0.5 for NT-proBNP) were sent once a week to 
the laboratory (at 4 °C for biochemistry and -80°C for NT-proBNP).  
 
IV.3. ANALYTICAL METHOD 
 
IV.3.A. PLASMA BIOCHEMISTRY 
 
In study 1, creatinine, urea, phosphate, sodium, potassium, chloride, total proteins and 
calcium, albumin, glucose, ALP, ALT, AST, triglycerides and cholesterol were assessed in 
the same laboratory (Laboratoire Vebiotel, Arcueil, France). Electrolytes and 
substrates/enzymes were determined by direct potentiometry with specific electrodes, 
absorption spectrophotometry and colorimetric methods, respectively (Konelab 60, 
ThermoClinical - 95, Cergy Pontoise, France). Method of analysis for plasma analytes 
measured in this study and results of the between-run coefficient of variations for control 
solutions are provided in Tables 15 and 16. 
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Table 15. Method of analysis for plasma urea, creatinine, total proteins, albumin and liver enzymes measured in a first study and results of 
the between-run coefficient of variations for control solutions (1- Abtrol, Thermo Electron Co, Madison, WI, USA; 2- Nortrol, Thermo 
Electron Co, Madison, WI, USA). 
 
Analyte 
Methodology Control 
concentration 1 
Between-run coefficient 
of variation (%) 
Control 
concentration 2 
Between-run coefficient 
of variation (%) 
Urea (mmol/L) Colorimetric (urease and glutamate 
dehydrogenase) 
14.8 3.90 6.5 3.22 
Creatinine (mol/L) Colorimetric (modified Jaffe: kinetic 
measurement) 
337 4.49 156 4.37 
Total proteins (g/L) Colorimetric (Biuret method) 45.8 2.73 63.1 2.41 
Albumin (g/L) Colorimetric (bromocresol green) 28.6 2.16 41.3 1.97 
ALT (U/L) Absorption spectrophotometry 
(alanine/oxoglutarate) without 
pyridoxal phosphate (30°C) 
157 3.13 40 5.07 
AST (U/L) Absorption spectrophotometry (L- 
aspartate/glutarate) without pyridoxal 
phosphate (30°C) 
158 2.46 36 2.30 
ALP (U/L) Absorption spectrophotometry (P nitro 
phenylphosphate) (30°C) 
275 5.10 80 6.90 
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Table 16. Method of analysis for plasma glucose, electrolytes, phosphate, cholesterol and triglycerides measured in a first study and results 
of the between-run coefficient of variations for control solutions (1- Abtrol, Thermo Electron Co, Madison, WI, USA; 2- Nortrol, Thermo 
Electron Co, Madison, WI, USA). 
Analyte 
Methodology Control concentration 1 Between-run coefficient 
of variation (%) 
Control 
concentration 2 
Between-run coefficient 
of variation (%) 
Glucose 
(mmol/L) 
Colorimetric (glucose oxidase/peroxidase) 15.9 1.92 5.0 2.05 
Sodium (mmol/L) Potentiometric (ion selective electrode) 152 1.38 137 1.10 
Potassium 
(mmol/L) 
Potentiometric (ion selective electrode) 6.5 1.92 4.2 1.85 
Chloride 
(mmol/L) 
Potentiometric (ion selective electrode) 117 1.82 100 2.02 
Calcium 
(mmol/L) 
Colorimetric (arsenazo III) 3.18 2.81 2.25 2.15 
Phosphate 
(mmol/L) 
Colorimetric (molybdate ammonium) 2.04 4.16 1.03 5.87 
Cholesterol 
(mmol/L) 
Colorimetric (cholesterol esterase) 6.79 1.83 4.28 2.36 
Triglycerides 
(mmol/L) 
Colorimetric (lipase/peroxydase) 2.09 3.20 0.75 3.30 
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IV.3.B. PLASMA N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE 
 
Plasma NT-proBNP assays (study 2) were performed in the same laboratory (Laboratoire Idexx, 
Alfort, France). Plasma NT-proBNP concentration was measured using EDTA-potassium 
samples and a commercially available canine specific assay (Cardiopet, IDEXX, Alfort, France). 
This sandwich ELISA assay has already been used and validated for diagnostic purposes in the 
dog (Boswood et al., 2008; Zieba et al., 2008). The inter- and intra-assay coefficient variations 
provided by the laboratory were between 5.3 and 9.2% and between 2.1 and 10.7% (for 
concentrations ranging from 900 to 2400 pmol/L), respectively. 
 
IV.4. CARDIOVASCULAR EXAMINATION  
 
A complete cardiovascular examination, including conventional echocardiography and standard 
Doppler examination, as well as systemic arterial blood pressure measurement was scheduled for 
outlier dogs in study 2 (see Chapter VI: Results and Original Articles). In study 3, all dogs 
underwent conventional echocardiography and standard Doppler examination. 
 
IV.4.A. CONVENTIONAL ECHOCARDIOGRAPHY AND STANDARD DOPPLER 
EXAMINATION 
 
Conventional echocardiography and standard Doppler examinations were performed by trained 
observers in awake dogs gently restrained in standing position, using continuous ECG monitoring 
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with an ultrasound unit (Vingmed system 5, Vivid 5, Vivid 7 dimension and Vivid 7 BT03, Vivid I 
BT 10 SW appl. R 10.3.0 General Electric Medical System, Waukesha, Wis) equipped with 3S 
(1.5-3.5 MHz), 5S (2.2-5 MHz), and 7S (3.5-8 MHz) phased-array transducers, as previously 
described (Chetboul et al., 2004b).  
Measurements of the Ao and LA diameters (Figure 14) were obtained at end-diastole by a 
bidimensional method using the right parasternal transaortic short-axis view using the calipers 
position described by Hansson et al. (2002), and the LA/Ao ratio was then calculated (Chetboul 
et al., 2005).  
 
 
Figure 14. Right parasternal transaortic short-axis view in bidimensional mode showing positioning 
of calipers (double arrows) allowing calculation of the left atrium (LA) on aorta (AO) ratio. HR, 
heart rate (in beat per minute); PA, pulmonary artery. Photograph: Cardiology Unit of Alfort. 
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Ventricular measurements were obtained according to the recommendations of the American 
Society of Echocardiography (Sahn et al., 1978) from the right parasternal location 
(transventricular short-axis view), using the bidimensional guided M-mode echocardiography 
(Figure 15). Measurements were made of the LVED and LVES, left ventricular free wall and 
interventricular septum thicknesses in diastole and in systole. The left ventricular fractional 
shortening (expressed in %) was then calculated using the following formula: (LVED-
LVES)/LVED. 
 
 
 
Figure 15. M-mode right parasternal left ventricular short-axis view. HR, heart rate (in beats per 
minute); IVS: interventricular septum; LV, left ventricle; LVFW, left ventricular free wall; RV, right 
ventricle. Photograph: Cardiology Unit of Alfort. 
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The maximal systolic pulmonary and aortic flow velocities were measured using the right 
parasternal transaortic short-axis and the left apical 5-chamber views, respectively (Figure 16). 
Additionally, maximal early (E) and late (A) diastolic mitral flow velocities were determined by 
pulsed-wave Doppler using the left apical 4-chamber view. 
 
 
 Figure 16. Pulsed wave Doppler mode showing the maximal systolic aortic velocity, on the left 
apical long axis 4-chamber view (A) and the maximal systolic pulmonary velocity (B), on the right 
parasternal transaortic short-axis view. Photograph: Cardiology Unit of Alfort. 
 
In study 2, conventional echocardiographic and Doppler variables of outlier dogs were compared 
with the previously established reference ranges (Gonçalves et al., 2002; Chetboul et al., 2005). 
These reference ranges are provided in Tables 17 and 18.  
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Table 17. Reference ranges proposed for the conventional and pulsed wave Doppler modes variables 
assessed in the present study. From Chetboul et al. Use of quantitative two-dimensional color tissue Doppler 
imaging for assessment of left ventricular radial and longitudinal myocardial velocities in dogs. Am J Vet Res 
2005;66:953-961. 
 
 
Table 18. Equation used to predict the reference ranges for the 6 body-weight dependent M-mode 
variables assessed in the present study (i.e., end-diastolic and end-systolic left ventricular wall 
thicknesses and internal diameters). From Gonçalves et al. Linear, logarithmic, and polynomial models 
of M-mode echocardiographic measurements in dogs. Am J Vet Res 2002;63:994-999. 
 
Variable Reference range Variable Reference range 
Fractional shortening (%) 30.1-40.0 Peak early (E) mitral diastolic 
velocity (m/s) 
0.58-1.17 
Left atrium to aorta ratio 0.52-1.13 Peak late (A) mitral diastolic 
velocity (m/s) 
0.39-0.86 
Peak aortic velocity (m/s) 0.92-1.88 Mitral E/A ratio 0.92-2.72 
Peak pulmonary velocity (m/s) 0.50-1.50   
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Moreover, in study 2, the left apical 4-chamber view was used for color-flow Doppler 
examination of the tricuspid valve. When tricuspid regurgitation (TR) was identified, the peak 
systolic TR velocity was quantitatively assessed using continuous-wave Doppler mode, and the 
systolic pulmonary arterial pressure was calculated by applying Bernoulli’s equation and adding 
the estimated right atrial pressure to the systolic right ventricle-to-right atrium pressure gradient, 
as previously described (Serres et al., 2006). Similarly, all ultrasound examinations included a 
color Doppler analysis of the pulmonary valve flow to detect a potential diastolic pulmonary 
regurgitant jet. When such a regurgitant jet was identified, the maximal regurgitant flow velocity 
was assessed using continuous Doppler mode, and high velocity values (i.e., ≥2.0 m/s) were 
considered for the diagnosis of diastolic pulmonary arterial hypertension (Serres et al., 2006).  
Finally, in studies 2 and 3, the morphological aspect of the mitral valve apparatus (i.e., mitral 
leaflets and chordae tendineae) was also assessed, and a color-flow Doppler examination was 
performed using right and left apical 4-chamber views in order to exclude DMVD (thickening of 
mitral valve leaflets and chordae tendineae and/or mitral valve prolapse associated with mitral 
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regurgitation). Heart rate was calculated by ECG monitoring during each echocardiographic 
examination via an ECG taken during the same cardiac cycles used for the M-mode 
measurements. 
 
IV.4.B. SYTEMIC ARTERIAL BLOOD PRESSURE MEASUREMENT  
 
Systemic systolic arterial blood pressure was indirectly measured before each echocardiographic 
examination in the conscious outlier dogs (study 2), in accordance with the ACVIM consensus 
statement (Brown et al., 2007), by the same trained observer using the Doppler method (811-BL, 
Parks Medical Electronics Inc. Aloha, Ore, USA; Figure 17). Dogs were gently held by the 
owner in sternal recumbency. An inflatable cuff (Soft-cuf, Ref 2422, 2 cm large, Parks Medica, 
USA) was placed on the tail, as previously described (Chetboul et al., 2010). A period of 
acclimatization was allowed for each patient before blood pressure was measured. Several 
measurements were performed over 5-10 minutes to obtain a stable set of 5 values and the mean 
was used for statistical analyses. Systemic arterial hypertension and hypotension were defined as 
systolic arterial blood pressure values >160 mmHg in unstressed animals and <100 mmHg, 
respectively (Brown et al., 2007). 
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Figure 17. Material used for systemic arterial blood pressure measurement using the Doppler 
method. Source: www.dispomed.com 
 
 
IV.5. STATISTICAL ANALYSIS  
 
IV.5.A. DESCRIPTIVE STATISTICS 
 
For each tested variable, median, range or interquartile ranges were calculated using a specific 
software (Systat version 8.0, SPSS Inc., Chicago, IL, USA). 
 
IV.5.B. GENERAL LINEAR MODEL 
 
Effects of breed, age, gender and BW on plasma biochemistry and NT-proBNP concentrations 
(studies 1 and 2) and effect of age, gender and BW on echocardiographic variables (study 3) were 
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tested using a statistical software package (Systat version 8.0, SPSS Inc, Chicago, IL, USA). A 
value of P<0.05 was considered significant. Age and BW in each breed were compared by 
ANOVA (studies 1 and 2).  
 
In studies 1 and 2, effects of breed, sex, age, and BW on the variables were tested using the 
following linear mixed effects model: 
 
Y=µ+Breed+Sex+aAge+bBW+ (Breed x Age) + (Breed x BW) + (Breed x Sex) + ε 
 
Where Y is the value of the plasma variable; µ is a constant term; a and b are the slope 
coefficients for age and BW irrespective of the breed. The other terms denote interactions 
between breed and age, breed and body weight, and breed and sex. ε is the residual term of the 
model. 
 
In study 3, effects of sex, age, and BW on the variables were tested using the following linear 
mixed effects model:  
 
Y=µ+Sex+aAge+bBW+ε 
 
Where Y is the value of the echocardiographic variable; µ is a constant term; Age and BW are 
continuous variables, a and b are the slope coefficients for Age and BW, and ε is the residual 
term of the model. 
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IV.5.C. DETERMINATION OF REFERENCE INTERVAL 
 
Identification of outliers and determination of RI were performed according to the current CLSI 
guidelines (CLSI, 2008). Native and Box-Cox transformed data were first tested for normality by 
use of the Anderson-Darling test. The set data were then examined for outliers. Tukey criterion 
was applied when the distribution was Gaussian. When the data distribution remained non-
Gaussian after Box-Cox transformation, the Tukey method was not applicable and visual 
inspection of values in both tails of the distribution was used. When a value was deemed 
questionable, the following criteria were used to decide whether to remove a dog from the study: 
any abnormality concerning medical history or clinical examination and an atypical value for 
more than one analyte from the same dog (study 1) or any abnormality concerning medical 
history, clinical and echo-Doppler examinations as well as systemic arterial blood pressure, and 
plasma blood urea nitrogen (BUN) and creatinine (study 2) or any abnormality concerning 
clinical and echo-Doppler examinations (study 3). Reference intervals were defined as central 
95% intervals bounded by the 2.5th and 97.5th percentiles. Upper and lower limits of the 
reference interval with the 90% CI were determined in the global population by a nonparametric 
approach, using a specific software (Geffré et al., 2011). 
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CHAPTER VI- RESULTS  
 
This part summarizes results of the 3 studies performed in the present work. The corresponding 
original articles that have been published are presented in the appendix section. 
 
 
- Article 1 (corresponding to study 1): “Basal plasma concentrations of routine variables and 
packed cell volume in clinically healthy adult small size dogs: effect of breed, body weight, age, 
and gender, and establishment of reference intervals” by Misbach C, Chetboul V, Concordet D, 
Gruet P, Speranza C, Hoffmann AC, Rocha A, Balouka D, Petit AM, Trehiou-Sechi E, 
Pouchelon JL and Lefebvre HP. Published in Veterinary Clinical Pathology in September 2014 
(volume 43, pages 371 to 380). 
 
- Article 2 (corresponding to study 2): “Basal plasma concentrations of N-terminal pro-B-type 
natriuretic peptide in clinically healthy adult small size dogs: effect of breed, body weight, age, 
and gender, and establishment of reference intervals” by Misbach C, Chetboul V, Concordet D, 
Gruet P, Speranza C, Hoffmann AC, Rocha A, Balouka D, Petit AM, Trehiou-Sechi E, 
Pouchelon JL and Lefebvre HP. Published in Research in Veterinary Science in December 2013 
(volume 95, pages 879 to 885). 
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- Article 3 (corresponding to study 3) on “Conventional and Doppler echocardiography in 
clinically healthy adult Cavalier King Charles Spaniels: effect of body weight, age, and gender, 
and establishment of reference intervals” by Misbach C, Lefebvre HP, Concordet D, Gouni V, 
Trehiou-Sechi E, Petit AM, Damoiseaux C, Leverrier A, Pouchelon JL and Chetboul V. 
Published in the Journal of Veterinary Cardiology in June 2014 (volume 16, pages 91 to 100). 
 
 
I. ARTICLE 1: Basal plasma concentrations of routine variables and 
packed cell volume in clinically healthy adult small size dogs: effect of 
breed, body weight, age, and gender, and reference intervals. 
 
 
Basal plasma concentrations of routine variables and packed cell volume in clinically 
healthy adult small size dogs: effect of breed, body weight, age, and gender, and 
establishment of reference intervals by Misbach C, Chetboul V, Concordet D, Gruet P, 
Speranza C, Hoffmann AC, Rocha A, Balouka D, Petit AM, Trehiou-Sechi E, Pouchelon JL and 
Lefebvre HP. Published in Veterinary Clinical Pathology in September 2014 (volume 43, pages 
371 to 380). 
 
Objectives 
The primary objective of this prospective study was to assess the potential effect of breed on 
routine plasma analytes in dogs from 7 different small size breeds and to assess the effects of 
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BW, age, and gender on the same plasma variables. A secondary objective was to use this small 
size dog population as a reference sample group to determine RI according to the procedures 
recommended by the CLSI guidelines. 
 
Material and Methods 
For this purpose, healthy small size dogs from 7 breeds (B, CKCS, KCS, MP, ST, YT and D) 
were prospectively included in this study. Animals were assessed as healthy on the basis of a 
complete physical examination and history. Blood was sampled in standardized conditions. 
Packed cell volume was measured immediately after sampling. Assays for 15 routine plasma 
variables (urea, creatinine, total proteins, albumin, glucose, ALT, AST, ALP, sodium, potassium, 
chloride, calcium, phosphate, cholesterol, and triglycerides) were performed by the same 
commercial laboratory using direct potentiometry with specific electrodes, and absorption 
spectrophotometry and colorimetric methods for electrolytes and substrates/enzymes, 
respectively. Effect of breed, BW, age and gender was tested using a general linear model. 
Identification of outliers and determination of RI were performed according to the current the 
CLSI guidelines. 
 
Results 
One hundred and fifty four healthy sexually intact small size dogs from 7 breeds were included in 
the study. Although a statistically significant effect (P<0.05) of breed, BW, gender, and age was 
evidenced for respectively 7/16, 8/16, 4/16, and 3/16 tested variables, establishment of breed, 
gender-, age- or BW-specific RI for most of the variables was considered clinically irrelevant.  
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More interestingly, according to the analyte, 3.8% to 76.6% of the observed values were lower 
than the lower limit of the laboratory’s RI used routinely for 9/12 tested variables and 4.5% to 
9.7% of the observed values were higher than the upper limit of the laboratory’s RI for 7/12 
tested variables, thus indicating that the laboratory’s RI was not appropriate for all variables 
except plasma glucose and chloride (Table 19). 
 
Conclusion  
This study seems to indicate that the determination of specific RI for routine variables in small 
size dogs could be clinically relevant. Inversely, the present results showed that the decision to 
partition RI into subclasses for these 16 routine variables in the studied population according to 
criteria such as breed, BW, age and gender seemed not to be of clinical interest. 
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Table 19. Reference intervals established from the 154 reference individuals and comparison with the laboratory’s reference intervals. 
BCG, Gaussian after Box-Cox transformation; CI, confidence interval; LL, lower limit; NG, non-Gaussian; UL, upper limit. 
 
Analyte Distribution LL (90% CI) UL (90% CI) LL-UL of the laboratory Number (%) of values 
< LL of the lab 
Number of values 
>LL of the lab 
Packed cell volume (%) BCG 35.9 (34-37) 56 (54-57) 37-55  6 (3.8%) 3 (1.9%) 
Urea (mmol/L) NG 3.3 (3.3-3.3) 11.6 (8.3-13.3) 3.3-8.3 0 7 (4.5%) 
Creatinine (µmol/L) NG 45 (45-54) 90 (81-99) 54-144 44 (28.6%) 0 
Total proteins (g/L) NG 47.6 (43-49) 67.1 (65-70) 60-80 118 (76.6%) 0 
Albumin (g/L) NG 23.9 (22-24) 33.0 (32-34) 30-40 118 (76.6%) 0 
Glucose (mmol/L) NG 3.9 (3.4-3.9) 6.2 (6.2-7.3) 3.9-6.2 2 (1.3%) 2 (1.3%) 
ALT (U/L) NG 19 (4-22) 261 (133-296) <80 - 15 (9.7%) 
AST (U/L) NG 3 (2-10) 66 (54-129) 10-50 6 (3.9%) 9 (5.8%) 
ALP (U/L) NG 7 (1-10) 92 (76-113) <80 - 7 (4.5%) 
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Analyte Distribution LL (90% CI) UL (90% CI) LL-UL of the laboratory Number (%) of values 
< LL of the lab 
Number of values 
>LL of the lab 
Sodium (mmol/L) NG 137 (132-139) 152 (152-154) 145-160 69 (44.8%) 0 
Potassium (mmol/L) NG 3.5 (3.3-3.5) 4.6 (4.4-5.2) 3.6-5.8 11 (7.1%) 0 
Chloride (mmol/L) NG 106 (102-107) 115 (115-119) 95-115 0 1 (0.6%) 
Calcium (mmol/L) NG 2.12 (2.00-2.20) 2.67 (2.62-3.29) 2.25-2.99 9 (5.8%) 1 (0.6%) 
Phosphate (mmol/L) NG 0.74 (0.55-0.81) 2.65 (1.84-2.91) 0.81-1.61 6 (3.9%) 13 (8.4%) 
Cholesterol (mmol/L) NG 1.81 (1.29-2.32) 7.48 (6.71-8.26) 0.52-6.45 0 8 (5.2%) 
Triglycerides (mmol/L) NG 0.23 (0.23-0.34) 2.51 (1.60-5.24) 0.23-1.71  0 6 (3.8%) 
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II. ARTICLE 2: Basal plasma concentrations of N-terminal pro-B-type 
natriuretic peptide in clinically healthy adult small size dogs: effect of 
body weight, age, gender and breed, and reference intervals  
 
Basal plasma concentrations of N-terminal pro-B-type natriuretic peptide in clinically 
healthy adult small size dogs: effect of body weight, age, gender and breed, and reference 
intervals by Misbach C, Chetboul V, Concordet D, Gruet P, Speranza C, Hoffmann AC, Rocha 
A, Balouka D, Petit AM, Trehiou-Sechi E, Pouchelon JL and Lefebvre HP. Published in 
Research in Veterinary Science in December 2013 (Volume 95, pages 879 to 885). 
 
Objectives 
The aims of this prospective study were 1) to evaluate plasma concentrations of NT-proBNP, 2) 
to identify potential effects of breed, BW, age, and gender and 3) to establish RI according to the 
statistical procedures recommended by the CLSI guidelines, in a large population of healthy adult 
small size dogs from different breeds known to be predisposed to DMVD.  
 
Material and Methods 
For this purpose, healthy small size dogs from 7 breeds (B, CKCS, KCS, MP, ST, YT and D) 
were prospectively included in this study. Animals were assessed as healthy on the basis of a 
complete physical examination, history and routine plasma panel. Blood was sampled in 
standardized conditions and assays for plasma NT-proBNP was performed by an ELISA method. 
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Effect of breed, BW, age and gender was tested using a general linear model. Identification of 
outliers and determination of RI were performed according to the current CLSI guidelines. 
 
Results 
The reference sample group included 154 sexually intact healthy small size dogs from 7 breeds. 
The commercial laboratory did not quantify the NT-proBNP concentration when it exceeded 
2842 pmol/L. Nine out of the 154 tested dogs had plasma NT-proBNP >2842 pmol/L, therefore 
their NT-proBNP value was set at 2842 pmol/L for statistical analysis. Despite standardized 
procedures with strict inclusion and exclusion criteria, plasma NT-proBNP showed a high 
individuality (Figure 18).  
 
Figure 18. Distribution of plasma N-terminal pro-brain-type natriuretic peptide (NT-proBNP) 
concentrations among the 154 healthy small size dog population. The thick horizontal bar represents 
the median (i.e., 783 pmol/L) and the thin horizontal bars represent the first and third quartiles (i.e., 476 
and 1232 pmol/L, respectively). 
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The inter-individual CV in the general population was 96% and the within-breed inter-individual 
CV ranged from 62% (CKCS) to 100% (MP). Although no age or breed or BW effect was 
observed on plasma NT-proBNP, a significant sex effect (P=0.01) was shown (males: 683 
pmol/L [404-892]; females: 844 pmol/L [550-1327]). Moreover, 11/154 dogs (7.1%) had plasma 
NT-proBNP >2617 pmol/L, and were statistically considered as outliers. These dogs underwent a 
complete cardiovascular work-up, including arterial blood pressure measurement, conventional 
echocardiography and Doppler examinations. Plasma BUN and creatinine as well as re-
assessment of plasma NT-proBNP were also scheduled 3 months after the first sampling. All 
dogs had normal cardiovascular examination, normal blood pressure and normal plasma BUN 
and creatinine concentrations. At recheck, only 4/11 dogs had plasma NT-proBNP values that 
still exceeded the upper limit of quantification of the assay (Figure 19) and the 7 remaining dogs 
showed a 1.2 to 6-fold decrease from their initial NT-proBNP value. The proposed RI for plasma 
NT-proBNP was 157-2842 pmol/L (i.e., the upper limit of the RI corresponded to the limit of 
quantification).  
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Figure 19. Comparison between plasma N-terminal pro-brain-type natriuretic peptide (NT-
proBNP) concentrations assessed in the 11 outlier dogs at first sampling and 3 months later. 
 
Conclusion  
This study suggests that plasma NT-proBNP concentration is characterized by a high inter-
individual variability in healthy adult small size dogs. Therefore, a single plasma value in a 
healthy small size dog should be interpreted with caution. Moreover, a gender effect has been 
demonstrated, with females having higher concentrations than males, but the clinical relevance of 
partitioning the RI according to gender needs further investigations.   
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III. ARTICLE 3: Echocardiography and conventional Doppler 
examination in clinically healthy adult Cavalier King Charles Spaniels: 
effect of breed, body weight, age, and gender, and establishment of 
reference intervals  
 
 
Echocardiography and conventional Doppler examination in clinically healthy adult 
Cavalier King Charles Spaniels: effect of breed, body weight, age, and gender, and 
establishment of reference intervals by Misbach C, Lefebvre HP, Concordet D, Gouni V, 
Trehiou-Sechi E, Petit AM, Damoiseaux C, Leverrier A, Pouchelon JL and Chetboul V. 
Published in the Journal of Veterinary Cardiology in June 2014 (volume 16, pages 91 to 100). 
 
 
 
Objectives 
 
The aims of this prospective third study were 1) to assess the potential effect of BW, age, and 
gender on the most common standard echocardiographic and conventional Doppler variables in a 
large population of clinically healthy adult CKCS, and 2) to establish the corresponding RI 
according to the statistical procedure recommended by the CLSI guidelines. 
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Material and Methods 
 
The reference sample group consisted of breeder- and client-owned healthy adult (≥12 months) 
CKCS presented for cardiac screening at the Cardiology Unit of Alfort (National Veterinary 
School of Alfort, France) between March 2001 and January 2013. Animals were considered 
healthy on the basis of a complete physical examination. Standard echocardiography and 
conventional Doppler examinations were performed by trained observers, with at least 3 years of 
experience in cardiology, in awake dogs gently restrained in standing position, using continuous 
electrocardiogram monitoring with an ultrasound unit equipped with phased-array transducers, as 
previously described and validated. Effect of BW, age and gender was tested using a general 
linear model. Identification of outliers and determination of RI were performed according to the 
current CLSI guidelines. 
 
Results 
 
A total of 134 healthy adult CKCS were included. A significant BW effect was observed for all 
variables except the M-mode, 2D and Doppler ratios, i.e., fractional shortening (FS%), LA/Ao 
ratio, and the E/A ratio, the two latter being the sole variables not significantly affected by any of 
the tested covariates. Unlike these ratios, all imaging variables (n=12) were significantly affected 
by BW as well as gender (4/12) and/or age (4/12). The clinical relevance of these results was 
discussed for each variable with regard to the observers’ variability. Only the BW effect on M-
mode variables was considered as clinically relevant and regression-based RI were built 
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accordingly (Table 20). Moreover, although all the M-mode echocardiographic RI established in 
the present study were within the predictive RI calculated with Cornell’s formula (which is an 
allometric scaling used to predict percentiles according to BW and developed from a large 
population of canine small, large and giant breeds), all were smaller than this latter (Table 21). 
 
Table 20. Predicted regression-based reference intervals (lower and upper limits) according to body 
weight for the six M-mode variables with a significant body weight effect assessed in a population of 
healthy adult Cavalier King Charles Spaniels (n=134). LVDd and LVDs, end-diastolic and end-systolic 
left ventricular diameters, respectively; LVFWd and LVFWs, end-diastolic and end-systolic left 
ventricular free wall thicknesses, respectively; IVSd and IVSs, end-diastolic and end-systolic 
interventricular septum thicknesses, respectively. 
Body weight 
(kg) 
LVDd (mm) LVDs (mm) LVFWd (mm) LVFWs (mm) IVSd (mm) IVSs (mm) 
5 20.2-29.8 10.6-20.3 4.0-7.0 6.6-11.3 4.3-7.7 6.0-11.6 
6 21.3-30.9 11.2-20.8 4.2-7.3 7.1-11.7 4.5-7.8 6.4-11.9 
7 22.5-31.9 11.8-21.3 4.5-7.5 7.6-12.2 4.6-7.9 6.7-12.2 
8 23.6-33.0 12.3-21.9 4.7-7.7 8.1-12.6 4.8-8.1 7.1-12.5 
9 24.6-34.1 12.9-22.4 4.9-7.9 8.5-13.1 4.9-8.2 7.4-12.9 
10 25.8-35.2 13.5-23.0 5.2-8.1 9.0-13.5 5.1-8.3 7.7-13.2 
11 26.8-36.3 14.0-23.6 5.4-8.4 9.4-14.0 5.2-8.5 8.0-13.5 
12 27.8-37.4 14.5-24.1 5.6-8.6 9.9-14.5 5.3-8.6 8.3-13.9 
13 28.8-38.5 15.0-24.7 5.8-8.8 10.3-14.9 5.4-8.8 8.6-14.2 
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Table 21. M-mode echocardiographic reference intervals (2.5
th
 and 97.5
th
 percentiles) from 134 
healthy adult Cavalier King Charles Spaniels determined according to the Clinical and Laboratory 
Standards Institute (CLSI, 2008) statistical procedures (A),
 
and predictive reference intervals 
calculated in the same population using Cornell’s formula (Cornell et al., 2004; B). See Table 20 for 
remainder of key. 
 
 
 
 
 
 
 
 
 
 
Conclusion  
In conclusion, although predictive RI assessed according to Cornell’s formula seem to be 
acceptable for CKCS dogs, the present results suggest that determining specific RI for 
echocardiographic and Doppler variables in this breed is relevant.  The present report also 
demonstrates a statistically significant and clinically relevant BW effect on M-mode 
echocardiographic variables including end-diastolic and end-systolic left ventricular wall 
thicknesses and diameters. The BW should therefore be considered when interpreting 
echocardiographic values in CKCS, except for the 2D, M-mode and Doppler ratios, i.e., LA/Ao, 
FS% and mitral E/A, respectively. 
M-mode echocardiographic variable A B 
LVDd (mm) 23.4-35.6 21.5-40.6 
LVDs (mm) 12.9-23.6 12.0-27.7 
LVFWd (mm) 5.0-8.3 4.9-13.2 
LVFWs (mm) 8.2-13.8 8.1-19.1 
IVSd (mm) 5.1-8.3 4.9-13.0 
IVSs (mm) 7.6-13.0 7.3-17.3 
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CHAPTER VII- DISCUSSION, CONCLUSION AND 
PERSPECTIVES   
   
Aims of the study 
The main goal of this work was to apply the concept of RI in veterinary cardiology through 
various clinical settings. One specific objective included determination of RI within a population 
of small size dogs for 1) PCV and routine plasma biochemisty variables, 2) the plasma biomarker 
NT-proBNP, and 3) standard echocardiographic and conventional Doppler variables. For such a 
purpose, the procedures recommended by the IFCC-CLSI guidelines (Solberg, 1987a, 1987b, 
1988; Solberg and Stamm, 1991; Petit Clerc and Solberg, 1987; Dybkaér 1987; CLSI, 2008) 
were applied. Although these guidelines have been generated specifically for clinical laboratory, 
we chose to extend the statistical recommendations to determine RI for echocardiographic 
variables in the CKCS breed. Another specific objective of this work was to assess the effect of 
covariates (breed, BW, age and gender) on the tested blood or imaging variables, by using a 
general linear model. Some of these effects have already been identified to different degrees in 
the literature, as previously stated in Chapter III. 
 
Selection of the reference sample group  
In the present work, sexually intact purebred dogs corresponding to the standard provided by the 
French kennel Club (Société Centrale Canine) were chosen to represent the reference population. 
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Only small size breeds were recruited because they are very popular in France. Hence, according 
to the figures provided by the French Kennel Club, 4 out of the 7 small breeds studied here (YT, 
ST, MP, CKCS, KC, B and D) are among the 20 breeds with the highest number of registrations 
to “Le Livre des Origines Françaises (LOF)”. Besides, within the 207 987 registrations to LOF 
in 2012, the CKCS, YT, ST and D were ranked in position 4, 9, 16 and 20, respectively. 
Moreover, these small size breeds account for an important part of dogs examined in cardiology 
consultations due to their predisposition to develop DMVD, which is the most common heart 
disease in dogs (Buchanan, 1977; Thrusfield et al., 1985). A French study performed in the area 
of Paris, France (Serfass et al., 2006) and including 942 small size breeds (i.e., YT, MP, B, D, 
ST) with a mean age of 6.5 years, showed that the prevalence of DMVD (confirmed by the 
presence of left apical systolic heart murmur at cardiac auscultation) ranged from 8.5 % (YT) to 
22.7% (MP) depending on the breed. Moreover, another French study (Chetboul et al., 2004a) 
conducted in the same geographic location and including a large number of dogs (n=451) from 
the same breed (CKCS) demonstrated a high prevalence of DMVD (i.e., 40.6%) in relatively 
young dogs (mean age of 4.5 years). Another breed predisposed to DMVD in France is the 
Lhassa Apso, with a prevalence of affected dogs that reached 6.5% in one previous study (Serfass 
et al., 2006). This breed was not recruited in the present study for technical reasons, because a too 
small number of breeders was found in the area of Paris, representing thus a limitation of the 
study.  
Regarding age, only adult dogs (i.e., > 10 months) were included in the study, because DMVD is 
an acquired heart disease. This observation was confirmed in one previous study, where the age 
at which 20% of a small breed developed a murmur secondary to DMVD was 8.6, 9.5, 10.4, 11.1 
and 12.7 years in respectively ST, D, B, MP and YT (Serfass et al., 2006). However, a limitation 
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of the present work was that the reference sample group was relatively young. In studies 1 and 2, 
the median age ranged from 2.3 to 4.2 years depending on the breed, whereas in study 3, median 
age of CKCS was 3 years. One of the main reasons for such a limitation is that prevalence of 
DMVD increases dramatically with age and may reach 100% in geriatric CKCS populations  
(Beardow and Buchanan, 1993; Häggström et al., 1992; Chetboul et al., 2004a). It was therefore 
challenging to find old unaffected small size dogs. Nevertheless, the range of age was relatively 
representative of the small size dog population seen in routine veterinary practice. The sex ratio 
(male:female) was well-balanced in study 3 (ratio=0.86), whereas it was 4:6 in studies 1 and 2 
which could be explained by the fact that all the dogs came from breeders.  
 
Definition of healthy status 
As for all the studies on RI determination, one important prerequisite for selection of the 
reference sample group was to define health criteria. In human beings, The World Health 
Organization (Anonymous, 1946) defines health as a “complete physical, mental and social well-
being.” Because this definition is not applicable to animals, the ASVCP Quality Assurance and 
Laboratory Standards Committee (Friedrichs et al., 2012; ASVCP, 2012) provided 
recommendations to define a reference population and verify the healthy status of reference 
individuals according to a study by Walton (2001), in which a non-exhaustive list of selection 
criteria was drawn up in order to help investigators for individuals’ selection. These criteria were 
as follows: biological (age, gender, breed, stage of reproductive cycle, production type); clinical 
(history and physical examination including BCS); geographical (location) and seasonal (effects 
of temperature and day length). Finally, it had been noticed in the ASVCP recommendations that 
additional testing may be required to establish the health criteria, depending on the intended use 
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of the proposed RI (Friedrichs et al., 2012; ASVCP, 2012). In the studies performed here, we 
applied the former recommendations without requiring any additional testing because we 
believed that the healthy status of individuals could be determined according to a combination of 
complete history and physical examination. Since all the recruited dogs were predisposed to 
DMVD (which is characterized by a heart murmur), an important step to define the health criteria 
was to rule out this heart disease. Therefore, physical examination included a careful cardiac 
auscultation performed by a trained observer with a 3-year experience in cardiology. Finally, a 
quite large healthy population of adult small size dogs was directly selected within the general 
canine population with strict criteria of inclusion and exclusion in order to minimize the need for 
partitioning RI into criteria such as size, pregnancy/lactation, BCS, geographic location and 
circadian rhythm. Additionally, the reference sample group appeared to be relatively 
representative of the small size dog population living in the Paris area. 
 
Selection of variables 
The echocardiographic and blood variables for which the RI were determined in the present study 
were selected because of their clinical usefulness in the direct and indirect assessment of DMVD. 
Firstly, the TTE is the gold-standard method for screening and evaluation of DMVD in dogs 
(Chetboul and Tissier, 2012). In CKCS, the French Spaniel Club recommends that each CKCS 
18 months old should undergo a mandatory echocardiographic screening to pass the 
confirmation examination. Using a specific TTE view (i.e., right parasternal 5-chamber view at 
the end of the T-wave on the ECG), presence or absence of DMVD is noted and mitral valve 
prolapse is graded from 0 (absence) to 4 (severe prolapse with chordae tendineae rupture). 
Moreover, in keeping with the ACVIM consensus statement on DMVD (Atkins et al., 2009), each 
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CKCS, even those without a heart murmur, should regularly undergo a complete 
echocardiographic examination. The M-mode and pulsed-wave Doppler variables assessed in 
study 3 have been shown to be the most common variables used for the first-line evaluation of 
DMVD consequences, in order to detect left heart enlargement and myocardial dysfunction. 
Among the 15 tested echocardiographic variables, the LA/Ao ratio, the end-diastolic LVED and 
the mitral E wave have been shown to be associated with the clinical outcome of DMVD dogs 
(Serres et al., 2007 & 2008; Borgarelli et al., 2008; Moonarmart et al., 2010; Reynolds et al., 
2012; Hezzell et al., 2012a).  
Secondly, the use of the plasma cardiac biomarker NT-proBNP in combination with TTE has 
been advocated in many studies to assess DMVD severity, as well as response to medical 
therapy. This biomarker can also help clinicians to make a prognosis in both asymptomatic and 
symptomatic dogs with DMVD (Boswood et al., 2008; Serres et al., 2008; Chetboul et al., 2009; 
Reynolds et al., 2012; Wolf et al., 2012 & 2013).  Finally, some plasma analytes may decrease 
(PCV, sodium, potassium and albumin) or increase (creatinine) during the course of DMVD, 
secondary to the development of CHF, but also secondary to administration of cardiac 
medications such as furosemide (Farabaugh et al., 2004; Boswood et al., 2006; Nicolle et al., 
2007; Boswood et al., 2009). All these variables were therefore considered as the most relevant 
clinical variables to assess DMVD in small size breeds. 
 
Study procedures 
In the present work, all study procedures were standardized and had been previously described in 
sufficient details to allow reproduction by a trained staff. Additionally, all methods had been 
previously validated. Regarding assays for routine plasma biochemistry and plasma NT-proBNP, 
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a precise description of the analytical method was provided, including results of the intra- and 
inter-assay CV. Moreover, results for quality controls were also available for plasma 
biochemistry. However, one of the limitations of this work was that quality controls were 
performed using human samples although current ASVCP quality assurance guidelines 
recommend the use of specific species samples (Flatland et al., 2010). Furthermore, the stability 
of routine biochemistry analytes had been investigated in previous studies and known to be good 
in samples at room temperature and after freezing (Thoresen et al., 1992 & 1995). To the 
contrary, little information was available regarding plasma NT-proBNP stability, representing 
another limitation of this work. Previous reports demonstrated that NT-proBNP concentration 
could be altered by sample handling and freezing. One study identified that NT-proBNP 
concentration was significantly greater in serum than in plasma of 53 healthy dogs (Kellihan et 
al., 2009). Additionally, NT-proBNP in EDTA plasma or serum taken from healthy dogs and 
dogs with heart disease showed a 50 to 51% decrease after 23-25 hours storage at room 
temperature (Farace et al., 2008; Collins et al., 2010). In the present work, a specific tube 
containing protease inhibitors helped limiting as much as possible degradation of NT-proBNP. 
One report showed that serum NT-proBNP increased significantly after freezing at -20°C to 
incorrectly group between 80 and 100% of normal dogs as having evidence of heart disease when 
using cut-off values suggested by some previous studies (Collins et al., 2010). An explanation 
raised by these authors was that freezing may have altered the morphology of the large proBNP 
molecule making more peptides available for measurement by the assay, or altered the protein 
structure so as to increase the affinity of the detection antibody for natriuretic antigen (Collins et 
al., 2010). However, stability of NT-proBNP at -80°C, i.e., the storage temperature in the present 
work remains unknown and should have been documented as recommended by the IFCC-CLSI. 
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Nevertheless, standardization of blood sampling and handling of blood specimen in this work 
allowed controlling as much as possible sources of pre-analytical and analytical variations. One 
of the major issues of this work was that limit of quantification of the NT-proBNP assay was 
2842 pmol/L. The consequence was that 9 out of the 154 dogs (5.8%) included in study 2 had an 
observed value of plasma NT-proBNP greater than 2842 pmol/L. Their NT-proBNP value was 
therefore set as equal to 2842 pmol/L for statistical analysis. In 2013, a new generation of assay 
has been developed, allowing a limit of quantification of 10 000 pmol/L.  
Procedures for cardiovascular examination (echocardiography and systemic arterial blood 
pressure measurement) were performed by trained observers (with at least 3 years of experience 
in cardiology), and had previously been described and validated (Chetboul et al., 2004b; 
Chetboul et al., 2010). These conditions helped to minimize the influence of the observer’s 
experience level and its own within-day and between-day variability. As an example, a study 
showed that for a trained observer, most of within-day and between-day intra-observer CV 
regarding measurements of 8 echocardiographic variables were acceptable, and ranged 
respectively, from 3.1% to 10.2% and from 4.1% to 25.8% (Chetboul et al., 2004a).  
 
Reference interval determination 
The reference sample group comprised a sufficient number of observed values to allow RI 
determination by using the nonparametric method (i.e., 154 dogs in studies 1 and 2, and 134 
CKCS in study 3). All RI were calculated thanks to a specific software (Geffré et al., 2011), 
although the rank number method could have been applied, as illustrated in the manuscript for 
plasma sodium concentration (see page 57). One exception was for E and A mitral wave 
velocities and mitral E/A ratio (study 3), where only 101 observed values were available. In 
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keeping with the IFCC-CLSI that recommends at least 120 observations to apply the 
nonparametric method, and since these variables were not normally distributed, percentiles 
should have been estimated by using the nonparametric approach and 90% CI by resorting to the 
Bootstrap method, which represents a limitation of this work. An advantage of the nonparametric 
method was that non-Gaussian data did not need to be transformed to fit Gaussian distribution. 
Finally, as stated above, the limit of quantification of the NT-proBNP assay was relatively low 
(i.e., 2845 pmol/L) and the upper limit of the calculated RI corresponded to this limit. Therefore, 
the upper limit of the RI for plasma NT-proBNP in this small size dog population was not 
interpretable, which represent one of the major limitations of this work. 
 
Identification and treatment of outlying observations 
Identification of outliers was performed by using one of the statistical methods recommended by 
the IFCC-CLSI (i.e., the Tukey method). No outliers were identified in study 1, whereas in study 
2, 11 outliers were detected (i.e., dogs with plasma NT-proBNP ≥2617 pmol/L). As the upper 
limit of the RI for plasma NT-proBNP corresponded to the limit of quantification of the assay 
(i.e., 2842 pmol/L), it was difficult to conclude if these 11 dogs were true outliers or not. 
Nevertheless, all these dogs underwent a complete cardiovascular examination, as well as 
assessment of plasma blood urea nitrogen and creatinine concentrations (since azotemia may 
increase plasma NT-proBNP concentrations, Raffan et al., 2009), 3 months after the first blood 
sampling. Additionally, study 3 revealed outlier dogs (n=3) for the maximal systolic pulmonary 
flow velocity variable. As stated in the material and methods section, we pre-determined criteria 
to decide whether to include or exclude outliers. These criteria were the following: any 
abnormalities about history, physical examination, TTE or systemic arterial blood pressure in 
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study 2, and any abnormality regarding physical examination and TTE in study 3. Since all 
outliers’ examinations were considered normal, none of them were excluded for the RI 
determination. This was in accordance with the IFCC-CLSI, which recommends that elimination 
of outliers should not only be based on statistical concepts but also on a rational basis (i.e., 
absence of clinical evidence of illness). 
 
 Effect of covariates and need for partitioning 
The effect of covariates such as breed, BW, age or gender was identified in all 3 studies by using 
a linear mixed-effect model. These covariates were chosen in the present work as they represent 
the most common covariates studied in veterinary medicine. In study 1, a breed, BW, age and 
gender effect was evidenced for 7/15, 8/15, 3/15 and 4/15 blood variables. In study 2, only a 
gender effect was identified for plasma NT-proBNP concentration, with females having higher 
median plasma NT-proBNP values than males. In study 3, a statistically significant effect of BW 
was observed for all variables except FS(%), LA/Ao ratio, mitral E/A ratio and heart rate. A 
significant effect of gender and age was also noticed for 5/15 and 4/15 of the tested 
echocardiographic variables, respectively. Partitioning criteria were presented in 1990 by Harris 
and Boyd who calculated the statistical significance of the difference between subclass means by 
the standard normal deviate z-test. The authors offered some specific recommendations for 
threshold or critical z-values to aid in deciding whether or not to calculate separate reference 
intervals (Harris and Boyd, 1990). This approach however assumes that the data follow a 
Gaussian distribution and take into account an unequal prevalence of subclasses (Geffré et al., 
2011). An alternative method based on direct estimation of the proportion of two subclasses 
outside the reference limit at each end of the combined distribution has been proposed: “If at 
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least one of the four proportions of the subgroup distributions cut off by the reference limits of 
the combined distribution exceeds 4.1% or lies below 0.9%, subgroup-specific reference intervals 
should be calculated instead of using the common reference limits of the common group” (Lahti 
et al., 2004). More recently, it has been advocated that the decision to partition into sub-classes 
should not only be made on the basis of statistical procedures but also on a clinical point of view, 
that is, if physiologic differences are expected to result in important clinical differences in RI 
(Kjelgaard-Hansen, 2010). In the present work, we therefore discussed the clinical relevance of 
the effect of covariates for each variable. In study 1, plasma urea differed significantly according 
to the breed. Nevertheless, when the mean values were considered, only MP and ST dogs showed 
a 32% higher value than the other breeds. The higher values observed in these two breeds did not 
exceed the upper value of the 90% CI for the upper limit of the RI, suggesting therefore that the 
RI established from the overall population could be suitable for all 7 selected breeds. Moreover, 
in the same study, a significant BW effect was observed for half of the tested variables. When 
BW, for example, was decreased by 3 kg (which is a quite large difference within a given breed), 
plasma urea was decreased by 1.8 mmol/L in MP whereas it was increased by 2.4 mmol/L in YT. 
It was therefore conclude that these findings will have but little impact on the clinical 
interpretation of the results. In study 3, the clinical relevance of the effect of covariates was 
discussed with regard to observers’ variability for TTE examination (Chetboul et al., 2004b). As 
an example, if BW was increased by 4 kg, the interventricular septum and the left ventricular free 
wall thicknesses was increased by 0.41 and 0.79 mm in diastole, and by 0.97 and 1.56 mm in 
systole, respectively. These differences were higher than the between-day SD assessed for a 
trained observer (i.e., 0.34 mm, 0.64 mm, 0.48 mm, and 1.34 mm, respectively). Similarly, for a 
4-kg BW increase, the LVED and LVES were increased by 3.95 mm and 1.97 mm, respectively 
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(with corresponding between-day SD of 2.51 mm and 1.39 mm, respectively). Therefore, only 
the BW effect on left ventricular M-mode measurement was considered clinically relevant and 
the use of regression-based RI according to BW categories was performed (Virtanen et al., 1998). 
Conversely, the statistically significant effect of gender on LVED and LVES and the end-
diastolic interventricular septum was considered as clinically meaningless, as demonstrated by 
the low slope coefficients (respectively, 0.641, 0.698, 0.178) in comparison to the corresponding 
between-day SD (respectively, 2.51, 1.39, 0.34). However, in study 2, although significantly 
higher values of plasma NT-proBNP were identified in females compared to males, RI according 
to gender were not determined. Hence, as stated above, the upper limit of the RI could not be 
interpreted as it corresponded to the limit of quantification of the NT-proBNP assay (i.e., 2842 
pmol/L). Therefore, it was hypothesized that the difference in plasma NT-proBNP between males 
and females could partially be due to this analytical issue and partitioning was not undertaken. 
 
The issue of individual variability 
In study 2, plasma NT-proBNP concentrations in the global population displayed a wide range of 
values.  Since we limited the sources of variability by standardizing the procedures for sample 
handling, storage and shipment of plasma samples, we therefore concluded that variability for 
plasma NT-proBNP was inter-individual rather than pre-analytical in this small size dog 
population. In the general population, the inter-individual CV was 96% and the within-breed 
inter-individual CV ranged from 62% (CKCS) to 100% (MP). When considering several other 
studies on plasma/serum NT-proBNP including groups of healthy dogs (Oyama et al., 2008; 
Atkinson et al., 2009; Kellihan et al., 2009 & 2011; Raffan et al., 2009; Schmidt et al., 2009; 
Chetboul et al., 2009; Collins et al., 2010; Wess et al., 2011; Cunningham et al., 2012; Hezzell et 
CHAPTER VII- DISCUSSION, CONCLUSION AND PERSPECTIVES  
 
 
168 
al., 2012b), only two reports included healthy comparable breeds as in our, but had too small 
sample size (lower than 31 versus 154 in the present study) to allow any conclusion on inter-
individual variability (Chetboul et al., 2009; Hezzell et al., 2012b). In one report including a 
higher number of dogs (n = 196) from the same large breed (Doberman Pinscher), inter-
individual CV according to age category reached 53% in dogs ≤ 3 years (Wess et al., 2011). 
Study 2 was therefore the first one to point out the inter-individual variability of plasma NT-
proBNP in small size dogs. However, according to the study by Collins et al., 2010, it was 
hypothesized that effect of sample handling and storage could have altered plasma NT-proBNP 
concentrations and explained this variability.  
In study 1, a large inter-individual variability was also observed in the reference sample group for 
several variables, especially liver enzymes, but not for well-controlled variables (sodium for 
example). Enzymatic measurements are nevertheless known for their relatively high inter- and 
intra-individual variability (Ruaux et al., 2012), but our findings for ALT here clearly need 
further investigation at least in B and MP as, to the best of the author’s knowledge, no previous 
publication has reported such a high upper limit.  
 
Clinical relevance of reference interval determination in small size dogs 
The clinical utility of RI establishment in small size dogs was evaluated. In study 1, according to 
the analyte, 3.8% to 76.6% of the observed values were inferior to the lower limit of the 
laboratory’s RI used routinely for 9 out of 12 tested variables, and 4.5% to 9.7% of the observed 
values were higher than the upper limit of the laboratory’s RI for 7 out of 12 variables, thus 
indicating that the laboratory’s RI was not appropriate for all variables except plasma glucose and 
chloride. These observations were already pointed out by other authors in adult dogs within a 
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specific breed such as Bernese Mountain dogs (Nielsen et al., 2006), Greyhounds and Lurchers 
(Campora et al., 2011a & 2011b) as well as Dogues de Bordeaux (Lavoué et al., 2013) or 
category of breeds (Craig et al., 2006).  
Regarding plasma NT-proBNP evaluation, study 2 was the first that tried to determine RI within 
a population of healthy dogs. High inter-individual variability was found within the studied 
population and led us to conclude that a single plasma value in a healthy adult small size dog 
should be interpreted carefully. Moreover, as for any laboratory test, many sources of variation 
may occur in the plasma NT-proBNP dosage, potentially leading to false-positive or false-
negative results. Therefore, the TTE remains the method of choice in the assessment of heart 
disease and plasma NT-proBNP dosage should be performed in combination with 
echocardiography. Finally, due to an analytical issue, the upper limit of the RI corresponded to 
the limit of quantification of the assay and was therefore not interpretable. As NT-proBNP 
concentration is supposed to increase in dogs with DMVD, the real interest of the assay with such 
a low limit of quantification was pointed out.  
Finally, in study 3, we compared all the M-mode echocardiographic RI with the predictive RI 
calculated using the Cornell’s formula. The Cornell’s formula (Cornell et al., 2004) is an 
allometric scaling allowing prediction of percentiles according to BW. It was developed from a 
compilation of various small and large breeds adult dogs originating from 12 previous studies. 
Although our RI were systematically comprised in the predictive percentiles calculated with the 
Cornell’s formula, all were smaller than this latter, as illustrated by the end-diastolic left 
ventricular free wall (i.e., 5.0-8.3 mm in the present study versus 4.9-13.2 mm with Cornell’s 
formula). This observation suggests that, according to Morisson et al., 1992, not only the BW, 
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but also the breed must be taken into account when determining RI for echocardiographic 
variables. 
 
Conclusion 
As a conclusion, the present results demonstrated that determination of specific RI in small size 
dogs is relevant regarding several blood and imaging variables because RI established from other 
canine breeds are not always suitable for small breeds. However, the need to partition RI for a 
specific small size breed was not identified for blood variables. These finding are of great clinical 
interest, not only for the longitudinal assessment of dogs with DMVD, but more widely, in other 
veterinary medicine specialties. Hence, veterinarians will now dispose of specific RI for routine 
biochemistry in the most common 7 small size breeds seen in practice. Moreover, effect of 
covariate such as BW, age and gender were observed in the present work but seemed to be 
negligible for biochemistry variables and PCV, and remain unclear for the plasma NT-proBNP. 
To the contrary, BW was strongly correlated with echocardiographic M-mode variables in 
CKCS, requiring regression-based RI according to range of BW. Finally, the plasma NT-proBNP 
is the most common cardiac biomarker used in veterinary medicine in the assessment of canine 
DMVD but also in the differential diagnosis of respiratory symptoms such as cough or dyspnea 
(i.e., cardiac or non-cardiac origin). However, due to high inter-individual variability observed in 
the present study, this useful biomarker should be interpreted with caution (especially high 
values) and in combination with echocardiography, which remains the gold standard of 
cardiovascular evaluation.  
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Perspectives 
This work opens up new perspectives. Firstly, determination of RI for other cardiologic variables 
in small size dogs including troponin I, VHS and other echocardiographic variables (e.g., 3-
dimensional, speckle tracking etc.) could be interesting. Moreover, RI for echocardiographic 
variables should be investigated in small size dogs other than CKCS, in order to confirm or 
infirm the need for determination of specific small breed-RI. As demonstrated here, the breed 
category should be taken into account when determining a RI for several blood and 
echocardiographic variables. Since morphological differences between canine breeds can be 
large, it is assumed that a RI should be ideally developed within a specific breed or category of 
breeds. This work will be huge as there are more than 300 breeds in the canine population but is 
however critical because it would probably avoid some mis-classifications of dogs with or 
without specific disease conditions. Moreover, the effects of BW, age and gender on the tested 
variables should be assessed when RI is being determined in order to know if further partitioning 
of is necessary. Additionally, evaluation of other effects such as training, pregnancy, BCS and 
neutered status could be highly relevant as only few studies reported their influence on blood and 
cardiovascular variables. However, according to Kjelgaard-Hansen and as demonstrated in the 
present work, partitioning should be undertaken only if a clinical relevance has been identified. 
Further studies are needed to better understand the concept of RI in the canine species and more 
widely in veterinary medicine. 
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ARTICLE 1: “Basal plasma concentrations of routine variables and 
packed cell volume in clinically healthy adult small size dogs: effect 
of breed, body weight, age, and gender, and establishment of 
reference intervals”  
 
 
 
This article was written by Misbach C, Chetboul V, Concordet D, Gruet P, Speranza C, 
Hoffmann AC, Rocha A, Balouka D, Petit AM, Trehiou-Sechi E, Pouchelon JL and Lefebvre HP 
and published in Veterinary Clinical Pathology in September 2014 (volume 43, pages 371 to 
380). 
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ARTICLE 2: “Basal plasma concentrations of N-terminal pro-B-type 
natriuretic peptide in clinically healthy adult small size dogs: effect 
of breed, body weight, age, and gender, and establishment of 
reference intervals”  
 
 
 
This article was written by Misbach C, Chetboul V, Concordet D, Gruet P, Speranza C, 
Hoffmann AC, Rocha A, Balouka D, Petit AM, Trehiou-Sechi E, Pouchelon JL and Lefebvre HP 
and published in Research in Veterinary Science in December 2013 (volume 95, pages 879 to 
885). 
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ARTICLE 3: “Conventional and Doppler echocardiography in 
clinically healthy adult Cavalier King Charles Spaniels: effect of 
body weight, age, and gender, and establishment of reference 
intervals”  
 
This article was written by Misbach C, Lefebvre HP, Concordet D, Gouni V, Trehiou-Sechi E, 
Petit AM, Damoiseaux C, Leverrier A, Pouchelon JL and Chetboul V and published in the 
Journal of Veterinary Cardiology in June 2014 (volume 16, pages 91 to 100). 
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Background: Plasma variables may be affected by breed or body weight
(BW). Small-sized dogs are very common, but no specific reference inter-
vals (RI) are used.
Objectives: The primary objective of this prospective study was to assess
the potential effect of breed, BW, age, and sex on routine plasma analytes
and packed cell volume (PCV) in small-sized dogs. A secondary objective
was to establish RI in this small-sized population.
Methods: Blood was sampled under standardized conditions from healthy
dogs. PCV and 15 routine plasma variables were measured at the same
laboratory. Effects of breed, BW, age, and sex were tested using a general
linear model. The procedure recommended by the Clinical and Laboratory
Standards Institute was used to establish RI.
Results: In this study, 154 healthy dogs from 7 breeds were prospec-
tively included. Although a significant effect of breed, BW, sex, or age
was evidenced for most variables (except plasma sodium, phosphates,
and triglycerides), it was considered as clinically irrelevant. More strik-
ingly, the percentage of values in the reference sample group under
the lower limit of the laboratory’s RI ranged from 3.8% to 76.6% for 9
variables, and those higher than the upper limit of the laboratory’s RI
ranged from 4.5% to 9.7% for 7 variables. For example, the RI for cre-
atinine in small-sized dogs was 45–90 lmol/L (vs 54–144 lmol/L for
the general dog population).
Conclusion: Specific RI should be considered for PCV and selected plasma
variables in small-sized dogs.
Introduction
Breed effects on biochemical variables have been
increasingly reported for dogs over the last 10 years1–7,
as illustrated for Sight Hound dogs.8 The dog provides a
unique model because there are > 300 breeds with
large phenotypic variations. The decision to partition
data according to breed might be valid not only for
Sight Hounds but also for other breeds, as previously
suggested.9–12 Although significant differences were
observed in Alaskan Malamute, Siberian Husky,
Golden Retriever, and English Setter populations for
various biochemical analytes, they were considered
irrelevant by the authors.13
According to the American Kennel Club 2011 Dog
Registration Statistics14, small-sized dogs, ie, dogs with
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a body weight (BW) < 12 kg, are popular. Yorkshire
Terrier (YT), Poodle, Dachshund (D), and Shih-Tzu
(ST), for example, rank 5, 8, 9, and 11, respectively, of
173 different canine breeds. These breeds are more
common in large cities. The most popular breed in
2011 in Detroit, New York City, and Tampa was, for
example, the YT. Therefore, specific reference intervals
(RI) for small-sized dogs could be more appropriate in
urban areas.
The phenotypic differences between small-breeds
might also affect plasma and serum variables. Interest-
ingly, limited data are available regarding the potential
effect of BW on plasma variables, although this factor
is probably confounded with the breed. The morpho-
logic differences between canine breeds can be large
with BW varying from < 1 kg (Chihuahua) to > 60 kg
(Irish Wolfhound). This is particularly true for small-
breed dogs as the BW range may vary more than 10-
fold (from < 1 to 12 kg). For example, plasma creati-
nine can be significantly affected by BW in the canine
species.15,16 Effects of age and sex onmost plasma vari-
ables are still poorly documented and could also affect
clinical interpretation.
The primary objective of this prospective study
was to assess the potential effect of breed on routine
plasma analytes in dogs from 7 different small-breeds,
and to assess the effects of BW, age, and sex on the
plasma variables that were measured. A secondary
objective was to use this small-sized dog population as
a reference sample group to establish RI.
Material andMethods
Animals
The reference sample group consisted of healthy and
sexually intact adult (age > 10 months and
< 8 years) breeder-owned dogs of 7 different breeds,
including Bichon Frise (BF), Cavalier King Charles
(CKC) and King Charles (KC) Spaniel, Miniature
Poodle (MP), ST, YT, and D, prospectively recruited
in the area of Paris, France. Breeder’s consent was
obtained for each animal before its enrollment in the
study, and all procedures were approved by a local
ethics committee and in compliance with the Proce-
dures and Principles of Good Clinical Practice.17 An
animal information form (documenting breed, sex,
date of birth, history, diet, reproductive status, vacci-
nation program, and parasite control), and a copy of
the pedigree were also obtained for each dog before
inclusion in the study. Moreover, a body condition
score (BCS) was determined for each dog based on a
9-point scale.18 Specific attention was paid to avoid
including dogs from the same family (eg, puppies
from the same litter and parents), and a maximum of
10 dogs were recruited from a given breeder to avoid
any bias due to breeder-dependent environmental
effects (housing, diet, exercise, etc). Dogs of different
breeds could be owned by the same breeder.
Animals were assessed as healthy on the basis of a
complete physical examination and history. Past his-
tory of medical problems (eg, infectious disease, lame-
ness, etc) was not an exclusion criterion if the animal
had totally recovered and if the treatment had been
stopped at least 3 months before the time of blood
sampling.
Dogs had to be fasted for at least 10 h before blood
sampling and the diet should not have been changed
over the last 15 days. Females had to be nonlactating,
not pregnant, and in anestrus.
Nonfasted dogs, dogs with abnormal clinical
findings, and dogs on medication at the time of blood
sampling were excluded from the study. Administra-
tion of antiparasitic drugs or vaccines during the
15 days preceding blood sampling was also an
exclusion criterion.
Blood sample collection and specimen handling
All dogs were sampled within an 8-week period
between July and August 2011, and during the same
period of day between 10.00 AM and 2.00 PM, to avoid
any potential circadian periodicity. Fasted dogs were
acclimated to the investigator and the room for about
10 min just before sampling. Blood was drawn from
the jugular vein of the unsedated animal in the same
position (sitting) with a 20-Gauge needle (Neolus NN-
2038S, Terumo Europe, Leuven, Belgium) and a 5-mL
syringe (BD Discardit II H-905S, Becton Dickinson,
Fraga, Espana). Three mL of blood were collected and
divided into 2 plastic tubes, one containing K3-EDTA
(Venosafe VF-052STK, Terumo France, Guyancourt,
France), and the other Lithium Heparin (Venosafe VF-
054SHL, Terumo France). Blood was centrifuged for
15 min at 1600g (EBA 20, Hettich, Tuttlingen, Ger-
many) at room temperature within 30 min of blood
sampling. The plasmawas then pipetted into 2 separate
Eppendorf tubes, and stored at 4°C before transfer to a
80°C freezer, less than 6 h after blood sampling.
Plasma assays were performed once a week during the
study period by the Laboratoire Vebiotel, Arcueil,
France (LVA).
The packed cell volume (PCV) was determined on
heparinized blood in a capillary tube immediately after
blood sampling, by centrifuging for 5 min at 12,000g
(Haemofuge 3522, Heraeus,MN, USA).
372 Vet Clin Pathol 43/3 (2014) 371–380©2014 American Society for Veterinary Clinical Pathology and European Society for Veterinary Clinical Pathology
Plasma variables in small-sized dogs Misbach et al
Assays
Details about the analytical methods used for plasma
biochemistry are provided in Table 1. Fifteen plasma
analytes were measured: sodium, potassium, chloride,
calcium, phosphate, urea, creatinine, total proteins,
albumin, glucose, cholesterol, and triglycerides con-
centrations, and activities of aminotransferase (ALT),
aspartate aminotransferase (AST), and alkaline phos-
phatase (ALP). Electrolytes and substrates/enzymes
were determined by direct potentiometry with specific
electrodes, and absorption spectrophotometry and col-
orimetric methods, respectively (Konelab 60, Thermo
Clinical – 95, Cergy Pontoise, France).
Statistical analysis
Identification of outliers and determination of RI were
performed according to the current Clinical and Labo-
ratory Standards Institute guidelines.19 Native and
Box–Cox transformed data were first tested for
normality by use of the Anderson–Darling test. When
the data distribution remained non-Gaussian after
Box–Cox transformation, the values in both tails of the
distribution were examined visually. Outliers were
identified by applying the Tukey method. When a
value was deemed questionable, the following criteria
were used to decide whether to remove a dog from the
study: any abnormality concerning medical history or
clinical examination and an atypical value for more
than one analyte from the same dog. RI were defined
as central 95% intervals bounded by the 2.5th and
97.5th percentiles. Upper and lower limits of RI with
their 90% confidence intervals (CI) were determined
in the global population by a nonparametric
approach.20
Effects of breed and other covariates on plasma
variables were tested using a statistical software pack-
age (Systat version 8.0, SPSS Inc, Chicago, IL, USA). A
value of P < .05 was considered significant. Age and
BW in each breed were compared by ANOVA. The
effect of breed, sex, age, and BW on plasma variables
was tested by the following linear mixed-effects
model:
Y ¼ lþ Breedþ Sexþ aAgeþ bBWþ ðBreed
 AgeÞ þ ðBreed BWÞ þ ðBreed SexÞ
þ e
where Y is the value of the plasma variable, l is a con-
stant term, age and BW are continuous variables, and a
and b are the slope coefficients for age and BW irre-
spective of the breed. The other terms denote interac-
tions between breed and age, breed and BW, and breed
and sex. e is the residual term of themodel.
Results
Population
Of the 183 dogs selected by breeders for examination
during the kennel visits, 29 were excluded from blood
sampling collection: 12 of these dogs were presented
with a heart murmur, 5 females were in estrus, 5 dogs
Table 1. Analytical methods for plasma analytes measured in a population of 154 healthy small-sized dogs, and between-run coefficients of variation
(CV) for human control solutions (Abtrol, Thermo Electron Co, Madison, WI, USA and Nortrol, Thermo Electron Co, Madison, WI, USA, respectively).
Analyte Methodology
Control
Concentration 1
Between-
Run CV (%)
Control
Concentration 2
Between-Run
CV (%)
Urea (mmol/L) Colorimetric (urease and glutamate dehydrogenase) 14.8 3.90 6.5 3.22
Creatinine (µmol/L) Colorimetric (modified Jaffe: kinetic measurement) 337 4.49 156 4.37
Total proteins (g/L) Colorimetric (Biuret method) 45.8 2.73 63.1 2.41
Albumin (g/L) Colorimetric (bromocresol green) 28.6 2.16 41.3 1.97
Glucose (mmol/L) Colorimetric (glucose oxidase/peroxidase) 15.9 1.92 5.0 2.05
ALT (U/L) Absorption spectrophotometry (alanine/oxoglutarate)
without pyridoxal phosphate (30°C)
157 3.13 40 5.07
AST (U/L) Absorption spectrophotometry (L aspartate/glutarate)
without pyridoxal phosphate (30°C)
158 2.46 36 2.30
ALP (U/L) Absorption spectrophotometry (P nitro
phenylphosphate) (30°C)
275 5.10 80 6.90
Sodium (mmol/L) Potentiometric (ion-selective electrode) 152 1.38 137 1.10
Potassium (mmol/L) Potentiometric (ion-selective electrode) 6.5 1.92 4.2 1.85
Chloride (mmol/L) Potentiometric (ion-selective electrode) 117 1.82 100 2.02
Calcium (mmol/L) Colorimetric (arsenazo III) 3.18 2.81 2.25 2.15
Phosphate (mmol/L) Colorimetric (molybdate ammonium) 2.04 4.16 1.03 5.87
Cholesterol (mmol/L) Colorimetric (cholesterol esterase) 6.79 1.83 4.28 2.36
Triglycerides (mmol/L) Colorimetric (lipase/peroxidase) 2.09 3.20 0.75 3.30
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had been vaccinated 2 days before examination, 3
dogs were nonfasted, 2 females had pseudolactation,
one dog had hyperthermia with severe neck dermati-
tis, and one dogwas obese (BCS of 7/9).
The final dog population included 154 dogs
belonging to 28 different breeders (see characteristics
in Table 2). According to a 9-point BCS scale, body
score was 4/9 (ie, slim) for 2 dogs (1.2%), 6/9 (ie,
slightly overweight) for 11 dogs (7.1%), and 5/9 (ie,
optimal) for the 141 remaining dogs (91.5%).
Breed effect
Descriptive statistics of plasma analytes and PCV for
each breed and for the reference sample group are
given in Table 3. Significant differences between
breeds were evident for BW (P < .001), as expected,
but not for age (P = .411). The difference in BW was
greatest between CKC and YT (8.3  1.4 and
3.0  0.7 kg, respectively). Some interactions
between breed and other covariates (BW, sex, but not
age) were statistically significant (Tables 4–6). A breed
effect was evident for PCV (P = .032), plasma urea
(P = .035), total protein (P = .019), albumin
(P = .032), glucose (P = .003), and chloride (P = .026)
concentration, and ALT activity (P = .002).
Effects of BW, sex, and age on plasma variables
A statistically significant effect of BW was observed for
PCV (P = .042), plasma urea (P = .046), creatinine
(P = .021), total protein (P = .001), albumin
(P = .007), cholesterol (P < .001), and calcium
(P = .028) concentration, and ALP (P = .027) activity.
A statistically significant sex effect was observed for
potassium (P = 0.002) and cholesterol (P = .033) con-
centration, and plasma ALT (P = .027) and AST
(P = .013) activities. Total protein (P < .001), potas-
sium (P = .031), and calcium (P = .001) concentra-
tions were significantly affected by age (Tables 4–6).
Determination of reference intervals
Box–Cox transformation yielded a Gaussian distribu-
tion only for PCV, whereas 15 of the 16 distributions of
plasma variables tested for normality could not be
transformed to fit a Gaussian distribution (Table 7).
Application of the Tukey method did not reveal any
outliers and therefore no value was deleted for RI
establishment.
The corresponding lower (LL) and upper (UL) lim-
its of the RI for tested plasma variables with 90%CI are
provided in Table 7. For each variable, the LL and UL
of the laboratory LVA are also given. The 90%CI upper
value for the LL of the RI established from the data
obtained in the 154 dogs was lower than the LL of the
general dog RI of the laboratory for total protein, albu-
min, sodium, potassium, and calcium concentrations.
The 90% CI lower value of the UL of the RI in the
small-sized dogs was higher than the UL of the labora-
tory’s RI for plasma phosphate and cholesterol concen-
trations, and ALT and AST activities. The number and
percentage of dogs with values lower (higher) than the
LL (UL) of the laboratory are given in Table 7.
Discussion
This study demonstrates a breed, BW, sex, and age
effect for 7/16, 8/16, 4/16, and 3/16 tested variables,
respectively. None of these covariates significantly
affected plasma sodium, phosphates, or triglyceride
concentrations. This study also demonstrates that com-
monly used RI of plasma variables could potentially
lead to misinterpretation of values obtained in small-
sized dogs.
The major advantages of this study were that (1) it
was prospective with well-standardized conditions
(fasting, standardized blood sampling procedure,
assays performed in the same laboratory), (2) the total
number of animals included was high enough to allow
Table 2. Represented breeds, sex, age, and body weight (BW) in the study population of 154 healthy small-sized dogs.
Breeds
Number of
Dogs (%)
Number of
Breeders*
Numbers for Each Sex (%)
Median Age
(Min–Max) (Years)
Median BW
(Min–Max) (kg)Females Males
Total 154 28 96 (62.3) 58 (37.7) 3.2 (0.7–9.1) 6.5 (1.9–12.3)
Bichon Frise 8 (5.2) 2 4 (4.2) 4 (6.9) 4.2 (1.5–6.3) 4.4 (2.5–7.5)
Cavalier King Charles Spaniel 36 (23.4) 8 21 (21.9) 15 (25.9) 2.3 (1.1–8.8) 8.5 (5.4–11.4)
King Charles Spaniel 17 (11.0) 4 14 (14.6) 3 (5.2) 3.7 (0.9–7.7) 7.5 (6.1–8.8)
Dachshund 27 (17.5) 4 15 (15.6) 12 (20.7) 3.0 (1.0–8.7) 5.0 (3.7–12.3)
Miniature Poodle 20 (13.0) 5 12 (12.5) 8 (13.8) 3.4 (1.0–7.2) 5.5 (2.9–9.2)
Shih-Tzu 28 (18.2) 5 17 (17.7) 11 (19.0) 3.5 (0.7–8.4) 6.5 (4.2–11.9)
Yorkshire Terrier 18 (11.7) 5 13 (13.5) 5 (8.6) 3.9 (1.5–9.1) 3.2 (1.9–4.2)
*Animals from different breeds could belong to the same breeder.
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calculation of the RI according to the current CLSI
guidelines, and (3) the age (0.7–9.1 years) and BW
(1.9–12.3 kg) ranges were representative of the small-
sized dog population seen in routine veterinary prac-
tice. The potential limitations were the differing num-
bers of represented breeds. The actual proportion of
each breed in the total canine population, however, is
not well balanced, but rather varies according to the
country and also to urban or rural areas. The reference
sample group of this study appears representative of
the small-sized dog population living in the Paris area.
However, the number of dogs per breed (8–36) is too
low to allow any extrapolation of the present results to
the global population of each breed.
Although a male: female sex ratio of 1:1 would
have been ideal, the sex ratio in the present study was
4:6, which could be explained by the fact that all the
dogs belonged to breeders.
Another limitation of this study were the quality
controls that were based on human material, which is
not compliant with the current ASVCP quality
assurance guidelines recommending the use of spe-
cies-specific quality control materials.21 This issue
should be addressed in future studies establishing
breed-specific RI.
The objective of this study was to assess the poten-
tial need for partitioning the reference sample group
according to covariables (breed, BW, age, and sex).
Nevertheless, the decision to partition into subclasses
should not only be made on the basis of statistical con-
cepts but also with physiologic differences expected to
result in important clinical differences in RI in mind.22
In the present study, a small-sized dog population was
preselected among the general canine population with
strict criteria of inclusion, as well as standardized and
controlled preanalytical and analytical procedures to
minimize the need for partitioning RI according to cri-
teria, such as breed size (eg, small, large, and giant
breed), pregnancy/lactation, reproductive status, geo-
graphic location, and circadian rhythm. Nevertheless,
a large variability was observed in the reference sample
group for several variables, especially liver enzymes,
but not for physiologically well-regulated variables,
such as sodium. This is also illustrated by the 90%CI of
the limits of the RI. Currently, the high variability
remains unexplained.
The clinical relevance of the statistically significant
differences due to the different covariates should
therefore be discussed for each variable. Plasma urea
concentration differed significantly according to the
breed. Nevertheless, when the mean values were con-
sidered, only MP and ST dogs showed a 32% higher
value than the other breeds. The higher valuesTa
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observed in these 2 breeds did not exceed the upper
value of the 90% CI for the UL of the RI, suggesting
therefore that the RI established from the overall pop-
ulation could be suitable for all 7 selected breeds. For
ALT activity, values > 80 U/L (the upper limit of the
laboratory’s RI) were observed in 15 dogs. This
explains why the upper limit of the RI for ALT activity
is quite high (261 U/L). The breed effect was statisti-
cally significant with BF dogs having the highest mean
value. This could be explained by the fact that 2/8 BF
dogs had high ALT activities (133 and 277 U/L). Simi-
larly, 4/20 MP showed ALT activities between 115 and
294 U/L. The reason for such high activities remains
unclear as these animals were clinically healthy and
did not show any abnormality. These values were
therefore kept for the RI determination. Nevertheless,
as enzymatic activity measurements are known for
their relatively high inter- and intra-individual vari-
ability, the ALT activities determined in this study for
BF andMP require further investigation, as, to the best
of the author’s knowledge, no previous publication
has reported such a high upper limit. Differences
between breeds, although significant, appear to be
clinically irrelevant for PCV, and plasma total protein,
albumin, glucose, and chloride concentrations.
A significant BW effect was observed for half of
the tested variables. Moreover, this effect differed
according to the breed for plasma urea, total protein,
and albumin concentration, and ALP activity. For
example, when BW was decreased by 3 kg (which is a
considerable difference within a given breed), plasma
urea concentration was lowered by 1.8 mmol/L inMP,
Table 4. Slope coefficients for the continuous variables age and body weight, and differential effects for the categorical variables breed and sex in the
model used for statistical analysis of select plasma variables in a population of 154 healthy small-sized dogs, with corresponding P-values. The slope
coefficients and differential effects are only given when the effect is statistically significant.
Tested Variable
Mean of
Entire Study
Population
Breed Sex Age BodyWeight
Differential
Effect P-Value
Differential
Effect P-Value
Slope
Coefficient P-Value Slope Coefficient P-Value
Urea (mmol/L) 7.3 BF:1.6
CKC: +1.6
KC:2.3
D:0.9
MP: +4.5
ST:2.6
YT: +1.2
.035 – .58 – .63 BF: +0.1328
CKC:0.4316
KC:0.1162
D:0.1992
MP:0.6142
ST: +0.4316
YT: +0.7968
.046
Creatinine (µmol/L) 60 – 0.14 – .25 – .07 +1.935 .021
Total protein (g/L) 50.080 BF: +1.660
CKC:7.722
KC:4.368
D:2.667
MP: +6.108
ST: +7.390
YT:0.351
.019 – .196 +0.869 < .001 BF:0.592
CKC: +1.013
KC: +1.030
D: +1.533
MP:0.331
ST:0.670
YT:1.983
.001
Albumin (g/L) 25.933 BF:3.092
CKC:1.681
KC:4.677
D: +2.485
MP: +5.617
ST: +0.005
YT: +1.343
.032 – .899 – .072 BF: +0.657
CKC: +0.623
KC: +0.433
D:0.679
MP:0.873
ST:0.156
YT: +0.595
.007
Glucose (mmol/L) 4.9 BF:0.6
CKC: +0.8
KC: +1.7
D: +0.9
MP:0.3
ST:0.3
YT:2.2
.003 – .22 – .56 – .15
BF indicates Bichon Frise; CKC, Cavalier King Charles Spaniel; KC, King Charles Spaniel; D, Dachshund; MP, Miniature Poodle; ST, Shih-Tzu; YT, Yorkshire
Terrier.
The general regression equation was calculated as follows (eg, plasma albumin in CKC): Plasma albumin (g/L) = 25.933  1.681 + 0.623 9 Age (years).
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whereas it was increased by 2.4 mmol/L in YT. Such
findings will have little effect on the clinical interpreta-
tion of the results. The underlying mechanisms for this
breed-dependent effect of BW cannot be explained,
but could be related more to differences in metabolism
rather than in renal excretion as this effect was not
observed for plasma creatinine. The effect of BW on
PCV, and plasma creatinine, calcium, and cholesterol
concentration is negligible as shown by the low value
of the BW slope coefficients. Therefore, a difference of
BW from 2 to 12 kg (ie, a 6-fold variation) between 2
small-sized dogs was related to an increase of about
9% for PCV, and 19 lmol/L for plasma creatinine,
0.28 mmol/L for calcium, and 1.3 mmol/L for
cholesterol concentration. Similar trends were seen for
total plasma protein and albumin concentrations. For
ALP activity, the slope coefficients were higher, indi-
cating that a 3 kg difference in BW was related to a
change in plasma enzyme activity of about 20 U/L in
BF or ST. Based on the small magnitudes of the differ-
ences found, it can be assumed that changes in BWwill
not affect the clinical decision for a tested variable
within the reference sample group.
A sex effect was evidenced for potassium and cho-
lesterol concentrations, and ALT and AST activities. A
significant interaction between breed and sex was
observed for plasma cholesterol concentration and
ALT activity, indicating that the sex effect was depen-
dent on the breed. Conflicting results regarding the sex
effect on plasma or serum variables have been pub-
lished by different authors.23–27 The sex effect could be
breed-specific as seen here with much higher ALT
Table 5. Slope coefficients for the continuous variables age and body weight, and differential effects for the categorical variables breed and sex of the
model used for statistical analysis of PCV, plasma cholesterol concentration, and ALT and AST activities in a population of 154 healthy small-sized dogs,
with corresponding P-values. The slope coefficients and differential effects are only given when the effect is statistically significant.
Tested
Variable
Mean of
Entire Study
Population
Breed Sex Age Body Weight
Differential
Effect P-Value
Differential
Effect P-Value
Slope
Coefficient P-Value
Slope
Coefficient P-Value
Packed cell volume (%) 39.8 BF: +8.4
CKC: +1.1
KC:18.5
D: +5.1
MP: +14.0
ST:1.6
YT:8.5
.032 – .426 – .971 +0.894 .042
Aminotransferase (U/L) 84 BF: +133
CKC: +14
KC:115
D:59
MP: +89
ST:44
YT:18
.002 BF: F:38, M: 38
CKC: F: +13, M:13
KC: F: +17, M:17
D: F: +6, M:6
MP: F:17, M: +17
ST: F: +4, M:4
YT: F: +16, M:16
.027 – .198 – .296
Aspartate
aminotransferase (U/L)
36 – .391 F:3, M: +3 .013 – .498 – .166
Alkaline phosphatase (U/L) 33 – .182 – .761 – .824 BF:7.193
CKC:5.330
KC: +0.310
D:0.632
MP: +2.200
ST: +6.984
YT: +3.661
.027
Cholesterol (mmol/L) 2.6 – .34 BF: F: +0.59, M:0.59
CKC: F: +0.82, M:0.82
KC: F:0.05, M: +0.05
D: F:0.45, M: +0.45
MP: F:0.29, M: +0.29
ST: F:0.18, M: +0.18
YT: F:0.44, M: +0.44
.033 – .76 +0.137 < .001
BF indicates Bichon Frise; CKC, Cavalier King Charles Spaniel; KC, King Charles Spaniel; D, Dachshund; MP, Miniature Poodle; ST, Shih-Tzu; YT, Yorkshire
Terrier.
The general regression equation for PCV was calculated as follows (eg, in Bichon Frise): PCV (%) = 39.8 + 8.4 + 0.894 9 Age (years).
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activities in male BF and MP dogs compared with
female dogs, as reported previously in Beagles.25 Our
results obtained for the large overall small-sized popu-
lation tested here showed nevertheless that there is no
need to establish sex-specific RI for most tested
variables.
A significant positive effect of age was observed on
total protein and potassium concentration, and a nega-
tive effect on calcium concentration. No interaction
between age and breed was observed here, contrary to
results obtained in Beagles and Labrador Retrievers.2
The slope coefficients were +0.869 for total protein,
+0.029 for potassium, and 0.025 for calcium concen-
tration. Therefore, a 5-year difference in age between
2 dogs is related to a change of +4.3 g/L in total protein,
+0.15 mmol/L in potassium, and 0.13 mmol/L in
calcium concentration in plasma. An increase in total
serum proteins with age has previously been
observed.24 In Beagles and Labrador Retrievers, the
plasma calcium concentration also decreases with age,
Table 6. Slope coefficients for the continuous variables age and body weight, and differential effects for the categorical variables breed and sex of the
model used for statistical analysis of the plasma potassium, chloride, and calcium in a population of 154 healthy small-sized dogs, with corresponding
P-values. The slope coefficients and differential effects are only given when the effect is statistically significant.
Tested Variable
Mean of Entire
Study Population
Breed Sex Age Body Weight
Differential
Effect P-Value
Differential
Effect P-Value
Slope
Coefficient P-Value
Slope
Coefficient P-Value
Potassium (mmol/L) 4.0 – .641 F:0.09
M: +0.09
.002 +0.029 .031 – .246
Chloride (mmol/L) 110 BF:1.9
CKC:1.4
KC:1.6
D:2.0
MP: +2.4
ST:3.1
YT: 7.5
.026 – .146 – .655 – .459
Calcium (mmol/L) 2.41 – .28 – .53 0.025 .001 +0.028 .028
BF indicates Bichon Frise; CKC, Cavalier King Charles Spaniel; KC, King Charles Spaniel; D, Dachshund; MP, Miniature Poodle; ST, Shih-Tzu; YT, Yorkshire
Terrier.
The general regression equation for calcium was as follows: Calcium (mmol/L) = 2.41  0.025 9 Age (years) + 0.028 9 body weight (kg).
Table 7. Reference intervals established for a study population of 154 healthy small-sized dogs and comparison with the reference intervals of the lab-
oratory (Laboratoire Vebiotel, Arcueil, France) determined in a healthy general canine population.
Analyte Distribution LL (90% CI) UL (90% CI)
LL–UL of the
Laboratory
Number (%) of
Values < LL of the
Laboratory
Number (%) of
Values > LL of the
Laboratory
Packed cell volume (%) BCG 35.9 (34–37) 56 (54–57) 37–55 6 (3.8%) 3 (1.9%)
Urea (mmol/L) NG 3.3 (3.3–3.3) 11.6 (8.3–13.3) 3.3–8.3 0 7 (4.5%)
Creatinine (µmol/L) NG 45 (45–54) 90 (81–99) 54–144 44 (28.6%) 0
Total proteins (g/L) NG 47.6 (43–49) 67.1 (65–70) 60–80 118 (76.6%) 0
Albumin (g/L) NG 23.9 (22–24) 33.0 (32–34) 30–40 118 (76.6%) 0
Glucose (mmol/L) NG 3.9 (3.4–3.9) 6.2 (6.2–7.3) 3.9–6.2 2 (1.3%) 2 (1.3%)
Aminotransferase (U/L) NG 19 (4–22) 261 (133–296) < 80 – 15 (9.7%)
Aspartate aminotransferase (U/L) NG 3 (2–10) 66 (54–129) 10–50 6 (3.9%) 9 (5.8%)
Alkaline phosphatase (U/L) NG 7 (1–10) 92 (76–113) <80 – 7 (4.5%)
Sodium (mmol/L) NG 137 (132–139) 152 (152–154) 145–160 69 (44.8%) 0
Potassium (mmol/L) NG 3.5 (3.3–3.5) 4.6 (4.4–5.2) 3.6–5.8 11 (7.1%) 0
Chloride (mmol/L) NG 106 (102–107) 115 (115–119) 95–115 0 1 (0.6%)
Calcium (mmol/L) NG 2.12 (2.00–2.20) 2.67 (2.62–3.29) 2.25–2.99 9 (5.8%) 1 (0.6%)
Phosphate (mmol/L) NG 0.74 (0.55–0.81) 2.65 (1.84–2.91) 0.81–1.61 6 (3.9%) 13 (8.4%)
Cholesterol (mmol/L) NG 1.81 (1.29–2.32) 7.48 (6.71–8.26) 0.52–6.45 0 8 (5.2%)
Triglycerides (mmol/L) NG 0.23 (0.23–0.34) 2.51 (1.60–5.24) 0.23–1.71 0 6 (3.8%)
BCG indicates Gaussian after Box–Cox transformation; NG, non-Gaussian; LL, lower limit; UL, upper limit.
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but the total plasma protein concentration remains sta-
ble.2 These changes are again clinically not relevant
enough to justify the establishment of RI based on age
categories, except perhaps in growing or geriatric ani-
mals for which further studies would be needed to
address this issue. In Beagles and Labrador Retrievers,
the hematocrit, calcium, phosphorus, and protein con-
centrations, and ALP activity were indeed shown to
have age-specific ranges within or during the first year
of life.2
It can therefore be assumed that there is no need
to establish breed-, sex-, age-, or BW-specific RI for
most of the variables in the 7 small-breeds tested here,
although further studies are needed to clearly identify
breed and BW effects on the tested plasma variables.
More interestingly, depending on the analyte, 3.8–
76.6% of the observed values were lower than the LL
of the laboratory’s RI used routinely for 9/12 tested
variables, and 4.5–9.7% of the observed values were
higher than the UL of the laboratory’s RI for 7/12
tested variables, thus indicating that the laboratory’s
RI (established for a general dog population) was not
appropriate for all variables except for plasma glucose
and chloride concentrations. Partitioning of RI is a crit-
ical issue in terms of statistical and clinical signifi-
cance.19 Partitioning criteria were presented earlier
where the statistical significance of the difference
between subclass means by the standard normal devi-
ate (z) test was calculated.28 The authors offered some
specific recommendations for threshold or critical z-
values to aid in deciding whether or not to calculate
separate RI.28 This approach, however, assumes that
the data follow a Gaussian distribution, and takes into
account an unequal prevalence of subclasses.19 An
alternative method based on direct estimation of the
proportion of 2 subclasses outside the reference limit at
each end of the combined distribution has been pro-
posed as follows: “If at least one of the four proportions
of the subgroup distributions cut off by the reference
limits of the combined distribution exceeds 4.1% or
lies below 0.9%, subgroup-specific reference intervals
should be calculated instead of using the common ref-
erence limits of the common group.”29 This approach
has been applied recently for the establishment of RI in
feline breeds.30 It is obvious from these partitioning
criteria that specific RI in small-sized dogs rather than
in the general canine population are needed for many
variables, and especially for creatinine, total protein,
albumin, and sodium concentration. For example, the
use of a value of 144 lmol/L as the UL value for creati-
nine concentration will lead to false-negative results
for the detection of renal dysfunction in small-sized
dogs, as previously suggested.16 Inversely, a normal
albumin concentration could be falsely interpreted as
hypoalbuminemia in small-sized dogs.
In conclusion, this study seems to indicate that the
establishment of specific RI for routine variables in
small-sized dogs rather than in the general canine pop-
ulation could be clinically relevant, especially in urban
areas where this subgroup is highly represented. Inver-
sely, the need for specific RI according to BW, sex, or
age in small-sized dogs is questionable. However, fur-
ther investigations are needed with a large number of
dogs to clearly document a breed effect on plasma vari-
ables in the small-sized dog population.
Disclosure: The authors have indicated that they have
no affiliations or financial involvement with any orga-
nization or entity with a financial interest in, or in
financial competition with, the subject matter or
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Plasma NT-proBNP has previously been evaluated in dogs with degenerative mitral valve disease
(DMVD). However, reference intervals (RI) established according to the Clinical Laboratory and Standards
Institute (CLSI) recommendations have never been provided. The objectives of this prospective study
were to assess effects of breed, body weight, age, and sex on plasma NT-proBNP, and to establish RI
according to CLSI for this biomarker in a large population of dogs predisposed to DMVD.
183 Healthy small-sized dogs from 7 breeds were included. Assays were performed by ELISA. Effects of
covariates were tested using a general linear model. Although a sex effect was demonstrated (P = 0.01),
no significant effect of breed, body weight or age was shown. The proposed RI was 157–2842 pmol/L.
7% of dogs had plasma NT-proBNP >2617 pmol/L, and were considered as outliers despite normal cardio-
vascular examination. In conclusion, plasma NT-proBNP may be high in a few healthy small-sized dogs.
Crown Copyright  2013 Published by Elsevier Ltd. All rights reserved.1. Introduction
Degenerative mitral valve disease (DMVD) is the most common
acquired heart disease in small size dogs, and is characterized by
degenerative valvular lesions resulting in systolic mitral regurgita-
tion with potential hemodynamic consequences, such as reduced
forward cardiac output and increased intracardiac pressures (Kvart
and Häggström, 2005; Borgarelli et al., 2008). As demonstrated in
humans (Francis, 1998; Ferrari et al., 1998), such hemodynamic
alterations may result in complex neurohormonal activation (espe-
cially adrenergic nervous and renin–angiotensin–aldosterone sys-
tem activation with overexpression of natriuretic peptides), in
order to maintain adequate cardiac output, blood pressure, and tis-
sue perfusion. To date, natriuretic peptides, including the inactive
aminoterminal portion of brain natriuretic peptide (N-terminal
pro-B-type natriuretic peptide, NT-proBNP), are considered asone of the most reliable neurohormonal markers of heart diseases
in dogs (Sisson, 2009; Boswood, 2009; Oyama, 2009a). Plasma NT-
proBNP is correlated with canine DMVD severity, and can be used
in combination with clinical status to predict outcome in both
asymptomatic dogs and dogs with congestive heart failure (CHF)
(Oyama et al., 2008; Serres et al., 2009; Chetboul et al., 2009; Rey-
nolds et al., 2012). Moreover, this biomarker has also been used to
discriminate between CHF and primary pulmonary disease in dogs
with cough or dyspnea (Fine et al., 2008; Oyama et al., 2009b).
Finally, plasma NT-proBNP has been shown to decrease with treat-
ment of CHF (Atkinson et al., 2009; Schöber et al., 2011) and the
reduction in plasma NT-proBNP after initiation of treatment is
considered as a useful predictor of overall cardiac survival (Wolf
et al., 2012). Plasma NT-proBNP has been previously evaluated in
a large population of healthy dogs (n = 550), including small and
large breed dogs from 9 different breeds (Häggström et al.,
2012). Highly significant breed differences were found and the
authors concluded that breed-specific reference ranges might
therefore be necessary for optimal clinical use of natriuretic
peptides as cardiac biomarkers.
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specifically documented reference intervals (RI), nor the potential
effects of physiological covariates (e.g., breed, body weight, age,
and sex) on plasma NT-proBNP concentration in a large population
of healthy adult small size dogs from different breeds predisposed
to DMVD.
The aims of this prospective study were therefore (1) to evalu-
ate plasma concentrations of NT-proBNP, (2) to identify potential
effects of breed, body weight, age, and sex and (3) to establish ten-
tative RI according to the statistical procedures recommended by
the Clinical Laboratory and Standards Institute guidelines (CLSI,
2008), in a large population of healthy adult small size dogs from
different breeds known to be predisposed to DMVD.2. Material and methods
2.1. Animals
The study population consisted of healthy non-neutered adult
(age >10 months and <8 years) dogs of 7 different breeds predis-
posed to DMVD (Bichon (B), Cavalier King Charles (CKC) and King
Charles (KC) Spaniels, miniature Poodle (MP), Shih-Tzu (ST), York-
shire Terrier (YT), and Dachshund (D)), prospectively recruited in
the Paris area (France). Breeder’s consent was obtained for each
animal before its enrolment in the study and all procedures were
approved by a local ethics committee and in compliance with the
Procedures and Principles of Good Clinical Practice (Food and Drug
Administration Good Clinical Practice, 2012). An animal informa-
tion form (including breed, sex, date of birth, history, diet, and also
reproductive, vaccination and deworming status) and a copy of the
pedigree were obtained for each dog before inclusion. Dogs from
different breeds could be owned by the same breeder. However,
specific attention was paid to avoid including dogs from the same
family (e.g., siblings, parents, and littermates), and a maximum of
10 dogs were recruited from a given breeder in order to avoid any
bias due to breeder-dependent environmental effects (housing,
diet, exercise, etc.).
Animals were assessed as healthy on the basis of a complete
physical examination, history, and routine plasma biochemistry.
Occurrence of clinical signs and past history of medical events
(e.g. infectious disease, lameness, etc.) did not lead to exclusion
of a dog from the study if the animal had totally recovered and if
the treatment had been stopped at least 3 months before blood
sampling. Occurrence of clinical signs between the time of blood
collection and 2 months later was assessed by a phone call inter-
view with the breeder.
Dogs had to be fasted for at least 10 h before sampling and the
diet should not have been changed during the previous 15 days. Fe-
males had to be in anoestrus, and neither lactating nor pregnant.
Non-fasted dogs, overweight dogs, dogs with an abnormal
clinical examination, and dogs on medication at the time of blood
sampling were excluded from the study. Other exclusion criteria
were antiparasitic drug administration or vaccination during the
15 days preceding blood sampling.2.2. Blood sample collection
To avoid any potential circadian periodicity, blood was collected
during the same period of the day (between 10.00 AM and
2.00 PM) and all the dogs were sampled within an 8-week period
(July–August 2011). Fasted dogs were acclimated to the investiga-
tor and the room for 10 min before sampling. Blood was drawn
with a 20 G needle and a 5 mL syringe from the jugular vein of
awake animals, which were always in the same position (sitting
position). Two mL of blood were collected and placed in a plastictube containing K3-EDTA (Venosafe VF-052STK, Terumo France,
Guyancourt, France). Blood was centrifuged (15 min, 1500g) (EBA
20, Hettich, Tuttlingen, Germany) at room temperature within
30 min of blood sampling. The plasma (at least 0.5 mL) was placed
into transport tubes containing proteases (Cardiopet, Idexx, Alfort,
France) provided by the commercial laboratory (Laboratoire Idexx,
Alfort, France), transferred at 4 C within 45 min of blood sampling
and then stored at 80 C (less than 6 h after blood sampling).
2.3. Plasma NT-proBNP assay
Plasma NT-proBNP concentration was measured using EDTA-
potassium samples and a commercially available canine specific
assay (Cardiopet, Idexx, Alfort, France). This sandwich ELISA assay
has already been used and validated for diagnostic purposes in the
dog (Boswood et al., 2008; Zieba et al., 2008). The inter- and intra-
assay coefficients of variation (CV) were 5.3, 6.6, 9.2%, and 10.7, 2.1,
4.2% for low (600 pmol/L), medium (1200 pmol/L) and high
(2400 pmol/L) concentrations, respectively. Samples were sent
every two weeks to the commercial laboratory (Laboratoire Idexx,
Alfort, France).
2.4. Statistical analysis
A value of P < 0.05 was considered significant. Identification of
outliers and determination of RI were performed according to the
current CLSI guidelines (2008). Native and Box-Cox transformed
data were first tested for normality by use of the Anderson–Darling
test. When the data distribution remained non-Gaussian after Box-
Cox transformation, visual inspection of values in both tails of the
distribution was used. Identification of outliers was performed
using the Tukey method. When an outlier was identified, further
examinations (see below) were specifically scheduled. The results
of these examinations were used as criteria to decide whether an
outlier dog should be removed or not from the study.
Effects of breed and other covariates on plasma NT-proBNP con-
centration were tested using a statistical software package (Systat
version 8.0, SPSS Inc, Chicago, IL). Age and body weight in each
breed were compared by ANOVA. The effects of breed, sex, age,
and body weight on plasma NT-proBNP concentration were tested
using the following linear mixed effects model:
Y = l + Breed + Sex + aAge + bBody weight + (Breed  Age) +
(Breed  Body weight) + (Breed Sex) + e, where Y is the value of
the plasma variable; l is a constant term; a and b are the slope
coefficients for age and body weight irrespective of the breed.
The other terms denote interactions between breed and age, breed
and body weight, and breed and sex. e is the residual term of the
model.
Reference intervals were defined as central 95% intervals
bounded by the 2.5th and 97.5th percentiles. The upper and lower
limits of the RI with their 90% confidence intervals (CI) were deter-
mined in the global population using a non-parametric approach
(Geffré et al., 2011). Data were expressed as median, [interquartile
ranges], except for results regarding systolic arterial blood pressure
and plasma BUN and creatinine (mean ± SD and [ranges] as mini-
mum and maximum) in outlier dogs.
2.5. Further examinations for NT-proBNP outliers
After the Tukey method was applied, some of the tested dogs
appeared as outliers (see statistical analysis). A complete cardio-
vascular examination, including conventional echocardiography
and Doppler examinations as well as systemic arterial blood pres-
sure measurement and plasma NT-proBNP, blood urea nitrogen
(BUN) and creatinine determinations were specifically scheduled
for these outliers 3 months after the first assay.
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each echocardiographic examination in conscious dogs, in accor-
dance with the ACVIM consensus statement (Brown et al., 2007)
by the same trained observer (CM) using the Doppler method
(811-BL, Parks Medical Electronics Inc. Aloha, Ore, USA). Dogs were
gently held by the owner in sternal recumbency. An inflatable cuff
(Soft-cuf, Ref 2422, 2 cm large, Parks Medical, USA) of appropriate-
size was placed on the tail, as previously described (Chetboul et al.,
2010). A period of acclimatization was allowed for each patient be-
fore blood pressure was measured. Several measurements were
performed over 5–10 min to obtain a stable set of 5 values, the
mean of which was taken as the patient’s systolic blood pressure.
Conventional echocardiographic and Doppler examinations
were performed by the same trained observer (CM) in awake dogs
gently restrained in standing position, using continuous ECG mon-
itoring with an ultrasound unit (Vivid i BT 10 SW appl. R 10.3.0, GE
Healthcare, 9900 Innovation Drive, Wauwatosa, WI 53226, USA)
equipped with a 5S (2–5 MHz) phased-array transducer, as
previously described (Chetboul et al., 2004, 2005). Echocardio-
graphic variables included the left ventricular diameters, the left
ventricular free wall and interventricular septum thicknesses at
end-diastole and end-systole as well as the fractional shortening
for M-mode, and the left atrium on aorta ratio for the two-dimen-
sional mode. Conventional Doppler variables included the maximal
systolic aortic and pulmonary velocities, maximal early (E) and late
(A) diastolic mitral flow velocities, as well as systolic pulmonary
arterial pressure and diastolic pulmonic artery-to-right ventricle
pressure gradient, when tricuspid and pulmonary regurgitations
were identified, respectively. Echocardiographic and Doppler vari-
ables were compared with the previously established reference
ranges (Gonçalves et al., 2002; Chetboul et al., 2005).
3. Results
3.1. Population
Twenty-nine of the 183 dogs selected by breeders for examina-
tion during the kennel visit were excluded from blood sample col-
lection. Twelve of these dogs presented with a heart murmur, 5
females were in estrus, 5 dogs had been vaccinated 2 days before
examination, 3 dogs were non-fasted, 2 females were having a
pseudolactation, one dog had hyperthermia with severe neck der-
matitis, and one dog was overweight.
One hundred and fifty-four dogs belonging to 28 different
breeders were therefore included in the study (see characteristics
in Table 1). Significant differences between breeds were foundTable 1
Epidemiologic characteristics of the reference sample group including 154 healthy adult s
Variable Global Breed
B CKC KC
n dogs (%) 154 8 (5.2) 36 (23.4) 17 (11
n breeders* 28 2 8 4
Sex (%)
F 96 (62.3) 4 (4.2) 21 (21.9) 14 (14
M 58 (37.7) 4 (6.9) 15 (25.9) 3 (5.2)
Age (years)
Median 3.2 4.2 2.3 3.7
IQR 1.9–4.8 2.7–5.5 1.7–3.8 2.4–6.4
BW (kg)
Median 6.5 4.4 8.4 7.5
IQR 4.6–8.3 3.1–6.8 7.8–8.9 6.6–8.3
n: Number of dogs; Global: the tested overall population; F: female; M: male; B: Bichon
miniature Poodle; ST: Shih-Tzu; YT: Yorkshire Terrier; BW: body weight; IQR: interquar
* Animals from different breeds could belong to the same breeder.for body weight (P < 0.001) as expected, but not for age
(P = 0.411). The greatest difference in body weight was observed
between CKC and YT (8.4 kg [7.8–8.9] and 3.2 kg [2.3–3.3],
respectively).
3.2. Plasma NT-proBNP concentration
The commercial laboratory (Laboratoire Idexx, Alfort, France)
did not quantify the NT-proBNP concentration when it exceeded
2842 pmol/L. In 9 out of the 154 tested dogs, plasma NT-proBNP
exceeded 2842 pmol/L, so their NT-proBNP value was set at
2842 pmol/L for the statistical analysis.
The plasma NT-proBNP values obtained in the global tested
population and in each of the 7 tested breeds are given in Table 2.
Distribution of plasma NT-proBNP concentrations among the refer-
ence sample group is illustrated in Fig. 1. Although no age or breed
effect was observed on plasma NT-proBNP, a significant sex effect
(P = 0.01) was shown (males: 683 pmol/L [404–892]; females:
844 pmol/L [550–1327]).
3.3. Characteristics of NT-proBNP outliers
After the Tukey method was applied, 11 of the 154 dogs in-
cluded in the study were considered as outliers (i.e., plasma NT-
proBNP concentration P2617 pmol/L). The plasma NT-proBNP
concentration was >2842 pmol/L for 9 dogs, and 2816 and
2829 pmol/L for the 2 remaining dogs. As described above, a
complete cardiovascular examination, as well as plasma BUN and
creatinine determination were specifically scheduled 3 months
after the first blood sampling.
The outlier population (8 females and 3 males, age: 3.2 years
[2.1–5.2]; body weight: 6.5 kg [5.4–9.1]) included 4 CKCS, 3 ST, 1
B, 1 D, 1 KC, and 1 MP. All conventional echocardiographic and
Doppler variables were within the reference ranges (Gonçalves
et al., 2002; Chetboul et al., 2005). Similarly, none of them were
hypo- or hypertensive (mean ± SD [ranges] systemic systolic arte-
rial blood pressure: 148 ± 10 mmHg [130–158]) (Brown et al.,
2007), and no arrhythmia was detected during the echocardio-
graphic examinations, using concomitant ECG tracing (mean ± SD
[ranges] heart rate: 115 ± 18 bpm [90–140]).
The 11 outlier dogs were also rechecked 3 months after the first
blood sampling for plasma NT-proBNP concentrations using the
same procedure described above. At recheck, the plasma NT-proB-
NP concentration was 2040 pmol/l [775–2842] versus 2842 pmol/l
[2842–2842] at the first visit. Only 4/11 dogs still had NT-proBNP
concentrations >2842 pmol/L, and those of the 7 remaining dogsmall size dogs from 7 different breeds.
D MP ST YT
.0) 27 (17.5) 20 (13.0) 28 (18.2) 18 (11.7)
4 5 5 5
.6) 15 (15.6) 12 (12.5) 17 (17.7) 13 (13.5)
12 (20.7) 8 (13.8) 11 (19.0) 5 (8.6)
2.9 3.4 3.4 3.9
1.6–4.2 1.8–4.9 1.9–5.6 2.4–5.9
5.0 5.5 6.5 3.2
4.3–8.9 4.4–6.9 5.7–8.0 2.3–3.3
; CKC: Cavalier King Charles spaniel; D: Dachshund; KC: King Charles spaniel; MP:
tile range.
Table 2
Descriptive statistics for plasma NT-proBNP assessed in 154 healthy adult small size dogs from 7 different breeds.
Global Breed
B CKC KC D MP ST YT
Number of dogs 154 8 36 17 27 20 28 18
NT-proBNP (pmol/L)
Median 783 804 1053 964 395 791 868 602
IQR 476–1232 700–1329 791–1446 637–1317 278–566 553–1436 533–1426 465–930
Global: the overall tested population; F: female; M: male; B: Bichon; CKC: Cavalier King Charles spaniel; D: Dachshund; KC: King Charles spaniel; MP: miniature Poodle; ST:
Shih-Tzu; YT: Yorkshire Terrier; IQR: interquartile range.
Fig. 1. Distribution of plasma NT-proBNP concentrations among the 154 healthy
small size dog population. The thick horizontal bar represents the median value
(i.e., 783 pmol/L) and the thin horizontal bars represent the first and third quartiles
(i.e., 476 and 1232 pmol/L, respectively).
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dogs showed an increase in plasma BUN and creatinine, i.e.,
mean ± SD [ranges] 4.83 ± 1.33 mmol/L [3.33–8.34] and
47.7 ± 10.6 lmol/L [26.5–70.7], respectively (RI provided by the
laboratory (Laboratoire Vebiotel, Arcueil, France): 3.33–
8.34 mmol/L and 53.0–132.6 lmol/L, for BUN and creatinine,
respectively). Owing to these results, none of the 11 outliers were
excluded for RI establishment.3.4. Reference intervals for plasma NT-proBNP
Reference intervals were established in the whole reference
sample group (n = 154 dogs). The distribution of plasma NT-proB-
NP concentration was tested for normality and could not be trans-
formed to fit a Gaussian distribution. The corresponding lower (LL)
and upper (UL) limits of the RI with 90% CI were, respectively, 157
[134–233] and 2842 [2842–2842] pmol/L.4. Discussion
In the present study, plasma NT-proBNP concentration was
measured in a large healthy adult small size dog population using
standardized procedures with strict inclusion and exclusion crite-
ria, in order to minimize sources of pre-analytical variations. More-
over, RI determination was performed according to the statistical
procedures recommended by the CLSI guidelines, to which the
American Society for Veterinary Clinical Pathology recently recom-
mended adherence (ASVCP Quality Assurance and Laboratory
Standards Committee, 2012). Despite these precautions, the plas-
ma NT-proBNP concentrations exhibited a wide range of values,
suggesting inter-individual variability, although all dogs belonged
to the same size category. Hence, in the general population, the in-
ter-individual CV was 96% and the within-breed inter-individual
CVs ranged from 62% (CKC) to 100% (MP). When considering sev-
eral other studies (Table 3) on plasma/serum NT-proBNP including
groups of healthy dogs (Oyama et al., 2008; Atkinson et al., 2009;
Kellihan et al., 2009, 2011; Raffan et al., 2009; Schmidt et al.,
2009; Chetboul et al., 2009; Collins et al., 2010; Wess et al.,
2011; Cunningham et al., 2012; Hezzell et al., 2012), two reports
included healthy comparable breeds as here (i.e., small size dogs),
but had a too small sample size (i.e., less than 31, versus 154 in the
present study) to allow any conclusion on inter-individual variabil-
ity (Chetboul et al., 2009; Hezzel et al., 2012). In one report includ-
ing a high number of dogs (n = 196) from the same large breed (i.e.,
Doberman Pinscher), inter-individual CV according to age category
reached 53% in dogs 63 years (Wess et al., 2011). Nevertheless, in
the latter studies, the material and methods used for sample
handling and assays were different as in our study, which
represents a limitation for such comparisons.
Eleven NT-proBNP outliers were detected in the present study.
All 11 dogs were confirmed to be free of cardiovascular diseases
using a complete standard echocardiography and Doppler exami-
nation as well as systemic arterial blood pressure measurement,
and were therefore kept for statistical analysis. When they were
re-tested for plasma NT-proBNP 3 months later using the same
procedures, only 4/11 dogs had plasma NT-proBNP values that still
exceeded the upper limit of detection of the assay, and the 7
remaining dogs showed a 1.2 to 6-fold decrease from their initial
NT-proBNP value. These findings are in accordance with a study
performed on the weekly variability of plasma NT-proBNP in 28
healthy dogs (Kellihan et al., 2009), showing that the difference be-
tween maximal and minimal NT-proBNP values was >500 pmol/L,
and between 100 and 200 pmol/L in 20% and 40% of the recruited
dogs, respectively. In healthy humans, NT-proBNP intra-individual
variability may be high, i.e., between 26% and 130% according to
studies (Melzi d’Eril et al., 2003; Wu et al., 2003), which thus
hampers the interpretation of changes in this biomarker with
disease progression and therapy adjustments in patients with
cardiovascular diseases (Bruins et al., 2004; Miller et al., 2009).
Nevertheless, owing to the very small number of outlier dogs
Fig. 2. Comparison between plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations assessed in the 11 outlier dogs at first sampling and 3 months
later.
Table 3
Comparison of plasma/serum N-terminal pro-B-type natriuretic peptide values in healthy dogs from 11 studies.
Authors n Age (year) Body weight
(kg)
Breeds Plasma/serum NT-proBNP (pmol/L)
Cunningham
et al.
(2012)*
17 Mean ± SD
5.8 ± 2.9
Mean ± SD
30.0 ± 6.9
Mixed breed, Doberman Pinscher, Golden Retriever and other breeds Median [ranges] 462 [38–1210]
Hezzell et al.
(2012)
30 Median
(IQR) 9.0
(6–11)
Median (IQR)
11 (7.2–13.8)
Cross-breeds, Cavalier King Charles Spaniel (n = 7), Miniature Poodle,
Yorkshire Terrier, Border Collie
Median (IQR) 324 (167–530)
Kellihan et al.
(2011)
8 Median
[ranges] 6
[1–9]
Median
[ranges] 28.5
[3.4–55.0]
Great Dane, German shepherd dog, Rottweiler, Dachshund, Boxer,
Maltese, Bearded Collie, Cocker spaniel.
Median [ranges] 744 [531–2710]
Wess et al.
(2011)
196 Mean 4.4 Mean 34.4 Doberman Pinscher Median [ranges] 303 [22–1325]
Collins et al.
(2010)
10 Data not
shown
Data not
shown
Cavalier King Charles Spaniels, crossbreds, Boxers, Lurchers, English
Springer and Cocker Spaniels, Doberman Pinscher, Bull Terriers, Labrador
and Golden Retriever, Great Dane, Irish, Wolfhound, Gordon and Irish
Setter, Whippet, Miniature Schnauzer, Fox Terrier
Median [ranges] 413 [356–487]
before freezing 709 [378–825] after
freezing
Atkinson
et al.
(2009)
9 Median 5 Median 19.8 Data not shown Median [ranges] 373 [209–738]
Chetboul
et al.
(2009)
22 Mean ± SD
9.1 ± 1.6
Mean ± SD
6.8 ± 3.6
Small size breeds: King Charles and Cavalier King Charles Spaniel,
Bichon, Yorkshire Terrier (n = 12); Other small breeds (n = 10)
Median [ranges] 278 [68–515]
Kellihan et al.
(2009)
28 Median 7 Median 20.4 Mixed breed, Labrador and Golden Retrievers, American Staffordshire
Terriers, other breeds
Median [ranges] Week 1: 377 [159–
631] Week 2: 320 [159–632] Week 3:
358 [159–650]
Raffan et al.
(2009)
39 Mean 6.0 Data not
shown
Unknown Median [ranges] 118 [2–673]
Schmidt et al.
(2009)
23 Median
(IQR) 7 (5–
8)
Median (IQR)
17.7 (10–30)
Mixed breed (48%), Golden Retriever, Keeshonds and other breeds Mean (95%CI) 261 (225–303)
Oyama et al.
(2008)
40 Median
(IQR) 7.0
(4.3–8.0)
Median (IQR)
19.9 (8.5–
30.5)
Mixed breed (40%), Great Dane, Golden retriever and other breeds Median (IQR) 290 (478–598)
n: number of dogs; IQR: interquartile range; CI: confidence interval; SD: standard deviation.
* Protocol using protease tubes.
C. Misbach et al. / Research in Veterinary Science 95 (2013) 879–885 883(n = 11), intra-individual variability of plasma NT-proBNP could
not be assessed in the present study.
As described in humans (Loke et al., 2003) and in one recent re-
port in dogs (Wolf et al., 2013), a sex effect on plasma NT-proBNP
was observed in the present study, with females having highermedian plasma NT-proBNP values than males. Conversely, no age
or body weight effects were found, in accordance with several
other reports (Boswood et al., 2008; Tarnow et al., 2009; Kellihan
et al., 2009; Oyama et al., 2008; Ettinger et al., 2012). However
plasma NT-proBNP concentration has been shown to be
884 C. Misbach et al. / Research in Veterinary Science 95 (2013) 879–885significantly increased in healthy Doberman Pinschers >8 years as
compared with younger dogs of the same breed (Wess et al.,
2011), and to be inversely related to body weight in a group of
39 asymptomatic CKCS with DMVD (Tarnow et al., 2009). Never-
theless, the absence of a significant effect of age on plasma NT-
proBNP may be attributable to the fact that all recruited dogs were
< 10 years old, and this could represent a limitation of the present
study.
Two studies reported a significant breed effect for plasma NT-
proBNP (Oyama et al., 2008; Häggström et al., 2012). However,
no breed effect was observed in the present study. This may be ex-
plained by the fact that all dogs belonged to the same size category.
This study presents several limitations. Firstly, plasma NT-proB-
NP concentrations were only measured on a second occasion in
dogs that were found to have exceptionally high concentrations
at the first time of measurement. Since these dogs were outliers,
it is likely that when measured on a second occasion, the variabil-
ity in their concentrations would be greater than that seen by more
typical members of the population (Bland and Altman, 1994a,b).
Therefore, conclusions cannot be drawn about natural variability
of plasma NT-proBNP concentration in typical individual dogs from
this study. Another limitation is that the UL of the RI determined in
the present study corresponds to the limit of quantification, as the
commercial laboratory responsible for the NT-proBNP assays did
not assess plasma NT-proBNP values >2842 pmol/L. Therefore,
the UL of the RI should be interpreted with caution. Moreover,
complementary cardiovascular examinations were only scheduled
for the outliers, and not for all the recruited dogs. However, one
important step, as for any study of reference intervals, was to de-
fine the criteria for health. Since echocardiography is not currently
considered as a prerequisite for NT-proBNP testing, the present
study was designed so that the conditions were similar to those
encountered in routine clinical practice, and dogs were considered
healthy on the basis of a complete physical examination, history
and routine plasma biochemistry. Finally, effect of sample handling
and storage could have affected plasma NT-proBNP concentrations,
as serum NT-proBNP has been shown to decrease at room temper-
ature and increase after storage at 20 C (Collins et al., 2010).
Nevertheless, according to the latter results, the authors recom-
mend that samples should be separated and frozen within 1 h of
blood collection and sent frozen to the laboratory until assays,
and this was the case in the present study.
In conclusion, this study suggests that plasma NT-proBNP con-
centration is characterized by a high inter-individual variability in
healthy adult small size dogs. Therefore, a single plasma value in a
healthy small size dog should be interpreted with caution. More-
over, a sex effect has been demonstrated, with females having
higher concentrations than males, but the clinical relevance of par-
titioning the RI according to sex needs further investigations. Pro-
spective studies including a larger sample size and other breeds are
therefore needed to better understand NT-proBNP physiology in
dogs.
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org/10.1016/j.jvc.2014Abstract Objectives: The objectives of this study were (1) to assess the potential
effect of body weight (BW), age, and gender on the most commonly used echocar-
diographic and conventional Doppler variables in a large population of healthy Ca-
valier King Charles Spaniels (CKCS), and (2) to establish the corresponding
reference intervals (RI).ort.fr (V. Chetboul).
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92 C. Misbach et al.UltrasoundList of abbreviations
2D two-dimensional
ACVIM American College of
nal Medicine
Ao aortic
BW body weight
CI confidence intervals
CKCS Cavalier King Charle
CLSI Clinical Laboratory
Institute
DMVD degenerative mitral
FS% fractional shortenin
IVSd interventricular sep
end-diastole
IVSs interventricular sep
end-systole
LA left atrium
LV left ventricular
LVDd left ventricular end-
LVDs left ventricular end-
LVFWd left ventricular free
end-diastole
LVFWs left ventricular free
end-systole
RI reference intervalsAnimals: 134 healthy adult CKCS.
Methods: Ultrasound examinations were performed by trained observers in awake
dogs. M-mode variables included left ventricular (LV) end-diastolic and end-
systolic diameters, LV free wall and interventricular septal thicknesses at end-
diastole and end-systole, and LV fractional shortening (FS%). The left atrium (LA)
and aortic (Ao) diameters were measured using a 2D method, and the LA/Ao was
calculated. Pulsed-wave Doppler variables included peak systolic aortic and pul-
monary flow velocities, mitral E and A waves, and E/A ratio. Effects of BW, age,
and gender on these 15 variables were tested using a general linear model, and
RIs were determined by applying the statistical procedures recommended by the
Clinical and Laboratory Standards Institute.
Results: A significant BW effect was observed for all variables, except LA/Ao, FS%,
and mitral E/A ratio. A significant but negligible effect of gender and age was also
observed for 5/15 and 4/15 of the tested variables, respectively. Only the BW effect
on M-mode variables was considered as clinically relevant and the corresponding
regression-based RIs were calculated.
Conclusions: Body weight should be taken into account when interpreting echocar-
diographic values in CKCS, except for LA/Ao, FS%, and mitral E/A ratio.
ª 2014 Elsevier B.V. All rights reserved.The Cavalier King Charles Spaniel (CKCS) breed
is known to be highly predisposed to develop
degenerative mitral valve disease (DMVD), with a
prevalence that may attain 100% in geriatric pop-
ulations.1e5 Based on the classification system
proposed by the American College of VeterinaryVeterinary Inter-
s spaniel
and Standard
valve disease
g
tum thickness at
tum thickness at
diastolic diameter
systolic diameter
wall thickness at
wall thickness atInternal Medicine (ACVIM) Consensus Statement on
DMVD and including 4 stages (A to D),6 all CKCS
(even those without a heart murmur) can be
assigned to stage A (i.e., are considered at high
risk for developing the disease). Therefore,
according to the ACVIM consensus recom-
mendations, CKCS should undergo yearly cardiac
screening as part of their regular health evalua-
tions.6 Standard transthoracic echocardiography is
currently considered as the non-invasive diag-
nostic method of choice for early detection of
DMVD-associated mitral valve lesions, evaluation
of mitral regurgitation severity, and for assessing
its impact on myocardial function and cardiac
remodeling (left atrial and ventricular dilation).7
However, for such a purpose, the measured echo-
cardiographic values need to be compared with
reference intervals (RI) established in healthy
dogs. Reference intervals are crucial for accurate
identification of the morphological and functional
cardiac changes associated with the disease. The
concept of RI is based on determining a set of
values within which 95% of the values of a partic-
ular variable in a population would fall.8 No spe-
cific recommendations for the determination of RI
are available in veterinary cardiology. The Ameri-
can Society of Veterinary Clinical Pathology advi-
ses adherence to the Clinical Laboratory and
Standard Institute (CLSI) recommendations9 and
has provided guidelines for the determination of
de novo RI in veterinary species.10
Due to the large variations in size and con-
formation within the canine population, significant
breed and body weight (BW) effects on echo-
cardiographic variables have been demonstrated,
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urements.11e13 Body weight independent differ-
ences among breeds have also been reported.11
For these reasons, the breed must be considered
when establishing echocardiographic RI in the
dog.11 Several methods have been proposed,
either for the overall canine population14e20 or in
specific breeds and breed categories.21e34 Some
studies also demonstrated an age and/or gender
effect on echocardiographic and Doppler varia-
bles, but the need to develop RI according to these
covariates remains unclear.22,24e26,28,31,33,34 How-
ever, to the best of our knowledge, no study has
focused on the determination of RI for echo-
cardiographic and conventional Doppler variables
in the CKCS breed.
The aims of this study were therefore (1) to
assess the potential effect of BW, age, and gender
on the most commonly used standard echocardio-
graphic and conventional Doppler variables in a
large population of clinically healthy adult CKCS,
and (2) to establish the corresponding RI according
to the statistical procedures recommended in the
CLSI guidelines.9Animals, material and methods
Animals
The case records of breeder- and client-owned
healthy adult (12 months) CKCS that pro-
spectively underwent a cardiac screening using a
standardized protocol at the Cardiology Unit of
Alfort (National Veterinary School of Alfort,
France) between March 2001 and January 2013
were reviewed. Dogs were considered healthy on
the basis of a complete physical examination. Dogs
with abnormal results in the physical examination
and those on medication were excluded from the
study.
Standard echocardiography and conven-
tional Doppler examinations
Standard echocardiography and conventional
Doppler examinations were performed by trained
observers, with at least 3 years of experience in
cardiology, in awake dogs gently restrained in
standing position, using continuous ECG monitoring
with an ultrasound unite equipped with 3S
(1.5e3.5 MHz), 5S (2.2e5 MHz), and 7S
(3.5e8 MHz) phased-array transducers, ase Vingmed system 5, Vivid 5, Vivid 7 dimension and Vivid 7 BT03,previously described and validated.35 Left ven-
tricular measurements were obtained using two-
dimensional (2D) guided M-mode as recom-
mended by the American Society of Echocardiog-
raphy,36 from the right parasternal
transventricular short-axis view. Measurements
were made of the LV end-diastolic (LVDd) and end-
systolic (LVDs) diameters as well as LV free wall
and interventricular septum thicknesses at end-
diastole (LVFWd and IVSd) and end-systole
(LVFWs and IVSs). For each M-mode echocardio-
graphic variable, a mean of 3 measurements was
determined from 3 consecutive cardiac cycles on
the same frame. The LV fractional shortening (FS%)
was then calculated. Measurements of the aortic
(Ao) and left atrium (LA) diameters were obtained
at end-diastole with a 2D method from the right
parasternal transaortic short axis view and using
the calipers position described by Hansson
et al.35,37 The LA/Ao ratio was then calculated.
The maximal systolic pulmonary and aortic flow
velocities were determined by pulsed-wave Dop-
pler using the right parasternal transaortic short
axis and left apical five-chamber views, respec-
tively. Early and late diastolic mitral inflow
velocities (mitral E and A waves) were also meas-
ured from the left apical four-chamber view, and
the E to A ratio was calculated. Finally, morphol-
ogy of the mitral valve apparatus was assessed and
color-flow Doppler examination was performed
using right and left apical four-chamber views in
order to exclude DMVD (i.e., thickening of mitral
valve leaflets and chordae tendineae and/or mitral
valve prolapse associated with mitral regur-
gitation). All other cardiac valves were also
assessed using both 2D and color-flow Doppler
modes. Mean heart rate was calculated by ECG
monitoring from the same cardiac cycles used for
the M-mode measurements.
Statistical analysis
Data were expressed as median and range. Outliers
were identified and RI determined by applying the
statistical procedures recommended by the CLSI
guidelines.9 Native and BoxeCox transformed data
were first tested for normality by use of the
Anderson-Darling test. Outliers were identified by
applying the Tukey method. When the data dis-
tribution remained non-Gaussian after BoxeCox
transformation, the values in both tails of the
distribution were subjected to visual inspection.
Effects of covariates (BW, age, and gender) on
standard echocardiographic and conventionalGeneral Electric Medical System, Waukesha, WI, USA.
Table 1 Median and ranges (minimumemaximum) of echocardiographic and Doppler variables in the whole study
population and according to gender (males and females).
All Males Females
Number of animals 134 62 72
Heart rate (beats/min) 120
(65e170)
120
(65e160)
120
(80e170)
Dimensional variables
LA (mm) 13.4
(9.7e19.7)
14.1
(11.0e19.7)
12.9
(9.7e17.8)
Ao (mm) 18.3
(14.3e23.9)
18.9
(15.6e23.4)
18.1
(14.3e23.9)
LA/Ao 0.74
(0.47e0.94)
0.76
(0.47e0.93)
0.72
(0.51e0.94)
LVDd (mm) 29.1
(21.4e41.1)
29.8
(23.3e41.1)
28.6
(21.4e34.7)
LVDs (mm) 17.6
(10.9e24.6)
18.8
(13.1e24.6)
16.8
(10.9e21.0)
LVFWd (mm) 6.4
(4.9e8.5)
6.4
(5.2e8.5)
6.3
(4.9e8.4)
LVFWs (mm) 10.8
(7.8e14.8)
10.9
(8.2e14.0)
10.6
(7.8e14.8)
IVSd (mm) 6.5
(4.8e8.8)
6.7
(4.8e8.8)
6.2
(4.8e8.2)
IVSs (mm) 10.1
(6.9e14.1)
10.4
(6.9e14.1)
10.0
(7.0e14.0)
Systolic function variables
FS (%) 39.1
(30.7e51.9)
38.3
(30.7e40.1)
41.1
(31.0e51.9)
Vmax Ao (m/s) 1.14
(0.75e1.71)
1.14
(0.80e1.71)
1.14
(0.75e1.70)
Vmax PA (m/s) 0.80
(0.50e1.56)
0.81
(0.50e1.56)
0.80
(0.55e1.10)
Diastolic function variables
E (m/s)* 0.72
(0.53e1.03)
0.76
(0.54e0.99)
0.72
(0.53e1.03)
A (m/s)* 0.50
(0.28e0.79)
0.50
(0.28e0.77)
0.50
(0.29e0.79)
E/A* 1.4
(1.5e2.4)
1.4
(1.1e2.4)
1.4
(1.0e2.2)
*Data available from 101 dogs (47 males and 54 females). LA: left atrium, Ao: Aorta, LA/Ao: left atrium/aorta ratio, LVDd and
LVDs: end-diastolic and end-systolic left ventricular diameters, respectively, LVFWd and LVFWs: end-diastolic and end-systolic
left ventricular free wall thicknesses, respectively, IVSd and IVSs: end-diastolic and end-systolic interventricular septum thick-
nesses, respectively, FS: fractional shortening, Vmax Ao and Vmax PA: systolic maximal aortic and pulmonary flow velocities,
respectively, E and A: mitral E and A wave velocities, respectively, E/A: mitral E/A ratio.
94 C. Misbach et al.Doppler variables were tested using a statistical
software packagef and the following linear mixed
effect model:
Y ¼ mþ Sexþ aAgeþ bBWþ ε;
where Y is the value of the echocardiographic
variable, m is a constant term, Age and BW are
continuous variables, a and b are the slope
coefficients for Age and BW, and ε is the residual
term of the model.f Systat version 8.0, SPSS Inc., Chicago, IL, USA.Reference intervals were defined as central
95% intervals bounded by the 2.5th and 97.5th
percentiles. The upper and lower limits of the RI
with their 90% confidence intervals (CI) were
determined in the global population by using a
non-parametric approach.38 When a significant
effect of a covariate on imaging variables was
found, the corresponding regression-based RIs
were built.38,39 A value of P < 0.05 was consid-
ered significant.
Table 2 Slope coefficients for the continuous variables (age and body weight) and differential effects for the
categorical variable (gender) in the model used for statistical analysis of echocardiographic and Doppler variables
assessed in the whole study population.
m Body weight Age Gender
Slope
coefficient
P value Slope
coefficient
P value Differential
effect
P value
Heart rate (beats/min) 107 e 0.109 e 0.134 e 0.695
Dimensional variables
LA (mm) 10.88 þ0.325 0.003 e 0.526 F: 0.395
M: þ0.395
0.018
Ao (mm) 14.02 þ0.438 <0.0001 þ0.175 0.008 e 0.100
LA/Ao 0.76 e 0.95 e 0.053 e 0.252
LVDd (mm) 20.52 þ0.987 <0.0001 e 0.952 F: 0.641
M: þ0.641
0.002
LVDs (mm) 13.66 þ0.493 <0.0001 e 0.297 F: 0.698
M: þ0.698
0.001
LVFWd (mm) 4.43 þ0.197 <0.0001 þ0.064 0.040 e 0.463
LVFWs (mm) 6.78 þ0.390 <0.0001 þ0.142 0.003 e 0.351
IVSd (mm) 5.55 þ0.102 0.032 e 0.383 F: 0.178
M: þ0.178
0.016
IVSs (mm) 7.31 þ0.244 0.002 þ0.171 0.003 e 0.233
Systolic function variables
FS (%) 34.8 e 0.153 e 0.187 F: þ1.168
M: 1.168
0.012
Vmax Ao (m/s) 0.78 þ0.039 0.001 e 0.361 e 0.471
Vmax PA (m/s) 0.61 þ0.026 0.003 e 0.290 e 0.725
Diastolic function variables
E (m/s)* 0.59 þ0.017 0.02 e 0.792 e 0.998
A (m/s)* 0.35 þ0.015 0.033 e 0.223 e 0.938
E/A* 1.58 e 0.975 e 0.08 e 0.974
*Data available from 101 dogs (47 males and 54 females). M: male, F: female, See Table 1 for remainder of key. The slope
coefficients and differential effects are only given when the effect is statistically significant. For example, the general regression
equation for interventricular end-diastolic septum (IVSd) in a female CKCS will be: IVSd (mm) ¼ 5.55  0.178 þ 0.102  body
weight (kg).
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A total of 134 healthy adult CKCS, 72 females and
62 males (age: 3.0 years [1.0e12.1]; BW: 8.7 kg
[6.0e14.5]), were included in the study. As inclu-
sion criteria, none of the 134 recruited dogs had
mitral valve lesions. Similarly, morphology of the
aortic, tricuspid, and pulmonary valves were con-
sidered normal. Physiologic minor tricuspid and/or
pulmonary regurgitations were detected in 94 out
of the 134 (70%) recruited dogs using color-flow
Doppler mode, whereas no aortic regurgitation
was found.
Heart rates and results for the 10 standard
echocardiographic and 5 conventional Doppler
variables in the whole study population and
according to gender are provided in Table 1.
As shown in Table 2, a statistically significant
effect of BW was observed for all variables
except FS%, LA/Ao, E/A, and heart rate. A sig-
nificant effect of gender and age was alsoobserved for 5/15 and 4/15 of the tested varia-
bles, respectively.
Eight of the 15 distributions of echocardio-
graphic variables tested for normality were Gaus-
sian. BoxeCox transformation yielded a Gaussian
distribution for the 2/7 remaining variables.
Application of the Tukey method revealed 3 outlier
dogs for the maximal systolic pulmonary flow
velocity variable, (i.e., values of 1.33, 1.37 and
1.56 m/s). Since echocardiography did not reveal
any abnormalities, these outliers were not exclu-
ded from the RI determination. The corresponding
lower and upper limits of RI for the 15 standard
echocardiographic and conventional Doppler vari-
ables tested, with 90% CI, are provided in Table 3.
Since only the BW effect on M-mode variables was
considered as clinically relevant (see Discussion
Section), regression-based RIs were built (Table
4). Finally, the M-mode echocardiographic refer-
ence intervals (2.5th and 97.5th percentiles)
established in the present study according to the
Table 3 Reference intervals (lower and upper limits with 90% confidence intervals) for the 15 standard echo-
cardiographic and conventional Doppler variables assessed in healthy adult Cavalier King Charles Spaniels (n ¼ 134)
and the corresponding within-day and between-day standard deviations obtained by a trained observer in a pre-
vious study.35
Lower limit
(90% confidence
interval)
Upper limit
(90% confidence
interval)
Within-day
SD
Between-day
SD
Dimensional variables
LA (mm) 10.1
(9.7e10.5)
17.6
(16.7e19.7)
e e
Ao (mm) 15.5
(14.3e15.9)
21.9
(21.5e23.9)
e e
LA/Ao 0.54
(0.47e0.56)
0.93
(0.90e0.94)
0.07 0.08
LVDd (mm) 23.4
(21.4e25.3)
35.6
(34.2e41.1)
1.74 2.51
LVDs (mm) 12.9
(10.9e13.8)
23.6
(21.4e24.6)
1.39 1.39
LVFWd (mm) 5.0
(4.9e5.3)
8.3
(7.9e8.5)
0.75 0.64
LVFWs (mm) 8.2
(7.8e8.8)
13.8
(13.2e14.8)
1.02 1.34
IVSd (mm) 5.1
(4.8e5.2)
8.3
(8.0e8.8)
0.84 0.34
IVSs (mm) 7.6
(6.9e8.1)
13.0
(12.5e14.1)
0.90 0.48
Systolic function variables
FS (%) 31
(30.7e31.6)
50.8
(49.1e51.9)
3.73 5.76
Vmax Ao (m/s) 0.80
(0.75e0.88)
1.62
(1.55e1.71)
e e
Vmax PA (m/s) 0.55
(0.50e0.61)
1.24
(1.06e1.56)
e e
Diastolic function variables
E (m/s)* 0.55
(0.53e0.57)
1.0
(0.93e1.03)
e e
A (m/s)* 0.32
(0.28e0.35)
0.76
(0.73e0.79)
e e
E/A* 1.04
(1.01e1.09)
2.17
(2.06e2.37)
e e
*Values calculated from 101 dogs (47 males and 54 females). SD: standard deviation. See Table 1 for remainder of key.
96 C. Misbach et al.CLSI guidelines9 and the predictive reference
intervals calculated in the same population using
Cornell’s formula20 (a  body weightb, with a and b
as covariates) are presented in Table 5.Discussion
Standard 2D and M-mode echocardiography com-
bined with conventional Doppler examination
plays a critical role in the initial and longitudinal
assessment of dogs affected by DMVD, providing
information on mitral valve anatomy, mitral
regurgitation severity and its hemodynamic con-
sequences on left heart size and function, as wellas cardiac and vascular pressures.7 The well-
known predisposition of the CKCS breed to
DMVD1e5 led us to determine specific RI for the
most commonly used standard echocardiographic
and conventional Doppler variables in a population
of healthy adult CKCS. The major strengths of this
study were as follows: (1) the reference sample
group was quite large (i.e., n ¼ 134 healthy adult
CKCS), with a balanced male/female ratio
(ratio ¼ 0.86), and a relatively wide range of age
(1.0e12.1 years) and BW (6.0e14.5 kg); (2) the RI
were determined according to the statistical pro-
cedures recommended in the CLSI guidelines9; and
(3) the imaging variables tested here are of clinical
interest, especially with regard to the
Table 5 M-mode echocardiographic reference intervals (2.5th and 97.5th percentiles) from 134 healthy adult
Cavalier King Charles Spaniels determined according to the Clinical and Laboratory Standards Institute (CLSI)
statistical procedures (A),9 and predictive reference intervals calculated in the same population using Cornell’s
formula (B).20
M-mode echocardiographic variable A B
LVDd (mm) 23.4e35.6 21.5e40.6
LVDs (mm) 12.9e23.6 12.0e27.7
LVFWd (mm) 5.0e8.3 4.9e13.2
LVFWs (mm) 8.2e13.8 8.1e19.1
IVSd (mm) 5.1e8.3 4.9e13.0
IVSs (mm) 7.6e13.0 7.3e17.3
See Table 1 for remainder of key.
Table 4 Predicted regression-based reference intervals (lower and upper limits) according to body weight for the
6 M-mode variables with a significant body weight effect assessed in a population of healthy adult Cavalier King
Charles Spaniels (n ¼ 134).
Body weight
(kg)
LVDd
(mm)
LVDs
(mm)
LVFWd
(mm)
LVFWs
(mm)
IVSd
(mm)
IVSs
(mm)
5 20.2e29.8 10.6e20.3 4.0e7.0 6.6e11.3 4.3e7.7 6.0e11.6
6 21.3e30.9 11.2e20.8 4.2e7.3 7.1e11.7 4.5e7.8 6.4e11.9
7 22.5e31.9 11.8e21.3 4.5e7.5 7.6e12.2 4.6e7.9 6.7e12.2
8 23.6e33.0 12.3e21.9 4.7e7.7 8.1e12.6 4.8e8.1 7.1e12.5
9 24.6e34.1 12.9e22.4 4.9e7.9 8.5e13.1 4.9e8.2 7.4e12.9
10 25.8e35.2 13.5e23.0 5.2e8.1 9.0e13.5 5.1e8.3 7.7e13.2
11 26.8e36.3 14.0e23.6 5.4e8.4 9.4e14.0 5.2e8.5 8.0e13.5
12 27.8e37.4 14.5e24.1 5.6e8.6 9.9e14.5 5.3e8.6 8.3e13.9
13 28.8e38.5 15.0e24.7 5.8e8.8 10.3e14.9 5.4e8.8 8.6e14.2
kg: kilograms, See Table 1 for remainder of key.
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lead to LA and LV dilation as well as myocardial
dysfunction. Additionally, some of the tested
echo-Doppler variables have been shown to be
related to clinical outcome in DMVD dogs. For
example, the high prognostic value of the degree
of LA dilation, as assessed by the LA/Ao ratio, has
been demonstrated in both symptomatic and
asymptomatic dogs with DMVD.7,40e45 Similarly, a
high velocity mitral E wave has been shown to be
associated with a higher risk of death or decom-
pensation in dogs with DMVD.41,42,45
In the present study, although all the M-mode
echocardiographic RI established according to the
CLSI guidelines were within the predictive RI cal-
culated using Cornell’s formula,20 all were more
narrow compared to the latter, as illustrated by
the end-diastolic LVFW (i.e., 5.0e8.3 mm in the
present study versus 4.9e13.2 mm with Cornell’s
formula). In accordance with Morrison et al.,11
these results suggest that not only the BW but
also the somatotype should be considered when
establishing echocardiographic measurement RI in
the dog.Another objective of the present study was to
assess the effect of covariates (i.e., BW, age, and
gender) on the standard echocardiographic and
conventional Doppler variables tested. A sig-
nificant BW effect was observed for all variables
except the 3 M-mode, 2D, and Doppler ratios,
i.e., FS%, LA/Ao, and E/A respectively, the latter
2 being the sole variables not significantly affec-
ted by any of the tested covariates. Unlike these
ratios, all imaging variables (n ¼ 12) were sig-
nificantly affected by BW as well as gender (4/12)
and/or age (4/12). These results are in accord-
ance with most echocardiographic studies which
focussed on specific breeds and included the CKCS
breed, and showed that BW is significantly cor-
related with most M-mode LV measurements, but
not with LA/Ao.22,24e26,29,34 Nevertheless, the
clinical relevance of these results needs to be
discussed with regard to the observers’ varia-
bility.35 Using the general linear model (see Table
2), if BW is increased by 4 kg, the IVS and LVFW
thicknesses will be increased by 0.41 and 0.79 mm
in diastole, and by 0.98 and 1.56 mm in systole,
respectively. These differences are higher than
98 C. Misbach et al.the between-day standard deviations assessed by
our group for a trained observer (i.e., 0.34 mm,
0.64 mm, 0.48 mm, and 1.34 mm, respectively),35
and therefore can be considered as clinically
relevant. Similarly, for a 4 kg BW increase, the
LVDd and LVDs will be increased by 3.95 mm and
1.97 mm, respectively (with corresponding
between-day standard deviations of 2.51 mm and
1.39 mm, respectively). Conversely, the statisti-
cally significant effect of gender on LVDd, LVDs,
and IVSd can be considered as clinically negli-
gible, as demonstrated by the low slope coef-
ficients (0.641, 0.698, 0.178) in comparison to the
corresponding between-day standard deviations
(2.51, 1.39, 0.34). A similar rationale can be
applied to the statistically significant age effect
on the 3 M-mode variables, i.e., LVFWd, LVFWs,
and IVSs. For example, when age is increased by 8
years, the LVFWd and LVFWs will be increased by
less than the corresponding between-day stand-
ard deviations, except for IVSs, which is never-
theless not considered as the most relevant
variable for assessing canine DMVD. Lastly, no
significant effect of covariates on the 4 Doppler
variables was found, except for BW. Nevertheless,
this BW effect can also be considered negligible,
as a 4 kg BW increase will only increase peak
velocities from 0.06 m/s to 0.15 m/s. It has been
recently advocated that the decision to partition
an RI into subclasses according to covariates
should not only be made on the basis of statistical
concepts, but also if physiologic differences are
expected to result in important clinical differ-
ences in RI.46 According to the results of the
present study, it can therefore be assumed that
only BW should be taken into account when
interpreting M-mode echocardiograms in the CKCS
breed. Therefore, the use of regression-based RIs
according to BW were proposed for the 6 M-mode
variables.47
This study presents several limitations. Firstly,
the present study allowed determination of ‘ref-
erence limits’ (i.e., the 2.5th or 97.5th percentiles
bounding the RI) and the corresponding 90% CI in a
healthy population of CKCS. The ‘decision limits’,
that is to say predetermined thresholds that help
distinguish 2 populations, should be further
defined by consensus and based on investigations
on individuals with and without a specific disease
or conditions. Moreover, an RI should be inter-
preted in light of each observer’s variability, which
should ideally be assessed for the considered
breed, which was not the case in the present
study. Another limitation is that the study pop-
ulation was relatively young (i.e., median age of 3
years), as most recruited CKCS were breeder-owned dogs that underwent cardiac screening
before mating. For this reason, the effect of age
on the tested variables could have been under-
estimated, especially for mitral flow velocities,
which have been demonstrated to be modified
with age, particularly in dogs >6 years old.48 On
the other hand, screening for cardiac diseases in
CKCS is often performed in young adult dogs.1,49
Another limitation is that the body condition
score of the 134 recruited dogs was not assessed,
and not only BW per se, but also body size may
have influenced some of the present results.
Moreover, the LA and Ao diameters were both
assessed from 2D frames at a specific phase of the
cardiac cycle, i.e., at end-diastole. Therefore, and
as for the 15 variables assessed in the present
study, the corresponding RI cannot not be applied
to measurements obtained using another method-
ology (i.e., at another time of the cardiac cycle,
from another view or using another mode). A fur-
ther limitation is that the E and A mitral flow
velocities and the E/A ratio were only recorded in
101/134 dogs, because cardiac screening protocols
for CKCS only began to systematically include
these Doppler variables in 2006. The CLSI guide-
lines recommend that when using the non-
parametric approach to determine RI, the sample
size should ideally be > 120 subjects, which was
not the case for these 3 variables.
In conclusion, although predictive RI assessed
according to Cornell’s formula seem to be
acceptable for CKCS dogs, the present results
suggest that establishing specific RI for echo-
cardiographic and Doppler variables in this breed is
relevant. The present report provides RI for
standard echocardiographic and conventional
Doppler variables, and demonstrates a statistically
significant and clinically relevant BW effect on M-
mode echocardiographic variables including end-
diastolic and end-systolic LV wall thicknesses and
diameters. Body weight should therefore be con-
sidered when interpreting echocardiographic val-
ues in CKCS, except for the 2 2D and M-mode
ratios, i.e., LA/Ao and FS% respectively. Further
prospective investigations in larger populations,
with wider ranges of ages, and including more
variables of interest (i.e., LV volumes, right
chambers dimensions) are needed to better
determine ultrasound-derived cardiovascular
imaging RIs within the CKCS breed.Conflict of interest
None.
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